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Abstract 
 
 
Regulation of the transition between motile planktonic and sessile biofilm-
associated lifestyles in Pseudomonas aeruginosa 
 
Many bacteria are able to adopt two fundamentally different lifestyles. While the planktonic 
mode of growth enables dissemination and exploration of novel niches, growing within 
multicellular, matrix-encased biofilms offers protection and survival in unfavorable 
environments. 
The aim of this thesis was to elucidate how the opportunistic pathogen Pseudomonas 
aeruginosa integrates and translates extra- and intracellular signals to regulate the transition 
between motile and sessile lifestyles in order to give an appropriate response to a changing 
environment. In this context, we characterized the chemotaxis methyltransferase CheR1 and 
demonstrated that its activity is not only essential for flagella-mediated chemotaxis but that it 
is also important for the formation and maintenance of biofilm structures. Another aim of this 
thesis was the identification of proteins that bind the small di-nucleotide c-di-GMP – an 
important bacterial second messenger which governs the switch between motility and 
sessility. We used immobilized c-di-GMP to perform affinity pull down experiments in which 
isolated proteins were identified by high-resolution mass spectrometry. This chemical 
proteomics approach proved to be sufficient for the isolation of c-di-GMP binding proteins 
harboring known but also novel c-di-GMP binding motifs in the model organism 
P. aeruginosa. To understand how environmental cues can influence bacterial behavior at the 
level of transcription, we identified the global regulon of the stationary phase sigma factor 
RpoS by performing chromatin immunoprecipitation experiments in combination with DNA-
microarray analysis. Our results provide evidence that RpoS controls transcription of genes 
directly linked to biofilm formation but also of genes encoding components of other 
regulatory systems that trigger the formation of biofilms. Overall, this thesis contributes to 
our understanding of adaptive pathways leading to the development and maintenance of 
bacterial biofilms. 
 
 VIII 
Zusammenfassung 
 
 
Regulierung des Übergangs zwischen motilen planktonischen und sessilen 
Biofilm-assoziierten Lebensweisen in Pseudomonas aeruginosa 
 
Viele Bakterien können zwei völlig verschiedene Lebensweisen annehmen. Während 
planktonisches Wachstum die Ausbreitung in neue Nischen ermöglicht, bietet Wachstum in 
multizellulären, matrixumhüllten Biofilmen Überlebensvorteile in widrigen Umgebungen. 
Ziel dieser Arbeit war es zu erforschen, wie der opportunistische Krankheitserreger 
Pseudomonas aeruginosa extra- und intrazelluläre Signale übersetzt, um den Übergang 
zwischen motilen und sessilen Lebensstilen zu regulieren und besser auf eine sich 
verändernde Umgebung zu reagieren. In diesem Zusammenhang haben wir die 
Chemotaxismethyltransferase CheR1 charakterisiert und konnten zeigen, dass ihre Aktivität 
nicht nur wichtig für flagellenvermittelte Chemotaxis ist, sondern auch für die Ausbildung 
und Strukturierung von Biofilmen. Ein weiteres Ziel dieser Arbeit war es, Proteine zu 
identifizieren, die c-di-GMP binden – einen wichtigen bakteriellen sekundären Botenstoff, der 
den Übergang zwischen Motilität und Sessilität steuert. Immobilisiertes c-di-GMP wurde als 
Affinitätsmatrix genutzt, um aus komplexen Proteingemischen c-di-GMP-Bindepartner zu 
isolieren. Die sich anschließende Massenspektrometrieanalyse zur Identifizierung der 
angereicherten Proteine ergab, dass nicht nur Proteine mit bereits bekannten sondern auch mit 
neuartigen c-di-GMP-Bindemotiven erfolgreich isoliert wurden. Mit dem Ziel zu verstehen, 
wie Umweltsignale bakterielles Verhalten auf der Ebene der Transkription beeinflussen, 
haben wir das globale Regulon des alternativen Sigmafaktors RpoS mit Hilfe von 
Immunopräzipitationsexperimenten in Verbindung mit DNA-Microarray-Analysen 
aufgeklärt. Unsere Ergebnisse zeigten, dass RpoS nicht nur die Transkription von Genen 
kontrolliert, die direkt mit der Bildung von Biofilmen zusammenhängen, sondern auch von 
Genen die Bestandteil anderer Biofilm-regulierender Systeme sind. Insgesamt trägt diese 
Arbeit zu unserem Verständnis bei, auf welchen Wegen Biofilme gebildet und erhalten 
werden. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dass ich erkenne, was die Welt 
im Innersten zusammen hält. 
 
- Faust - 
(J. W. v. Goethe) 
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1. Introduction   1 
1 Introduction 
1.1 The bacterial way of life 
More than 300 years ago, the fabrication and use of microscopes enabled the discovery of the 
microbial universe. One of the major discoverers was the Dutch draper Antoni van 
Leeuwenhoek who observed swimming bacteria – which he called animalcules – by the use of 
a simple single-lens microscope [1]. In the following centuries, extensive studies were carried 
out with regards to how bacteria move and how they are able to respond to chemical stimuli in 
their environment (reviewed by H. C. Berg, 1975 [2]). However, in the second half of the 20th 
century, it became evident that bacteria can adopt a lifestyle that is profoundly distinct from 
the planktonic, free-living lifestyle studied so far: that is growth within structured, surface-
associated bacterial communities commonly known as biofilms. In fact, biofilm communities 
represent not only the predominant mode of bacterial growth in the environment [3], but 
largely impact industry and human health as well [4, 5]. It has been estimated that up to 80% 
of the bacterial infections in industrialized countries are biofilm-associated infections, 
refractory to antimicrobial therapy [6]. In order to develop novel strategies for biofilm control, 
it is critical to understand the adaptive pathways leading to the development and maintenance 
of bacterial biofilms. 
 
1.2 Pseudomonas aeruginosa as a model organism 
The gram-negative γ-proteobacterium Pseudomonas aeruginosa has become one of the most-
studied model organisms in biofilm research. This ubiquitous environmental bacterium is able 
to thrive in a wide variety of natural habitats. Moreover, it is an opportunistic human 
pathogen and a significant source of life-threatening nosocomial infections [7]. P. aeruginosa 
can cause severe acute infections which are characterized by the use of a large arsenal of 
virulence factors [8]. On the other hand, P. aeruginosa is able to produce chronic infections, 
in which bacteria adapt to their environment, survive within biofilms, and persist in their host 
for years [9, 10]. The remarkable adaptability of P. aeruginosa is enabled by its large genetic 
diversity. Analysis of the complete genome sequence of the P. aeruginosa strain PA01 (6.3 
million base pairs) revealed 5570 predicted open reading frames (ORFs) [11]. Approximately 
10% of the identified genes are encoding for transcriptional regulators, sigma factors or two-
component regulatory systems [11] allowing P. aeruginosa to respond to a wide range of 
environmental conditions. 
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1.3 Principles of motility and chemotaxis 
P. aeruginosa is capable to explore its environment by three types of motility. Swimming in 
aqueous surroundings is enabled by the rotation of a single, polar flagellum. Twitching 
motility allows the translocation over wet surfaces in a flagellum-independent way by using 
polar type IV pili which extend, attach and retract [12, 13]. In addition, P. aeruginosa is 
capable of swarming, which is a rapid and coordinated group movement over semisolid 
surfaces and requires both, flagella and type IV pili [14, 15]. 
Motile bacteria can sense changes in the concentration of chemicals in their surroundings and 
are able to bias their movement towards a more favorable environment. This chemotactic 
response is achieved by modulating the frequency of changes in swimming direction. While 
peritrichously flagellated bacteria, such as Escherichia coli and Salmonella enterica serovar 
Typhimurium, move by “running” and active “tumbling” that reorients the cells, 
monotrichous bacteria exhibit a run/short back-up/run mode of swimming [2, 16, 17]. The 
two behaviors “run” and “tumble/back-up” are caused by the direction of flagellar rotation 
switching between clockwise (tumble/back-up) and counterclockwise (run) rotation. 
 
1.3.1 The chemotaxis system of E. coli 
The molecular mechanisms underlying bacterial chemotaxis have been studied most 
extensively in E. coli and S. Typhimurium [18, 19]. Chemotactic ligands are detected by cell 
surface chemoreceptors called methyl-accepting chemotaxis proteins (MCPs). Several 
homologous transmembrane receptors (MCPs) sense extracellular stimuli and produce signals 
that are transmitted to their cytoplasmic domains. This signal transduction impacts via the 
adaptor protein CheW on the associated CheA/CheY two-component system, in which CheA 
is the sensor kinase that phosphorylates the response regulator CheY. Activated CheY-P 
localizes to flagellar motor complexes and, upon interaction with the rotational switch protein 
FliM, causes a switch from counterclockwise rotation (run) to clockwise rotation (tumble) 
[20, 21]. The phosphorylation status of CheY is also controlled by the protein phosphatase 
CheZ, which enhances dephosphorylation of CheY-P. Upon binding of attractants, the kinase 
activity of CheA is reduced, which promotes the bacterial running mode, whereas the binding 
of repellents increases CheA activity - hence tumbling. The effect of ligand binding is 
counterbalanced by reversible MCP methylation, providing the ability to detect chemical 
changes over time. Thereby, the opposing activities of two specific enzymes, CheR, a 
methyltransferase, and CheB, a methylesterase, control the MCP methylation level. CheR 
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converts specific glutamic acid residues in the MCP cytoplasmic domain to glutamyl methyl 
esters, using S-adenosylmethionine (SAM) as the methyl donor [22]. CheB hydrolyses those 
methylated residues, releasing methanol and restoring glutamic acid [23]. CheR activity is 
unregulated, whereas CheB is another response regulator that becomes phosphorylated by 
CheA [24]. 
 
1.3.2 P. aeruginosa has multiple chemotaxis systems 
Studies of chemotaxis and MCP methylation in other organisms have revealed both 
similarities and differences to the E. coli/S. Typhimurium chemotaxis pathway [25-30]. 
Whole genome sequencing has demonstrated that many bacteria possess multiple paralogs of 
chemotaxis (che) genes which are often organized into independent systems [31]. Sequence 
analysis of the P. aeruginosa PA01 genome revealed a very complex chemosensory system 
with more than 20 che genes in five distinct clusters and 26 mcp-like genes (Figure 1.1) [11].  
Cluster I and V (Che1 system) and cluster II (Che2 system) have been implicated in flagella-
mediated chemotaxis [32-35]. Each of those che gene products is homologous to an E. coli 
Che protein [33], with the exception of CheD (encoded in cluster II) and CheV (encoded in 
cluster V), that cannot be found in E. coli but e.g. in Bacillus subtilis. In this organism, CheD 
is a receptor deamidase that converts specific glutamines to glutamates, but also regulates the 
kinase activity of CheA [26]. The B. subtilis CheV protein is, like CheW, an adaptor protein 
that is additionally involved in the adaptation process [26]. 
The two remaining P. aeruginosa che clusters encode chemotaxis systems that are unrelated 
to flagellar motility. The Pil-Chp system (encoded by cluster IV) has been shown to regulate 
type IV pili biosynthesis and twitching motility [36-38], whereas the Wsp system (encoded by 
cluster III) is involved in biofilm formation [39, 40]. 
Among the 26 MCPs of P. aeruginosa, nine have been identified as MCPs for amino acids, 
inorganic phosphate, oxygen, ethylene and volatile chlorinated aliphatic hydrocarbons [41], 
whereas 3 MCPs were demonstrated to be involved in type IV pili production and function, 
[42] and in biofilm formation [39, 43]. 
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1.4 Living within biofilms 
In environments that provide a little moisture and some nutrients, P. aeruginosa readily 
adheres to available surfaces to form sessile, matrix-enclosed biofilm communities. The 
biofilm mode of growth offers a competitive advantage over free-swimming individual cells, 
as the bacteria are protected from environmental stress (e.g. UV radiation [44], heavy metal 
toxicity [45], dehydration [46]) and from biological and chemical antibacterial agents [4, 47]. 
One key feature of the biofilm community is the self-produced, heterogeneous matrix which 
facilitates adhesion to the surface, forms the scaffold for the three dimensional architecture of 
the biofilm and acts as a protective shield. It consists of extracellular polymeric substances 
(referred to as EPS) including polysaccharides, proteins, lipids and extracellular DNA [48]. 
The structure of mature biofilms is not only determined by the composition of the EPS matrix, 
 
 
Figure 1.1. Overview of the complex chemotaxis systems of P. aeruginosa. 
(A) Distribution of putative mcp genes (outside the circle) and che gene clusters (inside the circle) on the 
genome of P. aeruginosa PA01. The mcp genes which have been characterized are underlined. (B) Genetic 
organization of the five distinct Che clusters. A, B, R, W, and Y in parentheses denote homologs of cheA, cheB, 
cheR, cheW and cheY, respectively. Modified from Kato et al. [41]. 
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but also depends on hydrodynamic conditions, nutrient conditions and cell-to-cell 
communication (“quorum sensing”). The resulting biofilm architecture can be filamentous, or 
smooth and flat or highly structured with mushroom-like macrocolonies that are separated by 
open water channels [5, 48, 49]. 
The formation of complex biofilm structures is a sequential process and involves several 
stages [50]. In the beginning, individual cells reversibly attach to a surface, followed by 
robust adhesion. Then cells aggregate to form microcolonies and further mature into complex 
biofilm structures, in which bacteria adapt to the conditions in their particular niches. From 
the established biofilm, individual cells are released and return to the planktonic mode of 
growth so that new habitats can be colonized with new biofilms. 
So far, research on global gene or protein biofilm expression patterns has not succeeded in the 
identification of a specific developmental biofilm program. New knowledge about 
mechanisms involved in biofilm formation has recently been obtained by the use of optical 
tools to monitor in vitro grown biofilms. From these studies, it has become evident that 
motility can have a profound impact on the colonization of surfaces [51-55]. However, the 
impact of chemotaxis on the formation of biofilms has been less intensively studied. While in 
E. coli chemotaxis seems to be dispensable for biofilm formation, there is evidence for the 
impact of chemotaxis on surface interactions and biofilm formation in other bacterial species 
[53, 56-58]. Given the different nature of the chemotactic system in the enteric bacteria and 
other environmental motile bacteria, it is not surprising that the role chemotaxis plays in 
biofilm development is quite distinct. 
 
1.5 C-di-GMP: the lifestyle switch 
The choice to settle down or move away is an important decision to be made by 
microorganisms, and requires the integration of many environmental cues into a sophisticated 
regulatory network. One key regulator for the switch between the motile planktonic and the 
sessile biofilm-associated lifestyle is the bacterial second messenger bis-(3'-5')-cyclic di-GMP 
(c-di-GMP) [59-61] (Figure 1.2). While low levels of this intracellular signaling molecule are 
known to promote motility, high c-di-GMP levels trigger the production of exopoly-
saccharides and biofilm formation. The intracellular c-di-GMP level is thereby tightly 
controlled by the opposing activities of two classes of enzymes, diguanylate cyclases (DGCs) 
and phosphodiesterases (PDEs) [62-67]. DGCs contain a conserved GGDEF domain and 
convert two molecules of GTP into a single c-di-GMP molecule. A common feature of most 
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DGCs is an allosteric feedback inhibition, as binding of c-di-GMP to an I-site motif within the 
GGDEF domain inhibits enzymatic activity [68, 69]. The break down of c-di-GMP to pGpG 
or two molecules GMP is mediated by PDEs harboring an EAL or, less common, an HD-GYP 
domain. 
In many cases, GGDEF and EAL/HD-GYP domains are fused to transmembrane or signal-
sensing partner domains which enables post-translational regulation of the enzymatic activity 
by environmental or cellular cues [71, 72]. Common partner domains are the small molecule-
binding PAS domain [73], the two-component receiver (REC) domain, the HAMP domain 
which is commonly found in signal-sensing histidine kinases [74] and the GAF domain which 
may bind nucleotides [75]. Until now, only a few signals which are sensed by these domains 
 
 
 
Figure 1.2. Components of c-di-GMP signaling pathways. 
C-di-GMP is synthesized from 2 GTP by diguanylate cyclases (DGC) which carry catalytic GGDEF domains. 
C-di-GMP is hydrolyzed to pGpG and/or GMP by phosphodiesterases (PDE) which carry catalytic EAL or 
HD-GYP domains. DGC and PDE activity is influenced by cellular and environmental signals that are sensed by 
associated partner domains (not shown). Most DGCs are prone to allosteric feedback inhibition which involves 
binding of c-di-GMP to a secondary site (I-site) within the GGDEF domain. By binding to diverse effector 
molecules, c-di-GMP inhibits cell motility and traits associated with bacterial virulence while sessility and 
biofilm formation is promoted. This figure is based on previous published models [59, 70]. 
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and which affect DGC or PDE activity have been identified, for example, oxygen, blue light 
and antibiotics [60, 76]. 
Additionally, knowledge of factors involved in the translation of intracellular c-di-GMP levels 
into bacterial behavior on the single cell level, still remains limited. So far, only few classes of 
c-di-GMP effectors are known. The best-studied class are proteins harboring a PilZ domain 
[59, 70]. Initially discovered by an bioinformatic approach [77], the PilZ domain is known to 
bind c-di-GMP and to impact virulence [78], flagellar motility [79-81] and the production of 
exopolysaccharides [82, 83]. Another class of c-di-GMP binding proteins are proteins that 
contain degenerate GGDEF or EAL domains, which have lost their enzymatic activity. For 
example, the PopA protein from Caulobacter crescentus has a catalytically inert GGDEF 
domain with an intact secondary c-di-GMP binding motif (I-site). Upon c-di-GMP binding, 
PopA localizes to the cell pole where it facilitates the degradation of the master cell cycle 
regulator CtrA [84]. In P. fluorescence, the catalytically inactive GGDEF-EAL hybrid protein 
LapD communicates intracellular c-di-GMP levels to the membrane-localized attachment 
machinery upon binding of c-di-GMP to its degenerate EAL domain [85-87]. The third class 
of c-di-GMP effector molecules are transcriptional regulators, including FleQ from 
P. aeruginosa [88], Clp from Xanthomonas axonopodis pv. citri and X. campestris pv. 
campestris [89-91], and VpsT from Vibrio cholerae [92]. However, these transcription factors 
do not share a common domain organization or c-di-GMP binding motif. Finally, conserved 
RNA domains (GEMM), which reside in 5'-untranslated regions of different mRNAs, have 
been shown to be c-di-GMP targets and to affect gene expression by functioning as 
riboswitches [93, 94]. Although c-di-GMP controlled riboswitches were found in several 
organisms, for example in V. cholerae, Bacillus cereus and Clostridium difficile, the 
conserved GEMM RNA binding motifs are absent in most species. In addition, there are 
many bacterial species, which encode functional GGDEF and EAL proteins but no proteins 
harboring PilZ domains. 
 
1.5.1 C-di-GMP signaling in P. aeruginosa 
GGDEF, EAL and PilZ domain proteins are widely distributed across the prokaryotic 
kingdom [71, 72, 77]. While some organisms tend to have only a few or no GGDEF or EAL 
proteins, other organisms encode multiple copies of those c-di-GMP metabolizing enzymes. 
The genome of P. aeruginosa strain PA01 encodes 17 proteins with a GGDEF domain, 5 
proteins with an EAL domain and 16 “hybrid” proteins that contain both a GGDEF and an 
EAL domain (listed in the appendix, Table 5.1) [62]. Furthermore, three genes encode 
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proteins with an HD-GYP domain [95]. Some of these proteins have been shown to be 
enzymatically active, while others seem to be degenerate or are still uncharacterized (for 
references see Table 5.1). One of the best characterized examples is the diguanylate cyclase 
WspR. In addition to its conserved GGDEF domain, WspR carries an N-terminal receiver 
domain and is part of the above mentioned Wsp chemotaxis-like system (see chapter 1.3.2). 
Upon phosphorylation by the WspE histidine kinase, WspR becomes active and produces a 
localized pool of c-di-GMP that triggers the production of the Pel and Psl exopolysaccharides 
and biofilm formation [32, 39]. 
One possibility of how the c-di-GMP level produced by WspR might be translated into an 
enhanced expression of the psl and pel genes is via the transcriptional regulator FleQ. 
Recently, Hickman and Harwood [88] demonstrated that c-di-GMP binds to FleQ and causes 
a derepression of pel and psl transcription. However, the exact FleQ binding site of c-di-GMP 
has not yet been identified. 
P. aeruginosa encodes a total of eight PilZ domain containing proteins (listed in Table 1.1). 
All but one of them, PA2960 (PilZ), were shown to bind c-di-GMP [82]. The PilZ domain 
protein Alg44 is involved in the biosynthesis of the exopolysaccharide alginate [82], but the 
molecular function of the remaining c-di-GMP binding PilZ domain proteins is still unknown. 
Two other proteins of P. aeruginosa have been demonstrated to bind c-di-GMP: the PelD 
protein is required for Pel exopolysaccharide production and exhibits secondary structure 
similarities to the I-site of DGCs [98]. FimX is a protein that governs twitching motility and 
Table 1.1. C-di-GMP binding proteins of P. aeruginosa. 
PA number Gene name Domainsa C-di-GMP binding site 
Selected 
references 
PA0012  PilZ PilZ domain [82] 
PA2799  PilZ PilZ domain [82] 
PA2960 pilZ PilZ -b [82, 96] 
PA2989  PilZ PilZ domain [82] 
PA3353  YcgR, PilZ PilZ domain [82] 
PA3542 alg44 TM, PilZ PilZ domain [82] 
PA4324  PilZ PilZ domain [82] 
PA4608  PilZ PilZ domain [82, 97] 
PA1097 fleQ FleQ, AAA σ54 interaction 
domain, HTH 
unknown [88] 
PA3061 pelD TM I-site like [98] 
PA4959 fimX REC, degenerate GGDEF, 
degenerate EAL 
EAL domain [99] 
a
 TM, transmembrane; HTH, helix-turn-helix; REC, receiver 
b no c-di-GMP binding demonstrated so far 
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that has lost enzymatic activity of its degenerate GGDEF and EAL domains, however, the 
inactive EAL domain has retained its c-di-GMP binding ability [99]. 
Overall, the c-di-GMP signaling network of P. aeruginosa and many other bacterial 
organisms is highly complex. As many genomes encode numerous c-di-GMP metabolizing 
and binding proteins, the question arises of how specificity within the signaling system is 
achieved. One answer might be the spatial separation of multiple c-di-GMP pathways by 
sequestration of c-di-GMP modulating proteins to different subcellular localizations where 
they create and respond to discrete, localized c-di-GMP pools. Thereby, some c-di-GMP 
metabolizing proteins might first require the perception of certain environmental signals via 
associated partner domains, before any c-di-GMP synthesizing or degrading activity is 
conducted. Furthermore, the separation of distinct c-di-GMP signaling systems can be 
achieved by tightly controlling the expression of subsets of c-di-GMP related genes in 
response to different environmental conditions. For example, a recent study by Weber et al. 
demonstrated that seven of the 29 GGDEF/EAL genes in E. coli depend on the alternative 
sigma factor RpoS – the master regulator of the general stress response [100]. Systematic 
approaches need to be applied in order to understand how environmental signals and global 
regulators control the c-di-GMP signaling network enabling a specific output response of the 
bacterial cell. 
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1.6 Aims of the thesis 
Biofilms constitute the predominant mode of bacterial growth and allow survival in hostile 
environments such as the human host. They have been associated with chronic and device-
related infections, and are a major challenge for clinicians due to their inherent resistance to 
antibiotic therapy and host defense mechanisms. In order to control such biofilm infections, it 
is important to understand the genetic and molecular basis of this bacterial community 
behavior. 
Various studies have demonstrated that motility, including swimming, swarming and 
twitching, seems to play an important role in the surface colonization and establishment of 
structured biofilms. Thereby, the impact of chemotaxis on biofilm formation has been less 
intensively studied. Another important factor for the transition between motile and sessile 
lifestyles is the bacterial second messenger c-di-GMP. Despite extensive research, many 
details of the complex c-di-GMP signaling network are still uncharacterized. One major area 
of interest is understanding the mechanisms by which c-di-GMP exerts its effects. Although 
some protein and RNA-based c-di-GMP targets have been identified, the fact that numerous 
cellular functions are regulated by c-di-GMP, calls for further classes of c-di-GMP effectors.  
 
In this thesis, we aimed at the characterization of the P. aeruginosa chemotaxis 
methyltransferase CheR1, and the investigation of a potential role in biofilm formation. 
Another main focus was to identify novel c-di-GMP binding proteins by applying a chemical 
proteomics approach using a c-di-GMP affinity resin as an enrichment tool in combination 
with high-resolution mass spectrometry. To understand how environmental signals can impact 
c-di-GMP signaling at the level of transcription, we furthermore aimed at the elucidation of 
the regulon of the alternative stationary phase sigma factor RpoS by performing chromatin 
immunoprecipitation experiments in conjunction with DNA-microarray analysis (ChIP-chip). 
The overall aim was to increase knowledge of how P. aeruginosa regulates the transition 
between motile planktonic and sessile biofilm-associated lifestyles in response to growth 
conditions and the sensing of diverse signals from the environment. 
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2 Materials and Methods 
2.1 Bacterial strains, plasmids and growth conditions 
The bacterial strains and plasmids used in this study are listed Table 2.1 and Table 2.2, 
respectively. All strains were maintained at -70°C as 15% (v/v) glycerol stocks. Escherichia 
coli strain DH5α was used for all cloning steps, strain BL21 (DE3) for protein overexpression 
and strain S17-1 for conjugative DNA transfer. 
Research on Pseudomonas aeruginosa was carried out using the well-established and 
sequenced PA01 and PA14 strains. P. aeruginosa transposon mutants were purchased from 
the Washington Genome Center PA01 mutant library [101] and the NR PA14 transposon 
mutant library [102], respectively. Of note, world-wide, diverse PA01 sublines have evolved 
from the original PA01 strain, displaying different pheno- and genotypes [103]. For example, 
the PA01 wild-type delivered together with the “Washington” transposon mutants is impaired 
in its twitching motility (own observations). Thus, we chose the transposon mutant 
P. aeruginosa PA01 PA4684, ID 8031, as wild-type control (PA01 wt control) in phenotypic 
characterization assays. The open reading frame (ORF) PA4684 is most likely coding for a 
non-functional gene product due to a large gene deletion [103, 104]. The respective 
transposon mutant is proficient in swimming, swarming and twitching motility (see chapter 
3.2.7). 
For all transposon mutants, correct insertion of the transposon into the respective gene was 
verified by PCR using gene-specific primers (as listed in Table 2.3). In case of the PA01 
“Washington” transposon mutants PA3740 (mutant ID 21422 and 55385) and PA4396 
(mutant ID 35076 and 36991), correct transposon insertion could not be confirmed. Instead, 
PA3740 and PA4396 transposon mutants from a distinct PA01 mutant library (Tn5 lux 
transposon library, [105]) were used (kindly provided by Robert E. Hancock, University of 
British Columbia, Canada). The PA01 strain used for the generation of this mutant library is 
termed H103 and exhibits all three types of motility (swimming, swarming and twitching). 
All P. aeruginosa and E. coli strains were cultured at 37°C in Luria-Bertani (LB) broth with 
shaking (180 rpm), unless otherwise indicated. When required for plasmid or transposon 
selection, 100 µg/ml ampicillin and 50 µg/ml kanamycin were used for E. coli and 400 µg/ml 
carbenicillin, 15 µg/ml gentamycin, 150 µg/ml streptomycin and 25 µg/ml tetracycline 
respectively for the selection in P. aeruginosa. For the growth of cells on agar plates, the LB 
medium was solidified by addition of 1.6% (w/v) agar. 
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Table 2.1. Strains used in this thesis. 
Strains Relevant characteristicsa Source or 
reference 
E. coli   
DH5α F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG 
Φ80dlacZ∆M15 ∆(lacZYA-argF)U169, hsdR17(rK- mK+), λ– 
[106] 
BL21 (DE3) F- ompT hsdSB(rB-mB-) gal dcm Stratagene 
S17-1 C600::RP-4 2-(Tc::Mu) (Kn::Tn7) thi pro hsdR hsdM+recA [107] 
HCB721 ∆(tsr)7021 trg::Tn10 ∆(cheA-cheY)::XhoI(Tn5), Kmr, Tcr [108] 
BL21 (DE3) pRP89 Strain carrying pET11:pleD* for overexpression of PleD*-His6 for 
the purpose of protein purification, Apr 
[109] 
M15 pREP4 pQERpoS Strain overexpressing His6-RpoS for the purpose of protein 
purification, Apr, Kmr 
[110] 
P. aeruginosa   
PA01 wt Wild-type Lab 
collection 
PA01 wt control PA4684 transposon mutant from the Washington Genome Center 
PA01 mutant library, ID 8031, Tcr 
[101] 
PA01 cheR1  cheR1 transposon mutant from the Washington Genome Center 
PA01 mutant library, ID 47867, Tcr 
[101] 
PA01 PA3353 PA3353 transposon mutant from the Washington Genome Center 
PA01 mutant library, ID 37088, Tcr 
[101] 
PA01 PA5017 PA5017 transposon mutant from the Washington Genome Center 
PA01 mutant library, ID 33729, Tcr 
[101] 
PA01 wt control_PA3353 PA3353 knockout mutant constructed in the PA01 wild-type 
control background, Gmr, Tcr 
This study 
PA01 wt control_PA3740 PA3740 knockout mutant constructed in the PA01 wild-type 
control background, Gmr, Tcr 
This study 
PA01 PA5017_PA3353 PA3353 knockout mutant constructed in the PA01 PA5017 
background, Gmr, Tcr 
This study 
PA01 PA5017_PA3740 PA3740 knockout mutant constructed in the PA01 PA5017 
background, Gmr, Tcr 
This study 
PA01 H103 wt Wild-type R. E. 
Hancock 
PA01 H103 PA3740 PA3740 transposon mutant from the PA01 mini-Tn5 lux transposon 
mutant library, ID PA01_lux_19_F11 and PA01_lux_51_E2, Tcr 
[105] 
PA01 H103 PA4396 PA4396 transposon mutant from the PA01 mini-Tn5 lux transposon 
mutant library, ID PA01_lux_25_C8, Tcr 
[105] 
   
PA14 wt Wild-type [102] 
PA14 cheR1  cheR1 transposon mutant from the NR PA14 transposon mutant 
library, ID 36949, Gmr 
[102] 
a
 Apr, ampicillin resistant; Gmr, gentamycin resistant; Kmr, kanamycin resistant; Tcr, tetracycline resistant 
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2.2 Plasmid and strain construction 
Isolation and manipulation of recombinant DNA molecules was performed in accordance with 
standard molecular cloning techniques or as indicated by the product manufacturers 
instructions. 
Table 2.2. Plasmids used in this thesis. 
Plasmid Relevant characteristicsa Source or 
reference 
pUCP20 Shuttle vector, Apr/Cbr [111] 
pUCP20:cheR1 cheR1 (promoter region and gene) cloned into BamHI-XbaI in 
MCS, Apr/Cbr 
This study 
pUCP20:PA3353 PA3353 (promoter region and gene) cloned into BamHI-XbaI in 
MCS, Apr/Cbr 
This study 
pUCP20:PA3740 PA3740 (promoter region and gene) cloned into BamHI-XbaI in 
MCS, Apr/Cbr 
This study 
pUCP20:PA4396 PA4396 (promoter region and gene) cloned into BamHI-XbaI in 
MCS, Apr/Cbr 
This study 
pET21a(+) Plasmid for overexpression of proteins with C-terminal His6-tag, 
Apr 
Novagen 
pET21a(+):cheR1 cheR1 gene without stop codon cloned into NdeI-HindIII in MCS, 
Apr 
This study 
pET21a(+):PA3353 PA3353 gene without stop codon cloned into NdeI-XhoI in MCS, 
Apr 
This study 
pET21a(+):PA3740 PA3740 gene without stop codon cloned into NdeI-HindIII in MCS, 
Apr 
This study 
pASK-IBA7(+) Plasmid for overexpression of proteins with N-terminal Strep-tag, 
Apr 
IBA 
pASK-IBA7(+):PA4396 PA4396 gene without start codon cloned into EcoRI-BamHI in 
MCS, Apr 
This study 
pSunny GFP expressing plasmid, Kmr, Smr [112] 
pHSe5:tsr Plasmid expressing the E. coli MCP Tsr, inducible with IPTG, Apr [113, 114] 
pHSe5:pctA
 
Plasmid expressing the P. aeruginosa MCP PctA, inducible with 
IPTG, Apr 
This study 
pPS856 Source of Gmr cassette, Apr, Gmr [115] 
pEX18Ap Gene replacement vector; oriT+ sacB+, Apr/Cbr [115] 
pCR-Blunt II-Topo E. coli cloning vector, Kmr Invitrogen 
pTopo:PA3353 BamHI-XbaI fragment of pUCP20:PA3353 subcloned into pCR-
Blunt II-Topo, Kmr 
This study 
pTopo:PA3353ΩGm Gm-cassette from pPS856 (cut with PstI) subcloned into 
pTopo:PA3353 cut with the same enzyme, Gmr, Kmr 
This study 
pEX18Ap:PA3353ΩGm PCR amplified PA3353ΩGm fragment (blunt end) cloned into SmaI 
site of pEX18Ap, Apr/Cbr, Gmr 
This study 
pEX18Ap:PA3740 PA3740 mutant allele constructed by SOE-PCRb and cloned into 
EcoRI-XbaI of pEX18Ap, Apr/Cbr 
This study 
pEX18Ap:PA3740ΩGm Gm-cassette from pPS856 (cut with BamHI) subcloned into 
pEX18Ap:PA3740 cut with the same enzyme, Apr/Cbr, Gmr 
This study 
a
 Apr, ampicillin resistant; Cbr, carbenicillin resistant; Kmr, kanamycin resistant; Smr, streptomycin resistant; 
IPTG, isopropyl 1-thio-β-D-galactopyranoside; GFP, green fluorescent protein; MCS, multiple cloning site 
b
 SOE, gene splicing by overlap extension 
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Primers used for cloning (listed in Table 2.3) were ordered from Eurofins MWG Operon and 
are based on the PA01 genome sequence (www.pseudomonas.com) [11]. All PCR 
amplifications were performed with Pfu polymerase using PA01 genomic DNA as a template. 
The primer dependent annealing temperatures and target specific extension times used in the 
respective PCR reactions are depicted in Table 2.4. Purified PCR products were digested with 
appropriate restriction enzymes (Fermentas) and cloned into the target vector as indicated in 
Table 2.2 and Table 2.4. All obtained constructs were sequenced to rule out PCR errors. 
For complementation studies, the individual ORFs including their promoter regions were 
cloned into the E. coli - P. aeruginosa shuttle vector pUCP20 [111] and introduced into 
P. aeruginosa by electroporation. For recombinant protein expression in E. coli, the 
respective genes were cloned into the expression vector pET21a(+) (Novagen) without their 
stop codon which led to a C-terminal His6-tag fusion. Alternatively, the gene was cloned in 
frame with an N-terminal Strep-tag into the pASK-IBA7(+) vector. The obtained plasmids for 
Table 2.3. Primers used for cloning strategies in this thesis. 
Primer Sequencea 
PA3348 fPr1 5'-AAAACATATGGTGTCGGCAGCTAATGCG 
PA3348 rPr2 5'-GATCAAGCTTCTTGGCCCGGTAGAT 
PA3348 fPr3 5'-GATCGGATCCTTGCATACTTCGTTGTCC 
PA3348 rPr3 5'-GATCTCTAGACTACTTGGCCCGGTAGATG 
PA3353 fPr1 5'-AAAACATATGGTGCTATCATTGAGGCAT 
PA3353 rPr1 5'-AAAACTCGAGGAACAGTTCGTCAAACTC 
PA3353 fPr3 5'-GATCGGATCCGAACTGCTGGAGCGTTGCCA 
PA3353 rPr3 5'-GATCTCTAGAGAGCATCACCTGTTGCCGGCG 
PA3740 fPr1 5'-AAAACATATGATGACCATGTCCAATCAACAAC 
PA3740 rPr2 5'-GATCAAGCTTGGGCCGCAGGCTGAT 
PA3740 fPr3 5'-GATCGGATCCAACGACTACCAGGCGCTGCA 
PA3740 rPr3 5'-GATCTCTAGAGGATCAGGGCCGCAGGCTGA 
PA3740KO UP FEco 5'-GGAATTCCCAATCCCACCTCGCAGCACG 
PA3740KO UP RBam 5'-CGGGATCCCGTGAAGTCTAGTCGGCGATTTCCGT 
PA3740KO DOWN FBamb 5'-ACGGAAATCGCCGACTAGACTTCACGGGATCCCG        
GAAACCGGCAAGACGCAAAGCA 
PA3740KO DOWN RXbaI 5'-GCTCTAGAGCGTGACCGTTTCCACCGATCG 
PA4396 fPr3 5'-GATCGGATCCTTTGCCTTTCAGGTCGAA 
PA4396 rPr3 5'-GATCTCTAGACTAGCGCAGTGCCGGTAG 
PA4396 fPr4 5'-GATCGAATTCCCCGCCGGTGTGGCGGAGAC 
PA4396 rPr4 5'-GATCGGATCCCTAGCGCAGTGCCGGTAGCC 
pctA fPr2 5'-GATCGGATCCATGATCAAAAGTCTGAAGTTCAGC 
pctA rPr2 5'-GATCAAGCTTTCAGATCTTGAAGCTGTCCAC 
a
 engineered restriction sites are underlined 
b
 the sequence which is complementary to the PA3740KO UP RBam primer is displayed in italics 
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protein overexpression were introduced into chemically competent E. coli BL21 (DE3) by 
transformation. An E. coli strain overexpressing the diguanylate cyclase PleD* [109] was 
kindly provided by Urs Jenal (University of Basel, Switzerland) and the E. coli strain used for 
overexpression of the stationary phase sigma factor RpoS [110] was a gift from Vittorio 
Venturi (International Center for Genetic Engineering and Biotechnology, Trieste, Italy). 
The IPTG inducible E. coli Tsr expression plasmid pHSe5 [113, 114], kindly provided by 
Robert M. Weis (University of Massachusetts, Amherst, USA), was modified for expression 
of the P. aeruginosa MCP PctA. The tsr sequence was removed by digestion with BamHI and 
HindIII yielding in a vector backbone (4.8 kb) and a tsr fragment (2.4 kb). The vector 
backbone was gel-purified and ligated to the PCR amplified and BamHI/HindIII digested pctA 
gene. The resulting construct, pHSe5:pctA, was transformed into chemically competent E. coli 
HCB721 cells. 
 
Table 2.4. Cloning strategies for the construction of plasmids used in complementation 
studies and for protein overexpression. 
Primer PCR
a 
Ta; tex; product length 
Cut with Clone into 
PA3348 fPr1 
PA3348 rPr2 
63.1°C; 1 min 50 s 
842 bp 
NdeI 
HindIII pET21a(+) 
PA3348 fPr3 
PA3348 rPr3 
63.1°C; 2 min 10 s 
1059 bp 
BamHI 
XbaI pUCP20 
PA3353 fPr1 
PA3353 rPr1 
61.1°C; 2 min 30 s 
810 bp 
NdeI 
XhoI pET21a(+) 
PA3353 fPr3 
PA3353 rPr3 
66.7°C; 2 min 30 s 
1104 bp 
BamHI 
XbaI pUCP20 
PA3740 fPr1 
PA3740 rPr2 
63.4°C; 1 min 30 s 
704 bp 
NdeI 
HindIII pET21a(+) 
PA3740 fPr3 
PA3740 rPr3 
65.9°C; 2 min 5 s 
1005 bp 
BamHI 
XbaI pUCP20 
PA4396 fPr3 
PA4396 rPr3 
64.2°C; 2 min 45 s 
1329 bp 
BamHI 
XbaI pUCP20 
PA4396 fPr4 
PA4396 rPr4 
63.7°C; 2 min 20 s 
1118 bp 
EcoRI 
BamHI pASK-IBA7(+) 
pctA fPr2 
pctA rPr2 
60°C; 4 min 20 s 
1910 bp 
BamHI 
HindIII pHSe5 
a
 Ta, annealing temperature; tex, extension time 
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2.3 Construction of knockout mutants 
Knockout mutants were created by gene disruption using the gene replacement vector 
pEX18Ap [115]. Thereby, the chromosomal wild-type allele of the respective gene was 
exchanged with a mutated, pEX18Ap-borne allele which carries a gentamycin cassette as 
selectable marker. The pEX18Ap vector and the plasmid pPS856 [115], source of the Gm-
cassette, were kindly provided by Robert E. Hancock (University of British Columbia, 
Canada). 
Different strategies were used to create the pEX18Ap knockout plasmids 
pEX18Ap:PA3353ΩGm and pEX18Ap:PA3740ΩGm. In the case of PA3353, the BamHI-
XbaI fragment of pUCP20:PA3353 was cloned into pCR-Blunt II-Topo to generate 
pTOPO:PA3353. An internal region of PA3353 (138 bp), flanked by two PstI restriction sites, 
was removed by PstI digestion and replaced with the gentamycin resistance cassette cut from 
pPS856 with the same enzyme. From the resulting vector, the PA3353ΩGm fragment was 
amplified using Pfu polymerase and primer pair PA3353 fPr3/rPr3. The blunt-ended PCR 
product was ligated into the SmaI site of pEX18Ap to create pEX18Ap:PA3353ΩGm. 
To engineer an internal deletion in PA3740, the method of gene splicing by overlap extension 
(SOE) was used [116]. In brief, N-terminal (490 bp) and C-terminal (509 bp) regions flanking 
the PA3740 gene were amplified using the primer pairs PA3740KO UP F/R and DOWN F/R, 
respectively (Table 2.3). The primer sequence of PA3740KO DOWN F included nucleotides 
at the 5' end which were complementary to the PA3740KO UP R primer, so that the PCR 
products of the two separate reactions share homologous sequences. Both PCR products were 
mixed and employed in a second PCR reaction using the primer pair PA3740KO 
UP F/DOWN R. The obtained 1000 bp fragment resembles PA3740 but lacks a significant 
part of the coding sequence (495 of 687 bp) and has an engineered BamHI restriction site in 
the middle. This fragment was ligated between the EcoRI and XbaI sites of pEX18Ap before 
the gentamycin resistance cassette of pPS856 was cloned into the PA3740 sequence via the 
introduced BamHI site to generate the final pEX18Ap:PA3740ΩGm plasmid. 
The generated gene replacement constructs were transformed into chemically competent 
E. coli S17-1 cells before being conjugated into P. aeruginosa PA01 wt control and PA01 
PA5017, respectively. Double recombinants were identified by their resistance towards 
gentamycin (200 µg/ml) and tetracycline (25 µg/ml) combined with their sensitivity towards 
carbenicillin (400 µg/ml) upon growth on LB plates containing the indicated antibiotics. The 
loss of the vector backbone was additionally confirmed by their ability to grow on LB plates 
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containing 5% (w/v) sucrose. Chromosomal mutant candidates were analyzed by colony PCR 
to verify disruption of the designated gene. 
 
2.4 DNA transfer techniques 
2.4.1 Transformation of E. coli  
Chemically competent E. coli DH5α, BL21 (DE3) and HCB721 cells were prepared as 
follows: an overnight culture of the respective strain was used to inoculate 25 ml fresh LB. 
This culture was grown to an OD600 of 0.3 at 37°C, before bacterial growth was stopped by 
cooling the culture on ice for 10 min. Cells were harvested by centrifugation at 4°C at 
3,200×g for 15 min, resuspended in 5 ml ice-cold 0.1 M CaCl2 and cooled on ice for 5 min. 
After a second centrifugation step, cells were resuspended in 1 ml ice-cold 0.1 M CaCl2 
containing 15% (v/v) glycerol and incubated on ice for 15 min. The competent cells were 
frozen as 100 µl aliquots in liquid nitrogen and stored at -70°C. 
For transformation, competent cells were gently thawed on ice, mixed with the DNA of 
interest and kept on ice for 20 min. After a heat shock for 90 s at 42°C, cells were placed back 
on ice for 2 min before 800 µl LB were added and the cells were incubated at 37°C in a 
thermomixer for 1.5 h. Thereafter, 100 µl of the transformation reaction were plated on LB 
agar containing antibiotics for selection of transformants. The plates were incubated overnight 
at 37°C. 
 
2.4.2 Electroporation of P. aeruginosa  
Electrocompetent P. aeruginosa PA01 and PA14 cells were always prepared fresh directly 
before use. The respective strains were plated on LB agar plates (one plate per electroporation 
reaction) and incubated for 20 h at 37°C resulting in a thick cell lawn. Cells were collected 
with an inoculation loop and resuspended in 1 ml deionized water (dH2O). The bacterial 
suspension was centrifuged at 18,000×g for 2 min and the cell pellet was repeatedly washed 
with dH2O to remove components of the extracellular matrix produced by P. aeruginosa cells. 
The bacteria were finally resuspended in 45 µl dH2O, mixed with 1 µl plasmid DNA and 
transferred to an electroporation cuvette (2 mm electrode gap). The electric pulse was 
delivered with a voltage of 2.45 kV, a capacitance of 25 µF and a resistance of 200 Ω (Gene 
Pulser II, Bio-Rad). The resulting time constant varied between 5-5.5 ms. Directly after the 
discharge, 1 ml LB was added and the suspension was transferred to a microcentrifuge tube. 
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The electroporation reaction was incubated for 1.5 h at 37°C in a thermomixer, before 100 µl 
were spread on selective LB agar. The plates were incubated overnight at 37°C. 
 
2.4.3 Plasmid transfer by conjugation 
In some cases, plasmids were introduced into P. aeruginosa by conjugation using E. coli 
S17-1 [107] as the donor strain. For conjugation experiments, P. aeruginosa was grown in 
5 ml nutrient broth (NB, Difco) for 24 h at 37°C, while E. coli S17-1 carrying the plasmid of 
interest was grown in 5 ml LB for 7 h at 37°C. Bacterial cells were harvested by 
centrifugation at 3,200×g for 15 min, resuspended in 500 µl fresh NB medium and transferred 
into a microcentrifuge tube. The cells were centrifuged again at 6,000×g for 5 min and finally 
resuspended in 100 µl fresh NB. 
Biparental mating mixtures of donor and recipient cells (1:1, 20 µl) were spotted on a fresh 
NB agar plate and incubated overnight at 37°C. The colony was resuspended in 1 ml 
phosphate buffered saline (PBS) and 100 µl of this bacterial suspension were plated on LB 
agar plates containing suitable antibiotics to positively select for P. aeruginosa 
transconjugants but to counterselect the E. coli donor cells. 
 
2.5 Protein overexpression and purification 
E. coli BL21 (DE3) and M15 cells carrying the respective expression plasmids were grown to 
an OD600 of 0.5-0.7 before inducing protein expression by adding 0.1-1 mM isopropyl 1-thio-
β-D-galactopyranoside (IPTG; for pET and pQE based overexpression) or 200 ng/ml 
anhydrotetracycline (AHT; for pASK-IBA based overexpression). The cultures were further 
shaken at temperatures and incubation times indicated in Table 2.5. 
Table 2.5. Culture conditions for heterologous overexpression of diverse proteins in E. coli. 
E. coli host strain Expression vector Induction witha 
Growth temperature 
and time following 
inductionb 
Resulting 
protein 
BL21 (DE3) pET21a(+):cheR1 0.1 mM IPTG 20°C, ON CheR1-His6 
BL21 (DE3) pET21a(+):PA3353 0.1 mM IPTG 37°C, 6 h PA3353-His6 
Cell-free expression pET21a(+):PA3740 0.1 mM IPTG 30°C, 1.5 h PA3740-His6 
BL21 (DE3) pASK-IBA7(+):PA4396 200 ng/ml AHT 20°C, ON Strep-PA4396 
BL21 (DE3) pET11:pleD* 0.1 mM IPTG 20°C, ON PleD*-His6 
M15 pQERpoS 1.0 mM IPTG 20°C, 4 h His6-RpoS 
a
 IPTG, isopropyl 1-thio-β-D-galactopyranoside; AHT, anhydrotetracycline 
a
 ON, overnight 
2. Materials and Methods   19 
After harvesting cells by centrifugation, the pellets were resuspended in suitable lysis buffers 
(3 ml lysis buffer per mg of wet cell pellet) containing 1 mM dithiothreitol (DTT), 1 mg/ml 
lysozyme, protease inhibitors (Complete mini, ethylenediaminetetraacetic acid (EDTA) free, 
Roche) and Benzonase Nuclease (Novagen). Cells were lysed by passage through a French 
pressure cell (SLM-Aminco) at 16,000 psi at least twice and then centrifuged at 37,500×g for 
45 min in order to remove unbroken cells. Proteins containing a C-terminal His6-tag were 
purified by affinity chromatography using Ni-NTA resin (Quiagen) following standard 
protocols. Proteins containing an N-terminal StrepII-tag were purified using Strep-Tactin as 
affinity resin and eluted as recommended by the supplier (IBA). Eluted fractions were 
examined for the presence and purity of recombinant protein by SDS-PAGE analysis. 
Preparations of pure protein (> 90%) were pooled and dialyzed for 16 h at 4°C using Slide-A-
Lyzer dialysis cassettes (Thermo Scientific) with a molecular weight cut off (MWCO) of 
10 kDa. The buffers used for cell lysis, protein purification (washing and elution) and dialysis 
of pure proteins are listed in Table 2.6. 
Due to an apparent toxicity of PA3740 towards the E. coli expression host, a cell-free 
expression system was used for biosynthesis of PA3740-His6 (EasyXpress, Quiagen). For this 
purpose, E. coli extracts were mixed with 1.5 µg pET21:PA3740 and the in vitro translation 
process was started by the addition of 0.1 mM IPTG (final reaction volume: 50 µl). After 
incubation at 30°C for 1.5 h under gentle agitation, His-tagged PA3740 was purified from the 
reaction mixture using Ni-NTA magnetic agarose beads (Quiagen) as recommended by the 
supplier. Eluted proteins were dialyzed in Slide-A-Lyzer mini dialysis units (MWCO 10 kDa, 
Thermo Scientific) for 16 h at 4°C (see also Table 2.5 and Table 2.6). 
Table 2.6. Buffers used for purification strategies of diverse proteins. 
Protein Lysis and washing buffer Elution buffer Dialysis buffer 
CheR1-His6 50 mM NaH2PO4, pH 8.0, 
300 mM NaCl, 10 mM imidazole
 
50 mM NaH2PO4, pH 8.0, 
300 mM NaCl, 250 mM imidazole 
50 mM NaH2PO4, 
pH 8.0, 300 mM NaCl 
PA3353-His6 50 mM NaH2PO4, pH 8.0, 
300 mM NaCl, 10 mM imidazole
 
50 mM NaH2PO4, pH 8.0, 
300 mM NaCl, 250 mM imidazole 
50 mM NaH2PO4, 
pH 8.0, 300 mM NaCl 
PA3740-His6 50 mM NaH2PO4, pH 8.0, 
300 mM NaCl, 10 mM 
imidazole, 0.05% (v/v) Tween 20 
50 mM NaH2PO4, pH 8.0, 
300 mM NaCl, 250 mM 
imidazole, 0.05% (v/v) Tween 20 
50 mM NaH2PO4, 
pH 8.0, 300 mM NaCl 
Strep-PA4396 100 mM Tris·Cl, pH 8.0,    
150 mM NaCl, 1 mM EDTA 
100 mM Tris·Cl, pH 8.0,            
150 mM NaCl, 1 mM EDTA,  
2.5 mM desthiobiotin 
100 mM Tris·Cl,      
pH 8.0, 150 mM NaCl 
PleD*-His6 50 mM Tris·Cl, pH 8.0,   
300 mM NaCl, 10 mM imidazole
 
50 mM Tris·Cl, pH 8.0, 300 mM 
NaCl, 250 mM imidazole 
50 mM Tris·Cl, 
pH 8.0, 300 mM NaCl 
His6-RpoS 50 mM Tris·Cl, pH 8.0,   
300 mM NaCl, 10 mM imidazole
 
50 mM Tris·Cl, pH 8.0, 300 mM 
NaCl, 250 mM imidazole 
50 mM Tris·Cl, 
pH 8.0, 300 mM NaCl 
 
2. Materials and Methods 20 
Protein concentrations were determined by measuring their absorbance at 280 nm (Table 2.7) 
or by using a Bradford assay (Bio-Rad protein assay). Purified and dialyzed proteins were 
commonly stored at 4°C. 
 
2.6 Protein assays 
2.6.1 Surface plasmon resonance analysis 
All surface plasmon resonance experiments were performed at the University of Kassel in co-
operation with the group of Friedrich W. Herberg (Daniela Bertinetti, Stefan Möller) and 
Bastian Zimmermann (Biaffin GmbH & Co KG, Kassel). 
SAM binding to CheR1-His6 
Surface plasmon resonance (SPR) was used to detect binding of S-adenosylmethionine 
(SAM) to immobilized CheR-His6. The interaction analyses were performed in 10 mM 
tris(hydroxymethyl)aminomethane (Tris), 300 mM NaCl, pH 8.0 (buffer A) at 25°C using a 
Biacore S51 instrument (GE Healthcare, Biacore). For covalent coupling of CheR-His6, 
carboxymethylated sensor chip surfaces (Series S CM5, Biacore GE Healthcare) were 
activated with a 1:1 ratio of 0.4 M EDC (N-ethyl-N'-(3-dimethylaminopropyl)carbodiimide) 
and 0.1 M NHS (N-hydroxysuccinimide) for 10 min and purified CheR-His6 (40 µg/ml in 
10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH 7.0) was injected 
for 20 min at a flow rate of 5 µl/min. Deactivation of the surface was performed using 1 M 
ethanolamine-HCl (pH 8.5) for 8 min. 
Interaction analyses were performed in buffer A containing 0.005% (v/v) surfactant P20 by 
injection of increasing concentrations (500 nM-1 mM) of SAM at a flow rate of 30 µl/min. 
Table 2.7. Characteristic protein properties. 
Protein MWa pIb A280 nmc of 1 corresponds tod 
CheR1-His6 32.2 kDa 9.3 1.06 mg/ml 
PA3353-His6 31.0 kDa 6.5 1.71 mg/ml 
PA3740-His6 26.4 kDa 9.2 20.61 mg/ml 
Strep-PA4396 42.9 kDa 5.6 2.06 mg/ml 
PleD*-His6 50.4 kDa 6.3 6.17 mg/ml 
His6-RpoS 39.2 kDa 5.6 1.66 mg/ml 
a
 molecular weight 
b isoelectric point 
c
 absorbance of the protein at 280 nm  
d
 those values depend on the amino acid sequence of the respective protein and were determined using the 
Vector NTI software (version 8, InforMax) 
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Association and dissociation signals were monitored for 60 s and 200 s, respectively. After 
subtracting the reference spot signal, resulting binding signals were fitted. Data evaluation 
was performed using the Biacore S51 evaluation software version 1.2.1. 
C-di-GMP binding studies 
All SPR experiments analyzing the interaction of purified proteins with immobilized 
c-di-GMP were performed on a Biacore 3000 instrument (GE Healthcare, Biacore) at 20°C. 
To generate a c-di-GMP sensor chip, 2'-AHC-c-di-GMP (obtained from F. Schwede, Biolog, 
Bremen, Germany) was dissolved in 150 mM NaCl, 20 mM 3-(N-morpholino)-
propanesulfonic acid (MOPS), pH 7 (buffer B) in an ultrasonic bath and by heating at 50°C. 
The concentration of the analog solution was determined via the respective extinction 
coefficient (ε = 23,700 l/(mol·cm)) [117]. For covalent coupling of 2'-AHC-c-di-GMP, a 
carboxymethylated sensor chip surface (CM5, Biacore GE Healthcare) was activated with 
EDC/NHS for 10 min according to the instructions of the manufacturer (amine coupling kit, 
Biacore GE Healthcare). The c-di-GMP analog (1 mM in 100 mM borate running buffer, 
pH 8.5) was injected for 7 min at a flow rate of 10 µl/min. Deactivation of the surface was 
performed using 1 M ethanolamine-HCl, pH 8.5 for 10 min. A reference cell was activated 
accordingly and deactivated subsequently without ligand immobilization. 
Binding analysis was performed in buffer B containing 0.005% (v/v) surfactant P20, 1 mg/ml 
CM dextran and 1 mM DTT. For some experiments, proteins were pre-incubated with a ten-
fold concentration of free c-di-GMP prior to injection. Association and dissociation were 
monitored for 9 min and 3 min, respectively (flow rate 10 µl/min). Nonspecific binding was 
excluded by subtracting blank runs performed on the reference cell. Resulting binding signals 
were plotted using the Biacore 3000 evaluation software, version 4.0.1. 
Protein/nucleotide interactions were monitored as solution competition experiments [118, 
119] in buffer B plus 0.005% (v/v) surfactant P20. In brief, proteins (15 nM – 1 µM) were 
pre-incubated with varying amounts of free c-di-GMP using at least eleven different 
concentrations and injected over the 2'-AHC-c-di-GMP surface. The association was 
monitored for 3 min and at the end of the association phase the binding signal was collected. 
After subtracting the reference cell, the resulting binding signals were plotted against the 
logarithm of the free c-di-GMP concentration and EC50 values were calculated from the dose 
response curve using GraphPad Prism 5.01 (GraphPad Software, San Diego, USA). 
After each binding experiment the sensor surfaces were regenerated by two injections of 3 M 
guanidinium HCl and one injection of 0.05% (sodium dodecyl sulfate) SDS and the drifting 
baseline was stabilized by one injection of 1 M NaCl. 
2. Materials and Methods 22 
2.6.2 CheR1 methyltransferase activity assay 
Preparation of membranes containing PctA 
E. coli strain HCB721 [108], kindly provided by Howard C. Berg (Harvard University), was 
used to prepare membranes enriched for the MCP PctA. HCB721 is deficient in all known 
E. coli MCPs and all cytoplasmic chemotaxis proteins except the CheZ phosphatase and thus 
ensures that the overexpressed PctA receptor does not undergo post-translational 
modification. Cells were grown at 30°C in 500 ml LB supplemented with 100 µg/ml 
ampicillin. At OD600 0.5-0.7, PctA expression was induced with 1 mM IPTG. After 3 h of 
induction, cells were harvested by centrifugation and resuspended in buffer containing 
100 mM potassium acetate, 50 mM HEPES, pH 7.5, 5 mM magnesium acetate, 0.05% (v/v) 
β-mercaptoethanol, protease inhibitors (Complete mini, EDTA free, Roche) and Benzonase 
Nuclease (Novagen). Cells were lysed by adding 1 mg/ml lysozyme and by passage through a 
French Pressure cell (16,000 psi) at least twice. After removing unbroken cells by 
centrifugation for 20 min at 7,000×g, the supernatant was loaded on a sucrose step gradient 
(0.5 M, 1.5 M and 2 M) and centrifuged at 100,000×g for 1 h at 4°C. The second band was 
removed, diluted 5 times with water containing protease inhibitors (Complete mini, with 
EDTA, Roche) and centrifuged for 1 h at 100,000×g at 4°C. The pellet was resuspended in a 
small amount of storage buffer (50 mM NaH2PO4, 1 mM EDTA, 10% (v/v) glycerol), 
analyzed on Coomassie-stained SDS-PAGE and the total amount of protein concentration was 
determined by scanning densitometry against the Low Molecular Weight Calibration Kit (GE 
Healthcare) as a reference. The membrane samples were adjusted to a final protein 
concentration of 2 mg protein/ml in storage buffer and stored as single-use aliquots at -70°C. 
Receptor methylation assays 
In vitro methylation assays were performed as previously described with slight modifications 
[120, 121]. In brief, the methylation reaction (final volume 100 µl) was carried out at 30°C in 
50 mM NaH2PO4, pH 8.0, 300 mM NaCl containing 50 µl receptor-enriched membranes, 
0.1 µM CheR1-His6 and with or without 1 mM serine or glutamine. After a pre-incubation 
step of 5 min, the reaction was started by adding 0.625 µM [3H-methyl]-S-
adenosylmethionine (specific activity 80 Ci/mmol, Amersham). At indicated time points, 
10 µl aliquots were removed, spotted on filter paper (1 cm2, Rotilabo, Roth) and quenched 
with 10% (w/v) trichloroacetic acid. The filters were washed twice with 10% (w/v) 
trichloroacetic acid and once with ethanol, for 15 min with gentle shaking. Air-dried filters 
were transferred into a 24-well sample plate, covered with 1 ml scintillation fluid and 
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incubated over night before radioactivity was quantified using a microplate liquid scintillation 
counter (1450 MicroBeta TriLux, Wallac). 
 
2.6.3 Diguanylate cyclase activity assay 
Diguanylate cyclase (DGC) assays were carried out as previously described [109, 122] with 
the following modifications. DGC-reactions in a total volume of 50 µl were performed at 
30°C in buffer containing 10 µM of purified protein, 50 mM Tris-HCl, pH 8.0, 300 mM NaCl, 
10 mM MgCl2 and [α-32P]GTP (3.33 pmol, 3,000 Ci/mmol, Hartmann analytic). At several 
time points, 5 µl aliquots were removed and mixed with an equal volume of 0.5 M EDTA, 
pH 8.0, to stop the enzymatic reaction. Product formation was analyzed with thin layer 
chromatography by spotting 1 µl on Polygram® CEL 300 polyethyleneimine cellulose plates 
(Machery-Nagel) and developing the plates in 1:1.5 (v/v) saturated NH4SO4 and 1.5 M 
KH2PO4, pH 3.6, for 60 min. Dried plates were exposed to a film for at least 1 h and 
qualitatively analyzed using a phosphor imager. In a control reaction, [32P]c-di-GMP was 
enzymatically synthesized by the DGC PleD*. 
 
2.6.4 Electrophoretic mobility shift assays 
Electrophoretic mobility shift assays (EMSAs) were conducted using purified His6-RpoS and 
fluorescence-labeled DNA fragments. The sequences of specific DNA probes were chosen 
such that they overlap with the peak ChIP-chip signal and/or the RpoS consensus box (see 
chapter 2.9). Non-specific control DNA fragments represent regions that were not enriched by 
the ChIP-chip experiments, e.g. that are part of the coding region of the house-keeping gene 
gltA or part of the intergenic region (igr) between the rsaL and lasI open reading frames. 
In the beginning, DNA probes ≈200 bp in length were generated by PCR amplification using 
primer pair cheY2 fPr2/rPr2 for a specific DNA probe and primer pair gltA F/R for a non-
specific DNA probe (Table 2.8). The primers used for amplification were ordered from 
Metabion (Martinsried, Germany) and carried the IRDye700 (excitation wavelength 
λex= 685 nm, emission wavelength λem= 705 nm) at their 5' end. As gel shift assays using 
those double-stranded, long DNA fragments failed, the procedure was changed and short, 
IRDye700-labeled oligos (≈30 bp, Metabion, Table 2.7) were directly used as single-stranded 
or double-stranded DNA probes. To obtain double-stranded, short DNA fragments, 
complementary primers (5 µM each) were annealed in buffer containing 20 mM Tris-HCl, 
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pH 8, 50 mM NaCl and 10 mM MgCl2 using the following conditions: 5 min at 95°C, 10 min 
at 58°C, 10 min at 37°C, 10 min at 20°C, cool down to 4°C.  
Binding reactions (final volume 15 µl) contained 0.33 µM (single-stranded) or 0.5 µM 
(double-stranded) DNA probes and 0.5 µg/µl purified His6-RpoS in binding buffer (20 mM 
HEPES, pH 7.5, 50 mM NaCl, 1 mM EDTA, 200 µg/ml BSA, 0.83 ng/µl poly(dIdC), 5% 
glycerol). The reaction mixture was incubated in the dark at room temperature for 30 min 
before being electrophoresed on native 5% Tris-borate-EDTA polyacrylamide gels (Bio-Rad) 
in TBE buffer (89 mM Tris base, 89 mM boric acid, 2 mM EDTA) at 4°C at 90 V for 45 min. 
Gels were scanned at 100 µm resolution with a FLA-9000 Reader (Fujifilm Europe GmbH, 
Düsseldorf, Germany) using the BPFR700 filter and 689 nm as excitation wavelength. 
Emitted light was detected at a wavelength of 700 nm. Each experiment was performed at 
least twice. 
For competition experiments, RpoS was incubated with an excess of non-labeled DNA probes 
(3.3 µM – 10 µM) in binding buffer for 10 min at room temperature, before labeled oligos 
were added and the samples were processed as described above. Supershifts were performed 
by adding rabbit polyclonal RpoS antibody (6.7 ng/µl, kindly provided by V. Venturi, 
International Center for Genetic Engineering and Biotechnology, Trieste, Italy) to RpoS in 
Table 2.8. Oligos used for electrophoretic mobility shift assays. 
Oligo Sequence 5' Modificationa 
cheY2 fPr2 5'-CGATAGCCAATCCGTCTAAC IRDye700 
cheY2 rPr2 5'-ATCAGAATCGGTTTGCCCAT IRDye700 
gltA F 5'-GAACGCAACCTGTACCCGAACG IRDye700 
gltA R 5'-TTGTAGGGGCCGGAGAGCATTT IRDye700 
cheY2 short Fb 5'-ACCGGACATTGTCTTTACTGGAACTAGCAA IRDye700 
cheY2 short Rb 5'-TTGCTAGTTCCAGTAAAGACAATGTCCGGT IRDye700 
igr short Fc 5'-ACCGAAATCTATCTCATTTGCTAGTTATAAAAT IRDye700 
igr short Rc 5'-ATTTTATAACTAGCAAATGAGATAGATTTCGGT IRDye700 
gltA short F 5'-TGTACAAGTACTCCAAGGGCGAGCCGATGA IRDye700 
gltA short R 5'-TCATCGGCTCGCCCTTGGAGTACTTGTACA IRDye700 
PA3353 short F 5'-CCTGAACCCGACCAGCACACGTATCAAGGCACA IRDye700 
PA3353 short R 5'-TGTGCCTTGATACGTGTGCTGGTCGGGTTCAGG IRDye700 
rsmA short F 5'-CCGGCGGGACTGGTCAATACTGGGTGAAGG IRDye700 
rsmA short R 5'-CCTTCACCCAGTATTGACCAGTCCCGCCGG IRDye700 
PA0861 short F 5'-GGCAAACAGCCACTAGACTCCTACTGTTTG IRDye700 
PA0861 short R 5'-CAAACAGTAGGAGTCTAGTGGCTGTTTGCC IRDye700 
a
 labeled oligos only 
b
 originally termed rpoS box F/R 
c
 igr, intergenic region; originally termed lasR box F/R 
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binding buffer, followed by incubation at room temperature for 10 min and addition of labeled 
oligos. In some experiments, E. coli core RNA polymerase (1 U/µl, Epicentre Bio-
technologies) was added to the EMSA reaction mixture to test for improved binding of RpoS 
to the target DNA. 
 
2.7 Phenotypic characterization assays 
2.7.1 Growth curves 
Planktonic growth rates of diverse P. aeruginosa wild-type and mutant strains were 
monitored using an automated growth analysis system (Bioscreen C MBR, iLF bioserve, 
Langenau, Germany). 
LB pre-cultures were grown overnight at 37°C, diluted to an OD600 of 0.02 in fresh LB and 
transferred into a 100-well honeycomb plate (iLF bioserve, 100 µl/well, three replicates per 
strain). The plates were covered with a lid and incubated at 37°C with continuous shaking in a 
computer-controlled Bioscreen incubator. Turbidity of the bacterial suspensions (OD600) was 
automatically measured every 15 min for a period of 16 h. 
 
2.7.2 Motility assays 
Swimming and swarming motility assays were performed as previously described [123]. In 
brief, swimming was evaluated on BM2 glucose plates (40 mM K2HPO4, pH 7, 7 mM 
(NH4)2SO4, 2 mM MgSO4, 10 µM FeSO4, 0.4% (w/v) glucose) containing 0.3% agar and 
swarming on modified BM2 glucose plates (40 mM K2HPO4, pH 7, 2 mM MgSO4, 10 µM 
FeSO4, 0.4% (w/v) glucose) containing 0.5% agar supplemented with 0.1% Casamino acids 
(Difco). Freshly prepared plates (25 ml motility agar per plate) were allowed to dry for 15 min 
(swimming plates) or 60 min (swarming plates) under laminar flow directly before use. Plates 
were inoculated with 1 µl of a LB pre-culture with OD600 > 1.0 and incubated overnight at 
37°C. Due to the fast swarming motility of PA01 strains, the incubation temperature was 
reduced to 30°C in some cases. Swimming results were analyzed by measuring the diameter 
of the swimming zone, while swarming was evaluated photographically. 
Twitching assays were performed on LB plates with 1% agar by stab inoculation of single 
colonies with a toothpick. After 24-48 h incubation at 37°C, the diameter of the twitching 
zone at the plastic-agar interface was measured. For non-circular zones, the longest and 
shortest dimensions were measured and averaged. 
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2.7.3 Motility tracking 
Bacterial cells were grown to exponential phase (OD600 ~1.0) in LB, diluted 1:200-1:1000 in 
0.9% NaCl containing 3% (v/v) Ficoll (Sigma) and transferred into a 96-well plate with a thin 
glass bottom. Cells were monitored with an inverted microscope (Axiovert 135TV, Zeiss), 
equipped with a 25×/0.80 oil objective and a CoolSnap HQ2 camera (Visitron Systems) and 
operated with the MetaMorph software (version 7.5.3, Molecular Devices Corporation). 
Phase-contrast images visualizing cells near the glass bottom were acquired for 30 s at 5 
frames per second, imported as stacks into ImageJ 1.42, where trajectories of swimming 
bacteria were monitored by hand. 
 
2.7.4 Biofilm and attachment assays 
Crystal violet staining of adherent cells was adopted from O’Toole and Kolter [124] with the 
following modifications. Overnight LB cultures were diluted to an OD600 of 0.02 with fresh 
medium. The bacterial suspensions were inoculated in PVC (polyvinyl chloride) 96-well 
plates (Becton Dickinson Labware) with 100 µl per well (eight replicates per strain), sealed 
with an air-permeable BREATHseal cover foil (Greiner Bio-One) and grown under static 
conditions at 37°C in an incubator with humid atmosphere. After 24 h of incubation, 
planktonic cells were removed and wells were washed with water (200 µl/well) prior to 
staining with 0.1% (w/v) crystal violet for 30 min at room temperature (150 µl/well). Wells 
were carefully washed with water to remove excess staining solution, air-dried and the 
retained crystal violet was solubilized in 95% ethanol (200 µl/well) for 30 min at room 
temperature. For quantification, 125 µl of the resulting solution were transferred into a 
96-well polystyrene microtiter plate (Nunc) and absorbance was measured at 550 nm using a 
Tecan Sunrise microplate reader. 
Analysis of static biofilms grown at the bottom of 96-well plates was performed as previously 
described [125]. In brief, overnight LB cultures were adjusted to an OD600 of 0.02 with fresh 
medium and transferred into a half-area 96-well µClear plate (Greiner Bio-One, 100 µl/well, 
four replicates per strain). The plate was covered with an air-permeable foil and incubated at 
37°C in an incubator with humid atmosphere. After 24 h, bacteria were stained with 50 µl 
diluted staining solution (LIVE/DEAD BacLight Bacterial Viability kit, Molecular 
Probes/Invitrogen, final concentration of 1.4 µM Syto9 and 8.3 µM propidium iodide) and 
further incubated for 48 h at 37°C. Microscopic analysis of biofilm formation on the bottom 
of microtiter plates was performed using an Olympus Fluoview 1000 confocal laser scanning 
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microscope equipped with a 40×/0.90 air objective. Image stacks were acquired in the center 
of each well with a step size of 2 µm. Images of each experiment were processed and 
analyzed as previously described [125] and visualized using the IMARIS software package 
(version 5.7.2, Bitplane). 
To monitor biofilm formation in the microtiter plates over time, the constitutively GFP-
expressing plasmid pSunny [112] was transferred into P. aeruginosa by conjugation and 
biofilms were grown, images acquired and data analyzed as described above except that the 
staining step was omitted. To determine the amount of bacteria attached to the substratum, 
single images at the bottom of the wells were acquired. The images were processed with a 
pseudo flat field filter to adjust uneven luminance. The filtered, gray-scale images were 
thresholded to segment objects’ pixel area from background pixels. The percentage of 
attached bacteria was calculated by determining the ratio of object pixels to the total number 
of pixels. All processing steps were performed using ImageJ (version 1.43). 
 
2.8 Identification of c-di-GMP binding proteins 
2.8.1 Immobilization of c-di-GMP on Sepharose 6B 
C-di-GMP was synthesized by Michael Morr (Helmholtz Center for Infection Research, 
Braunschweig, Germany) as specified before [126]. Preparation of c-di-GMP affinity resin 
was performed in co-operation with Frank Schwede (Biolog, Bremen, Germany) as described 
previously for the immobilization of cGMP [127] with some modifications: a total of 500 mg 
epoxy-activated Sepharose 6B (GE Healthcare) was treated ten times with 25 ml cold 
deionized water. The washed resin was resuspended in 3 ml coupling buffer (100 mM 
Na2B4O7, 100 mM NaCl, pH 11) and incubated with 2.2 mg (3 µmol) c-di-GMP at 40°C in a 
thermomixer. Progress of immobilization was monitored by analytical high-performance 
liquid chromatography (HPLC) using a 5% acetonitrile/ 20 mM triethylammonium formate 
buffer, pH 6.8, as eluent. The HPLC-system consisted of a L 6200 pump, a L 4000 variable 
wavelength UV-detector, and a D 2500 GPC integrator (all Merck-Hitachi). The stationary 
phase was YMC ODS-A 120-10 (YMC, Kyoto, Japan) in a 250 x 4.6 mm stainless steel 
column. The coupling reaction was proceeded for 144 h and any unreacted epoxy groups were 
blocked with 100 µmoles ethanolamine in coupling buffer for 24 h. After filtration and 
multiple washing steps (2 x 25 ml 20% ethanol, 2 x 25 ml water, 2 x 25 ml 30 mM NaH2PO4, 
pH 7) the affinity resin was stored in 30 mM NaH2PO4, 1% NaN3, pH 7, at 4°C. Ligand 
density was 0.45 µmoles/ 100 mg resin (dry basis), as determined by HPLC-analysis during 
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coupling. In a control experiment, c-di-GMP was incubated in coupling buffer without 
affinity resin at 40°C for 144 h. After this period less than 15% degradation of c-di-GMP was 
detected by analytical HPLC. 
To identify functional groups that react with epoxy-activated sepharose, a model reaction was 
performed under the above mentioned coupling conditions using the related cyclic nucleotide 
cGMP (Biolog, Bremen, Germany) and (S)-(-)-1,2-epoxy-butane (Aldrich). Obtained reaction 
products were analyzed with HPLC, nuclear magnetic resonance (NMR) and mass 
spectrometry (MS). 
A control affinity resin was prepared by incubating epoxy-activated Sepharose 6B with 
100 µmoles ethanolamine in coupling buffer at 40°C for 48 h. 
 
2.8.2 Affinity pull down protocol 
Main cultures (500 ml) of P. aeruginosa PA14 and PA01 were inoculated with a pre-culture 
and grown to stationary phase at 37°C. Cells were harvested by centrifugation for 10 min at 
4°C and 6,000×g, the pellet was washed once with ice-cold phosphate buffered saline (PBS), 
pH 7.4, followed by a second centrifugation step. The bacteria (3.5 - 4.5 g wet weight) were 
resuspended in 15 ml ice-cold PBS containing 1 mM DTT, protease inhibitors (Complete 
mini, EDTA free, Roche) and Benzonase Nuclease (Novagen). The cells were lysed by bead 
beating (3 x 20 s at 4.5 m/s, Hybaid ribolyser) or by passage through a French Pressure cell 
(at 16,000 psi, SLM-Aminco). After a centrifugation step at 4°C, at 37,500×g for 45 min, the 
supernatant was mixed with 200 µl sepharose slurry, which has been pre-equilibrated with 
PBS buffer. Binding of proteins to the affinity matrix was allowed to progress for 2 h at 4°C 
under gentle rotation in a batch format. Subsequently, the resin was washed six times with 
10 ml ice-cold PBS, before transferring the resin into a small reaction tube. Nonspecific 
binding was tried to be further reduced by incubating the beads with 250 µl of 10 mM cGMP 
in PBS and/or 10 mM GTP in PBS for 20 min at 4°C, followed by two washing steps. 
C-di-GMP binding proteins were then eluted by incubating the resin with 100 – 500 µM 
c-di-GMP in PBS for 40 min at 4°C under gentle rotation. All eluates were finally precipitated 
with chloroform/ methanol according to Wessel and Fluegge [128] and subjected to SDS-
PAGE analysis. 
This standard protocol was slightly modified. In PA01 experiment A, proteins bound to the 
c-di-GMP affinity beads and the control resin were finally eluted by heat treatment (95°C, 
10 min). In PA01 experiment B and C and PA14 experiment 1, 1% (w/v) SDS instead of 
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c-di-GMP was used for final elution of proteins bound to the control sepharose. To all buffers 
used in PA01 experiment C, 1% (v/v) Triton was added to improve solubility of membrane 
associated proteins. In PA14 experiment 2, BugBuster reagent (Novagen) in 10 mM Tris-HCl, 
140 mM NaCl, pH 7.4, containing protease inhibitors was used for the chemical lysis of cells 
(10 min at room temperature). In PA14 experiment 3, a pull down was performed using a 
membrane fraction in addition to the pull down with the soluble cell lysate fraction. 
Therefore, the pellet obtained after cell lysis and the following centrifugation step was 
resuspended in PBS and membranes were solubilized by adding 0.5% β-dodecylmaltoside for 
1 h at 4°C and 35 rpm. The sample was then centrifuged in an ultracentrifuge for 60 min at 
100,000×g, 4°C and the supernatant was incubated with the affinity resin as described above 
except that all buffers and solutions contained 0.5% β-dodecylmaltoside. 
 
2.8.3 Sample preparation for LC-MS/MS 
Coomassie stained protein bands were excised and destained in a solution containing 30% 
acetonitrile and 50 mM NH4HCO3. Destained gel slices were reduced for 30 min at 56°C with 
20 mM DTT in 50 mM NH4HCO3 and subsequently alkylated with 20 mM iodoacetamide in 
50 mM NH4HCO3. Gel slices were cut in small pieces, washed twice in 50 mM NH4HCO3 
and then dried after dehydration in acetonitrile. For all procedures the volume of the solutions 
was higher than 20 times the gel volume. Dried samples were reswollen in a solution 
containing 50 mM NH4HCO3, 10% acetonitrile and sequencing grade modified trypsin 
(Promega) in a ratio of about 1:20. Digestion of the protein was performed at 37°C overnight. 
Peptides were subsequently eluted with H2O, 1% triflouroacetic acid and two times 30% 
acetonitrile containing 0.1% triflouroacetic acid and dried in a vacuum centrifuge (Jouan RC 
1010). For LC-MS/MS the dried peptides were desalted using ZipTip RP18 Tips (Millipore), 
evaporated again and resolubilized in 3% acetonitrile with 0.5% formic acid and centrifuged 
for 20 min at 100,000×g at 20°C. 
 
2.8.4 LC-MS/MS analysis and database searching 
LC-MS/MS was performed at the Helmholtz Center for Infection Research (Josef Wissing, 
Lothar Jänsch) on an Acquity Ultra Performance LC-system (Waters Corp., USA) connected 
to a Q-TOFmicro mass spectrometer (Waters Corp., USA) or to an Orbitrap XL mass 
spectrometer (Thermo Scientific). Peptides were flushed onto a C18 precolumn (5 µm 
Symmetry C18, 180 µm x 20 mm, Waters Corp.) with a flow rate of 15 µl/min and washed at 
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constant flow for 3 min. Peptides were then separated on an analytical column (1.7 µm 
BEH130, 75 µm x 150 mm, Waters Corp.) with UPLC buffer A (0.1% formic acid in water) 
and UPLC buffer B (0.1% formic acid in acetonitrile) via linear B gradients from 0 – 25% at a 
flow rate of 300 nl/min controlled with AcquityUPLC software V1.22. Data-dependent 
acquisition of MS and MS/MS data was under control of MassLynx (V4.1, Q-TOFmicro) or 
Xcalibur ™ software (V2.1, Orbitrap XL). Doubly and triply charged peptide ions were 
automatically selected and fragmented with m/z dependent collision energy settings. The peak 
lists (Q-TOFmicro) or raw data files (Orbitrap XL) were processed using the Mascot Deamon 
(V2.1). Database searches were carried out with a local Mascot server (V2.2) in a PA01 or 
PA14 database (NCBI) using the given settings (enzyme, trypsin; maximum missed 
cleavages, 1; fixed modification: carbamidomethyl (Cys), and variable oxidation (Met); 
peptide tolerance, 150 ppm (Q-TOFmicro) or 10 ppm (Orbitrap XL); MS/MS tolerance, 
0.3 Da). Scaffold (version Scaffold_3_00_03, Proteome Software Inc.) was used to validate 
MS/MS based peptide and protein identifications. Proteins were only accepted as identified 
when at least 1 unique peptide showed 95% confidence and the total protein identification 
confidence was at least 95%. Peptide probabilities were specified by the Peptide Prophet 
algorithm [129] and protein probabilities were assigned by the Protein Prophet algorithm 
[130]. 
 
2.9 ChIP-chip 
2.9.1 Chromatin immunoprecipitation 
Chromatin immunoprecipitation (ChIP) was carried out based on previously described 
procedures [131, 132]. PA01 wild-type cells were grown in LB at 37°C to stationary phase 
(OD600 of 2.0). To cross-link protein to DNA, formaldehyde was added to 30 ml culture to a 
final concentration of 1%. After incubation at room temperature for 20 min with gentle 
agitation, the reaction was quenched by the addition of glycine (final concentration 0.5 M) 
followed by incubation for 5 min at room temperature. Cells were harvested by centrifugation 
at 2,500×g at 4°C for 10 min, washed once with cold Tris buffered saline (TBS), pH 7.6, and 
resuspended in 500 µl of lysis buffer (10 mM Tris-HCl, pH 8, 20% (w/v) sucrose, 50 mM 
NaCl, 10 mM EDTA) containing 4 mg/ml lysozyme. The bacterial cells were incubated for 
30 min at 37°C, before 500 µl immunoprecipitation (IP) buffer (50 mM HEPES-KOH, 
pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% (v/v) Triton, 0.1% (m/v) sodium deoxycholate) 
containing 1 mM phenylmethylsulfonyl fluoride (PMSF) was added. The lysates were chilled 
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on ice and then DNA was shared to an average fragment size of 50-500 bp using a Branson 
S250 sonicator with a 5 mm standard tip (settings: 8 x 60 s, 90% duty, output control: 6). Cell 
debris were removed by centrifugation at 18,000×g for 10 min and the supernatant was 
aliquoted and stored at –70°C until use. 
For immunoprecipitation, 20 µl pre-equilibrated Protein A-sepharose 4B beads (Sigma) were 
coated with 10 µg rabbit polyclonal RpoS antibody (kindly provided by V. Venturi, 
International Center for Genetic Engineering and Biotechnology, Trieste, Italy) in IP buffer 
for 1 h at room temperature with gentle mixing. For control experiments, an irrelevant rabbit 
polyclonal antibody was coupled to the Protein A-beads under the same conditions. In 
parallel, chromosomal DNA of 100 µl cross-linked cell extracts was pre-cleared by incubation 
with 20 µl blank Protein A-beads in 700 µl IP buffer containing 1 mM PMSF. The samples 
were centrifuged for 2 min at 425×g, and the supernatant was then incubated with the 
antibody-coated Protein A-beads for 1.5 h at room temperature under gentle agitation. The 
beads were washed twice with IP buffer, once with IP buffer supplemented with 500 mM 
NaCl, once with wash buffer (10 mM Tris-HCl, pH 8, 250 mM LiCl, 1 mM EDTA, 0.5% 
(v/v) Nonidet-P40, 0.5% (m/v) sodium deoxycholate) and once with TE buffer (10 mM Tris-
HCl, pH 7.5, 1 mM EDTA). Immunoprecipitated complexes were eluted by incubation of the 
beads with 60 µl elution buffer (50 mM Tris-HCl, pH 7.5, 10 mM EDTA, 1% (m/v) SDS) at 
65°C for 10 min. Beads were removed by centrifugation and cross-links were reversed by the 
addition of protease (0.1 µg/µl, dissolved in deionized water, Sigma) and incubation for 2 h at 
42°C and for 6 h at 65°C. DNA was purified using a PCR purification kit (Quiagen). All 
ChIPs were performed twice. 
 
2.9.2 Amplification of immunoprecipitated DNA 
ChIP DNA was amplified based on the Affymetrix chromatin immunoprecipitation assay 
protocol [133]. 
In an initial round of linear amplification, random primers (PrimerA: 
5'-GTTTCCCAGTCACGGTC(N)9) were incorporated into immunoprecipitated DNA. 
Briefly, 10 µl purified ChIP DNA were mixed with 4 µl random primers (200 µM) in 
Sequenase reaction buffer (USB Corporation, Cleveland, Ohio, USA) and incubated for 4 min 
at 95°C followed by rapid cooling on ice. To this mixture, 2.6 µl first cocktail (specified in 
Table 2.9) was added and linear amplification was performed as described in Table 2.10. 
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After DNA purification (PCR purification kit, Quiagen), DNA was PCR amplified using the 
corresponding 5'-GTTTCCCAGTCACGGTC primer (PrimerB) and a dNTP/dUTP mix 
(10 mM dATP, 10 mM dCTP, 10 mM dGTP, 8 mM dTTP, 2 mM dUTP). The detailed 
reaction mixture and the PCR program are listed in Table 2.11 and Table 2.12. Amplified 
DNA was purified using a PCR purification kit (Quiagen). 
 
Table 2.9. First cocktail for linear amplification of ChIP DNA. 
Component Volume for 1 reaction 
20 mg/ml BSA 0.1 µl 
0.1 M DTT 1 µl 
25 mM dNTPs 0.5 µl 
Sequenasea 1.3 U/µl 1 µl 
Total volume 2.6 µl 
a
 purchased from USB Corporation, USA 
Table 2.10. Reaction conditions for linear amplification of ChIP DNA. 
Step Conditions 
1 10°C for 5 min 
2 Ramp from 10°C to 37°C in 9 min 
3 37°C for 8 min 
4 95°C for 4 min 
5 Rapid cooling on ice 
6 10°C hold 
7 Add 1 µl of 1.3 U/µl Sequenase to each sample 
8 Repeat step 1-7 three times 
9 4°C hold 
 
Table 2.11. Reaction mixture for PCR amplification of ChIP DNA. 
Component Volume for 1 reaction 
Purified DNA 10 µl 
10 mM dNTPs+dUTP 3.75 µl 
100 µM PrimerBa 4 µl 
GoTaq (5 U/µl, Promega) 2 µl 
5x PCR buffer 20 µl 
25 mM MgCl2 10 µl 
Nuclease-free water 50.25 µl 
Total volume 100 µl 
a
 PrimerB: 5'-GTTTCCCAGTCACGGTC 
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2.9.3 Microarray analysis 
Approximately 7.5 µg of amplified DNA from the control and the RpoS IPs were fragmented 
to a fragment size of 50-500 bp and terminally labeled using the GeneChip WT double 
stranded DNA terminal labeling kit (Affymetrix) according to the instructions of the 
manufacturer. The biotin-labeled DNA was hybridized to an Affymetrix P. aeruginosa 
genome chip as described previously [104]. 
Enrichment of hybridization signals was calculated (by Andreas Dötsch, Helmholtz-Center 
for Infection Research) with the Tiling Analysis Software (TAS, Affymetrix) from two 
independent RpoS IPs compared to two independent control IPs (bandwidth parameter was 
set to 150 bp). For each gene (PA01 annotation taken from the Pseudomonas genome 
database, [134]), the promoter region was defined as the sequence from -300 to -1 bp, 
excluding overlap to upstream coding regions. Promoter enrichment was defined as the 
maximum enrichment found within the promoter region. 
 
2.9.4 Identification of an RpoS consensus sequence 
Promoter regions were scanned by Andreas Dötsch (Helmholtz Center for Infection Research) 
with the web-based programs CONSENSUS and PATSER [135] (available at 
http://rsat.ulb.ac.be/rsat/) to detect RpoS consensus sequences. Sequence logos were created 
with WebLogo (http://weblogo.berkeley.edu). The initial consensus sequence was derived 
from a set of 16 RpoS-regulated genes as described previously [136] and used for the pattern 
based search of the sequences from -300 to -1 bp upstream of each open reading frame, 
Table 2.12. Reaction conditions for PCR amplification of ChIP DNA. 
Step Temperature Time 
1 95°C 5 min 
2 95°C 30 s 
3 45°C 30 s 
4 55°C 30 s 
5 72°C 1 min 
6 step 2-5 repeated 15-30 times 
7 95°C 30 s 
8 45°C 30 s 
9 55°C 30 s 
10 72°C 1 min, dt 5 sa 
11 step 7-10 repeated 15-30 times 
12 4°C hold 
a
 add 5 s for each subsequent cycle 
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excluding coding regions. A revised consensus sequence was derived analogously from a set 
of 32 genes that were positive in all three criteria (enriched by ChIP, differentially regulated, 
consensus sequence identified, see chapter 3.3.2). The detection of consensus sequences by 
PATSER was limited to a weight score of 6.0. 
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3 Results 
3.1 Characterization of the chemotaxis methyltransferase CheR1 and its impact 
on biofilm formation 
3.1.1 Objective 
In E. coli, CheR methylation activity is strongly enhanced upon binding to a conserved 
pentapeptide sequence (NWETF) at the C-terminus of highly abundant methyl-accepting 
chemotaxis proteins [137, 138]. Homologous pentapeptide structures are present in 
P. aeruginosa in only 2 of the 26 MCPs (CttP and Aer2 [33]). These two are organized on the 
chromosome in the vicinity of the che2 system, whose predicted gene products (including 
CheR2) exhibit an even higher overall sequence identity to orthologous E. coli chemotaxis 
proteins [33]. To test whether P. aeruginosa CheR1 methylates MCPs that lack the 
pentapeptide motif, methylation assays with the chemoreceptor PctA (PA4309) were 
established. Another aim was to elucidate the role that the Che1 chemotaxis system might 
play in biofilm formation of P. aeruginosa. 
 
3.1.2 Methylase activity of CheR1 
The PA01 PA3348 gene product is predicted to be a probable chemotaxis protein 
methyltransferase (CheR1, www.pseudomonas.com, [139]). This function was proposed 
based on limited amino acid identity (31%) to the experimentally studied CheR gene product 
in E. coli and a conserved domain for S-adenosylmethionine (SAM) binding. 
To characterize P. aeruginosa receptor methylation and to gain insight into methylation of 
MCPs lacking the pentapeptide motif, CheR1 was expressed with a C-terminal His6-tag and 
purified by affinity chromatography using Ni-NTA agarose resin. Since chemotaxis 
methyltransferases use SAM as a substrate for receptor methylation, interaction of this 
coenzyme with P. aeruginosa CheR1 was analyzed by surface plasmon resonance in co-
operation with the group of F. W. Herberg (University of Kassel). Purified CheR1-His6 was 
immobilized on a sensor chip and SAM was injected over the sensor surface as an analyte in 
the mobile phase. In general, complex formation on the sensor surface causes SPR signals that 
are displayed as resonance units (RU, 1000 RU corresponds to 1 ng/mm2) [140]. Here, 
increasing concentrations of injected SAM resulted in increased binding signals (Figure 
3.1A). The obtained binding signals were plotted against the employed SAM concentration 
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and analyzed with a steady-state model (Figure 3.1B), revealing a binding constant (KD) of 
61 µM. 
Next, in vitro methylation assays were performed by the utilization of purified P. aeruginosa 
His-tagged CheR1 protein, the methyl donor SAM and membranes from an E. coli strain 
(HCB721) effectively gutted of all the chemotaxis genes [108]. HCB721 cells were 
transformed with an IPTG inducible plasmid encoding the P. aeruginosa PctA receptor and 
membranes containing PctA were prepared as described under Materials and Methods (see 
chapter 2.6.2). Figure 3.2A depicts the initial methylation rate of the PctA receptor and 
demonstrates that PctA was methylated by the methyltransferase CheR1. 
Previous studies have demonstrated, that PctA, in concert with the MCPs PctB and PctC, is 
responsible for the detection of amino acids in P. aeruginosa [141, 142]. Chemotactic assays 
of pctA pctB pctC triple mutants supplemented with either one of these MCP genes revealed 
that PctA, PctB and PctC detected 18 amino acids, 6 amino acids and 2 amino acids, 
respectively [142]. Among these amino acids, for example, serine was only detected by PctA, 
whereas glutamine was only detected by PctB. Therefore, the effect of these two amino acids 
on the methylation rate of PctA was tested. In accordance to the previous chemotactic 
experiments, the presence of serine, but not glutamine, increased the methylation rate of PctA 
by at least 1.2-fold (p<0.001, Figure 3.2B). 
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Figure 3.1. Surface plasmon resonance (SPR) analysis of the interaction of CheR1-His6 
and SAM using a Biacore S51. 
CheR1 was immobilized on the sensor surface using standard amine coupling chemistry. The CheR1 interaction 
partner SAM was injected over the sensor surface. (A) SPR signals were detected for association (60 seconds) 
and dissociation (200 seconds) of SAM to CheR1. The graph shows the kinetic data for 12 SAM concentrations 
with data for the lowest (500 nM) to the highest (1 mM) SAM concentration displayed from bottom to top. (B) 
Data from (A) were analyzed with a steady state model. The resulting dissociation constant (KD) was determined 
to be 61 µM. 
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3.1.3 Motility defect of the cheR1 mutant 
In agreement with results described by Kato et al. [34], analysis of cheR1 transposon mutants 
in the PA01 and PA14 strain background (correct insertion of transposon was confirmed by 
PCR) revealed a severely impaired swimming motility in minimal medium soft agar plates 
(Figure 3.3A and B). Both cheR1 transposon mutants formed only small diameter swim rings 
in contrast to the diffuse large-diameter swim rings observed in the wild-type control and the 
complemented mutant strains. This phenotype defect is characteristic for mutants that cannot 
respond to a chemical gradient generated upon nutrient consumption, and was not due to a 
defect in the growth rate (data not shown). By contrast, the cheR1 mutant and complemented 
mutant strain were positive in swarming (Figure 3.3C and D) and twitching (Figure 3.3E and 
F) in both the PA01 and PA14 strain background. 
To characterize the swimming motility defect in more detail, the cells were observed by light 
microscopy. In general, E. coli bacteria move unidirectional with periodic pauses that involve 
active tumbling, which reorients the cell prior to continued forward motion. This essential 
random movement can be biased through taxis mechanisms that modify the frequency of 
reorientations [18, 19]. However, the mono-flagellated P. aeruginosa swims in a straight,  
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Figure 3.2. Methylation of the methyl-accepting chemotaxis protein PctA by CheR1-His6 
using [3H-methyl]-SAM as the methyl donor. 
(A) Methylation rate of E. coli HCB721 membranes containing no MCP (dashed line) or the P. aeruginosa MCP 
PctA (continuous line). (B) Methylation reactions carried out for 15 min in the presence of 1 mM serine resulted 
in a significantly increased methylation rate of the MCP PctA (* p<0.001, paired t-test), whereas the addition of 
glutamine had no effect. 
Representative data from one experiment out of at least two are shown. Error bars are standard deviations of 
three replicates. ccpm – corrected counts per minute. 
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Figure 3.3. Motility phenotype of the cheR1 mutant and the complemented strain of 
PA01 (A, C, E) and PA14 (B, D, F).  
(A, B) Swimming assays were performed on minimal medium soft agar plates supplement with 0.3% agar. The 
impaired swimming motility of the cheR1 mutant can be complemented by providing the cheR1 gene in trans. 
(C, D) Swarming assays were performed on minimal medium plates supplemented with 0.5% agar. All strains, 
the wild-type/wild-type control, the cheR1 mutant and the complemented cheR1 mutant, were capable of 
swarming. (E, F) Twitching zones were measured at the plastic-agar (LB-agar, 1.5%) interface after 36 h. All 
strains, the wild-type/wild-type control, the cheR1 mutant and the complemented cheR1 mutant displayed similar 
twitching motility. 
Representative data from one experiment out of at least three are shown. Error bars are standard deviations of 
three replicates. 
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back-up, turn mode (described by Pratt et al. [55]), driven by a (i) counter-clockwise rotation 
of the flagellum, (ii) brief reversal and (iii) reorientation. Both P. aeruginosa strains (PA01 
and PA14) were motile and exhibited the run/back-up/run mode of swimming, although 
obviously the PA14 strain did not exhibit as many stops/reorientations, as compared to the  
 
 
 
Figure 3.4. Motility defect of the cheR1 mutant as observed by light microscopy. 
(A, B) The wild-type (A, PA01 wt control and B, PA14 wt) exhibits a straight forward - short backup/reversal - 
straight forward mode of swimming. (C, D) The cheR1 mutant (C, PA01 and D, PA14) changes its direction less 
frequently than the wild-type and tends to swim straight. (E, F) The cheR1 mutant complemented with 
pUCP20:cheR1 in trans (E, PA01 and F, PA14) is oscillating rapidly between forward and backward swimming. 
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PA01 wild-type control under the tested conditions (Figure 3.4A and B). The cheR1 mutants 
were also motile, but tended to swim straight and exhibited less frequent stops/reorientations 
as opposed to the PA01 and PA14 wild-type controls (Figure 3.4C and D). When the cheR1 
mutants were complemented with cheR1 in trans, the effect of CheR became more 
pronounced. The complemented cheR1 mutants exhibited clearly more reversals as compared 
with the respective wild-type control and cheR1 mutant in both strain backgrounds (Figure 
3.4E and F). 
 
3.1.4 Compromised biofilm formation of the cheR1 mutant 
The cheR1 mutant of PA14 was further monitored for attachment and biofilm formation. A 
microtiter plate based crystal violet (CV) staining assay was used for the determination of 
attached biomass following a 24 h incubation period of static cultures. As depicted in Figure 
3.5, no clear difference in biomass attached to the well-wall could be observed between the 
PA14 wild-type, the PA14 cheR1 transposon mutant and the complemented strain. 
 
Next, the formation of biofilms on the bottom of a 96-well plate was examined. Confocal 
laser scanning microscopy (CLSM) of biofilms stained with the BacLight Live/Dead stain 
revealed a severe biofilm defect of the PA14 cheR1 mutant after 72 h of static growth in LB. 
A plasmid-borne copy of the deleted wild-type cheR1 gene complemented the mutant 
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Figure 3.5. Crystal violet (CV) staining assay for the determination of attached biomass. 
PA14 wild-type carrying the vector control (pUCP20), the PA14 cheR1 mutant carrying the vector control 
(pUCP20) and the complemented PA14 cheR1 mutant (carrying pUCP20:cheR1) were grown in LB for 24 h at 
37°C under static conditions before staining with CV. Representative data from one experiment out of five are 
shown. Error bars are standard deviations of eight replicates. 
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phenotype (Figure 3.6). To characterize the differences in biofilm formation in more detail, 
PA14 wild-type and cheR1 mutant cells were tagged with plasmid-borne GFP (which did not 
alter their phenotypes on swim-agar plates and in the crystal violet biofilm assay, data not 
shown) and biofilm formation was monitored over time. 
After 1 h, only a few cells were found at the bottom of a 96-well plate, in both the wild-type 
and the cheR1 mutant, the majority of which was non-motile. Within the next hours, the 
number of swimming bacteria increased. Thereby, bacteria of the wild-type strain 
accumulated at the bottom of the well but remained highly motile until the space was 
 
 
Figure 3.6. Confocal laser scanning micrographs of P. aeruginosa biofilms grown in LB 
at the bottom of a 96-well plate. 
Biofilms were stained with the BacLight Live/Dead stain. Biofilm development at 72 h is shown for (A) PA14 
wild-type carrying the vector control (pUCP20), (B) the PA14 cheR1 transposon mutant carrying the vector 
control (pUCP20) and (C) the complemented PA14 cheR1 mutant (carrying pUCP20:cheR1). The central image 
shows a XY section through the biofilm and the flanking pictures show vertical sections. Scale bars, 50 µm. 
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Figure 3.7. Differences in the development of GFP-expressing PA14 wild-type and cheR1 
mutant biofilms. 
(A) Quantification of the substratum coverage at the well-bottom of a 96-well plate after 1 h, 4 h and 7 h. (B) 
Quantification of the biovolume after 10 h, 24 h and 48 h. Representative data from one experiment out of at 
least two are shown. Error bars are standard deviations of at least four replicates. 
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completely occupied by bacteria. In contrast, far less bacteria of the cheR1 mutant strain were 
found in the proximity of the bottom, and surface sampling of motile bacteria proceeded only 
slowly. The differences in early substratum coverage by the wild-type and the cheR1 mutant 
are quantified in Figure 3.7A and representative pictures for both strains at different time 
points are depicted in Figure 3.8. 
 
 
Figure 3.8. Substratum coverage by GFP-tagged bacteria as monitored by CLSM. 
The coverage of the well-bottom of a 96-well plate was monitored after (A, B) 1 h, (C, D) 4 h and (E, F) 7 h. The 
cell clusters observed in (A) and (B) are likely to originate from cell clumps of overnight grown pre-cultures 
used for inoculation. (A, C, E) PA14 wild-type and (B, D, F) PA14 cheR1 transposon mutant. 
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The formation of mature biofilms was then monitored by three dimensional confocal laser 
scanning microscopy (CLSM). After 10 h, biofilm formation of the cheR1 mutant was 
severely delayed as compared with the wild-type (Figure 3.7B and Figure 3.9A and B). 
Nevertheless, after 24 h, the structure and biovolume of cheR1 biofilms were found to be very 
similar to that of wild-type biofilms (Figure 3.7B and Figure 3.9C and D). In the following 
hours, the wild-type and the cheR1 mutant biofilm underwent structural rearrangement.  
 
 
 
Figure 3.9. Confocal laser scanning micrographs of P. aeruginosa biofilms grown in LB. 
Biofilm development in a well of a 96-well plate at (A, B) 10 h, (C, D) 24 h and (E, F) 48 h is shown for (A, C, 
E) PA14 wild-type carrying the GFP-expression vector pSunny and (B, D, F) the PA14 cheR1 transposon mutant 
carrying the GFP-expression vector pSunny. The central image shows a XY section through the biofilm and the 
flanking pictures show vertical sections. Scale bars, 50 µm. 
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Whereas the wild-type formed cohesive and densely packed biofilm structures, the mutant 
biofilm was characterized by a more loosely, and in parts disconnected, architecture and an 
overall lower biomass (Figure 3.7B and Figure 3.9E and F). In summary, cells lacking the 
chemotaxis methyltransferase CheR1 were delayed in biofilm formation on the bottom of a 
96-well plate and their mature biofilms displayed a different architecture compared with the 
structures of wild-type biofilms. 
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3.2 Identification and characterization of c-di-GMP binding proteins 
3.2.1 Objective 
High levels of the second messenger c-di-GMP are known to suppress motility and to 
promote the establishment of biofilms, but little is known about how c-di-GMP mediate its 
regulatory effects. The identification of c-di-GMP binding proteins by extensive bioinformatic 
studies seems to have come to an end and the search for new output targets has been largely 
hampered by the limited disposability of pure c-di-GMP. 
The chemist Michael Morr, working at the Helmholtz Center for Infection Research, was able 
to perform the complicated and laborious chemical synthesis of c-di-GMP, and in co-
operation with Frank Schwede (Biolog Life Science Institute in Bremen), this c-di-GMP was 
immobilized on sepharose beads. The aim of this thesis was to use the c-di-GMP coupled 
sepharose as an affinity matrix for the isolation of c-di-GMP binding proteins of 
P. aeruginosa, which subsequently should be identified by mass spectrometry (in co-
operation with the group of Lothar Jänsch, Helmholtz Center for Infection Research). 
Furthermore, phenotypic assays should be employed to elucidate molecular functions of 
verified c-di-GMP binding proteins. 
 
3.2.2 Coupling of c-di-GMP to sepharose beads 
For the utilization of immobilized c-di-GMP as a bait for its cellular effector molecules, 
chemically synthesized c-di-GMP was coupled to epoxy-activated sepharose under alkaline 
conditions (communicated by Frank Schwede, Biolog, Bremen). Although very high amounts 
of c-di-GMP were required and the coupling reaction proceeded only slowly, c-di-GMP was 
covalently linked to the sepharose beads at sufficient quantities and at an overall efficiency of 
75%. Under these conditions, degradation of c-di-GMP was below 15% (data not shown). 
HPLC analysis during the coupling reaction indicated a final ligand density of 0.45 µmol per 
100 mg resin (dry basis). 
HPLC, NMR and MS analysis were further used to identify functional groups of the 
c-di-GMP molecule involved in the chemical binding to the sepharose matrix. As a model 
compound accessible in larger quantities, the closely related nucleotide cGMP was reacted 
with epoxybutane under similar coupling conditions resulting in one main product (more than 
35%) and at least six byproducts. For the main product, a monosubstitution at position N1 of 
the guanine-ring was demonstrated by NMR (data not shown). The byproducts seemed to be 
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partly multisubstituted at position N7 (guanine-ring) and position 2'OH (ribose-ring) as 
depicted in Figure 3.10. As c-di-GMP contains two guanosine moieties, it cannot be excluded 
that the compound is, at least partially, coupled to the sepharose beads via both guanosine 
units. 
 
3.2.3 The P. aeruginosa PA01 c-di-GMP interactome 
The c-di-GMP coupled sepharose served as an enrichment tool to isolate c-di-GMP binding 
proteins from the P. aeruginosa strain PA01 by affinity chromatography. Epoxy-activated 
sepharose transformed with ethanolamine was used as a negative control, in order to identify 
proteins that bind to the sepharose matrix nonspecifically. 
Three independent experiments were performed, termed A, B and C. The c-di-GMP affinity 
and control beads were incubated with freshly prepared soluble PA01 cell lysates obtained 
from stationary phase cultures. After extensive washing steps, bound proteins were eluted by 
heat treatment (10 min, 95°C) in experiment A, while in experiment B and C enriched 
proteins were eluted with a 0.5 M c-di-GMP solution from the c-di-GMP resin and with a 1% 
SDS solution from the control resin. In experiment C, 1% Triton was included in the lysis-, 
wash- and elution-buffer. Eluted proteins were analyzed following SDS-PAGE by automated 
peptide sequencing (LC-MS/MS), and the inspection of the derived result lists was supported 
 
 
Figure 3.10. Chemical structure of c-di-GMP. 
The black arrow indicates the main coupling position of c-di-GMP to the sepharose matrix, framed arrows 
indicate possible coupling positions of byproducts. Multisubstitutions within the same or with the second 
guanosine moiety cannot be excluded. In 2'-AHC-c-di-GMP, the 2'OH group of one ribose-ring is substituted 
with a 6-aminohexylcarbamoyl group. 
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by the Scaffold software program. Thereby, proteins were only included in the final result list 
if they had been identified with a very high probability (confidence interval ≥ 95%, see 
chapter 2.8.4). 
Table 3.1 displays the total number of proteins identified in each PA01 pull down experiment. 
Overall, more proteins were isolated on the control sepharose as compared with the respective 
c-di-GMP sepharose, suggesting that c-di-GMP coupling reduces nonspecific binding of 
proteins to the resin. Comparison of the results of all three control pull downs revealed a large 
overlap in the control bead-proteome: 43 out of 66 proteins were found to bind to the control 
resin in at least two of the three performed experiments (Figure 3.11). To validate specificity 
of protein binding, results of each of the three c-di-GMP pull down experiments were first 
compared to the results of the respective control pull down, before using the combined results 
of all control pull downs (experiment A-C) as a reference. This evaluation led to the 
identification of ten distinct putative c-di-GMP targets of PA01, listed in Table 3.2. 
Among those candidates, there is one protein for which c-di-GMP binding has been recently 
demonstrated [82]: PA3353 which harbors a conserved PilZ domain. The specific 
identification of this known c-di-GMP effector molecule in all three performed pull down 
experiments is strong evidence for the applicability of our approach. Furthermore, two 
proteins possessing domains involved in c-di-GMP metabolism were identified in at least two 
of the three pull downs conducted: PA2567 and PA4396. Of particular interest is PA4396, a  
 
Table 3.1. Pulled down proteins of three distinct experiments performed with PA01 lysates 
using the c-di-GMP affinity resin and the control resin. 
 
Experiment 
Aa 
Experiment 
Bb 
Experiment 
Cc 
Number of distinct 
proteins 
Proteins enriched by the c-di-GMP 
sepharose 13 5 9 18 
Proteins enriched by the control 
sepharose 30 44 61 66 
Proteins enriched by the c-di-GMP 
sepharose, but not by the respective 
control sepharose 
10 5 3 10 
Proteins enriched by the c-di-GMP 
sepharose, but not by any        
control sepharose 
10 5 3 10 
a
 performed with soluble cell lysate, elution of bound proteins by heat treatment 
b
 performed with soluble cell lysate, elution of bound proteins with 0.5 M c-di-GMP (c-di-GMP resin) or 1% 
SDS (control resin) 
c
 performed with soluble cell lysate, 1% Triton in all buffers, elution of bound proteins with 0.5 M c-di-GMP 
(c-di-GMP resin) or 1% SDS (control resin) 
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Figure 3.11. Comparison of proteins that were pulled down in P. aeruginosa PA01 
lysates using the control resin in three different experiments. 
In all experiments, the control resin was incubated with soluble lysate of PA01. In experiment C, 1% Triton was 
included in the lysis-, wash- and elution-buffer. Proteins were eluted from the control resin by heat treatment 
(experiment A) or with a 1% SDS solution (experiments B and C). 
Table 3.2. Putative PA01 c-di-GMP binding proteins. 
PA 
numbera 
(Alternate) 
gene name Product name Comment 
PA0174 cheD conserved hypothetical protein   
PA1092 fliC flagellin type B   
PA2567  hypothetical protein degenerate GGDEF domain without  
I-site motif, EAL domain [62]  
PA3309 uspK conserved hypothetical protein   
PA3348 cheR1 probable chemotaxis protein methyltransferase   
PA3353  hypothetical protein PilZ domaina 
PA3529 tsaA probable peroxidase   
PA3740  hypothetical protein   
PA3831 pepA leucine aminopeptidase   
PA4396  probable two-component response regulator degenerate GGDEF domain [62] with 
I-site motif 
aThose proteins are listed that were identified with a probability of ≥ 95% in at least one of three c-di-GMP pull 
downs, but not in any of the controls (with a probability of ≥ 50%). The proteins are listed according to 
ascending PA numbers. 
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probable two-component response regulator containing a degenerate GGDEF domain with the 
additional c-di-GMP binding site (I-site). Thus, this protein might not act as a diguanylate 
cyclase (DGC), but as a true c-di-GMP effector molecule. The hypothetical protein PA2567 
harbors a degenerate GGDEF domain without I-site motif, which is fused to a conserved EAL 
domain possessing phosphodiesterase (PDE) activity ([143] and own observations). This 
protein might have been “trapped” on the c-di-GMP sepharose during its attempt to degrade 
the immobilized c-di-GMP, though the presence of a distinct and unknown c-di-GMP binding 
site cannot be excluded. 
Three other proteins were specifically enriched by the three pull down experiments more than 
once: the hypothetical protein PA3740, and the two chemotaxis proteins CheR1 (PA3348) 
and PA0174 (CheD) [144]. 
 
3.2.4 The P. aeruginosa PA14 c-di-GMP interactome 
In the following, the c-di-GMP sepharose was also used for the isolation of c-di-GMP binding 
proteins from P. aeruginosa PA14. Three independent experiments were performed (termed 
1, 2 and 3) using soluble lysate in experiment 1, and BugBuster lysate obtained by chemical 
lysis of cells in experiment 2. Experiment 3 is the combination of two pull downs that were 
performed in parallel: after cell lysis and the following centrifugation step, the supernatant 
(soluble lysate) was used for one pull down, and membranes isolated from the insoluble pellet 
were used for a second pull down. In all cases, freshly prepared cell lysates derived from 
stationary phase cultures were incubated with the c-di-GMP affinity resin and control beads, 
and after extensive washing steps, enriched proteins were eluted by the addition of free 
c-di-GMP (0.1 M). 
While a Q-TOF mass spectrometer was used for the analysis of PA01 eluates, all PA14 
eluates were analyzed with a highly sensitive Orbitrap XL mass spectrometer, which led to 
the detection of a significantly higher number of proteins (Table 3.3). As in the PA01 pull 
downs, more proteins were isolated on the control beads as compared with the respective 
c-di-GMP affinity resin, and analysis of the control bead proteome once again revealed an 
extensive overlap of proteins derived from the individual control pull downs (Figure 3.12). 
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The various proteins enriched by the c-di-GMP and control resin were categorized according 
to their function as proposed by the Pseudomonas Genome Database 
(www.pseudomonas.com) [139]. In Figure 3.13, those functional categories are depicted to 
which at least 5% of the c-di-GMP or control proteins could be assigned to. Approximately 
81% of all proteins isolated by the control sepharose could be grouped into six main 
Table 3.3. Pulled down proteins of three distinct experiments performed with PA14 lysates 
using the c-di-GMP affinity resin and the control resin. 
 
Experiment 
1a 
Experiment 
2b 
Experiment 
3c 
Number of distinct 
proteins 
Proteins enriched by the c-di-GMP 
sepharose 23 166 152 236 
Proteins enriched by the control 
sepharose 171 268 377 457 
Proteins enriched by the c-di-GMP 
sepharose, but not by the respective 
control sepharose 
8 78 48 122 
Proteins enriched by the c-di-GMP 
sepharose, but not by any        
control sepharose 
2 59 36 87 
a
 performed with soluble cell lysate 
b
 performed with BugBuster cell lysate 
c
 combination of two pull downs (soluble cell lysate and membrane fraction) 
PA14 
experiment
1
19 54
135
97
110
35
7
PA14 
experiment 
2
PA14 
experiment 
3
 
Figure 3.12. Comparison of proteins that were pulled down in P. aeruginosa PA14 
lysates using the control resin in three different experiments. 
In experiment 1, the control resin was incubated with soluble cell lysate and in experiment 2 with BugBuster cell 
lysate. Experiment 3 is the combination of two pull downs in which the control beads were incubated with 
soluble lysate and a membrane fraction, respectively. 
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categories, whereas the c-di-GMP sepharose pull down showed a broader distribution and 
only 67% of the identified proteins belong to the depicted categories. Remarkably, a large 
number of the enriched proteins were involved in translation, post-translational modification 
and degradation, and the categorization of proteins isolated by the c-di-GMP sepharose 
revealed a higher relative number of proteins in this category as compared with the control. 
Furthermore, the relative proportion of proteins involved in energy metabolism was found to 
be increased in the c-di-GMP sepharose pull down. This group includes proteins binding ATP 
and NADH, small molecules with nucleotide-like structures. 
 
3.2.5 PA14 proteins specifically enriched by the c-di-GMP sepharose 
In order to reduce the number of false positives on our protein lists, results of all control pull 
downs (experiment 1-3) were included as a reference to validate the specificity of results in 
each of the three c-di-GMP pull down experiments. As depicted in Table 3.3, overall 87 
distinct putative c-di-GMP binding proteins were identified in P. aeruginosa PA14. In order 
to further minimize the rate of false positives, more stringent parameters were applied in the 
control samples (i.e. a confidence interval of > 50% was accepted for protein identification). 
When these parameters were applied, 23 of the 87 proteins also appeared in the control bead-
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Figure 3.13. Classification of the pulled down proteins in PA14 according to PseudoCAP 
function. 
Proteins isolated by the c-di-GMP sepharose are depicted by white bars, proteins isolated by the control 
sepharose are depicted by black bars. Only groups including at least 5% of the c-di-GMP or control interactome 
are shown. 
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proteome list and were therefore excluded from the list of putative c-di-GMP binding 
proteins. Remarkably, most of the 23 proteins were identified in the BugBuster experiment in 
which cells have been lysed chemically. The remaining 64 c-di-GMP binding candidate 
proteins are listed in Table 3.4. 
Table 3.4. Putative PA14 c-di-GMP binding proteins. 
PA14   
numbera 
PA 
number 
(Alternate) 
gene name Product name Comment 
PA14_49030 *  hypothetical protein anion-transporting ATPaseb 
PA14_00090 PA0008 glyS glycyl-tRNA synthetase beta chain   
PA14_00130 PA0012  hypothetical protein PilZ domainb 
PA14_02190 PA0174 cheD putative chemotaxis protein   
PA14_03940 PA0302 spuF, potG polyamine transport protein PotG ABC-type spermidine/putrescine  
transport systems, ATPase componentsc 
PA14_06750 PA0519 nirS nitrite reductase precursor   
PA14_54640 PA0745  probable enoyl-CoA hydratase/isomerase   
PA14_52180 PA0934 relA GTP pyrophosphokinase   
PA14_51730 PA0971 tolA TolA protein   
PA14_51390 PA0999 pqsD, fabH1 3-oxoacyl-[acyl-carrier-protein] synthase III   
PA14_49470 PA1155 nrdB ribonucleoside reductase, small chain   
PA14_49200 PA1178 oprH PhoP/Q and low Mg2+ inducible outer membrane 
protein 
  
PA14_45590 PA1458 cheA putative two-component sensor   
PA14_45580 PA1459 cheB putative chemotaxis methylesterase   
PA14_45560 PA1460 motC, motA2 chemotaxis protein MotC   
PA14_43950 PA1588 sucC succinyl-CoA synthetase beta subunit ATP-grasp domainb 
PA14_41670 PA1770 ppsA phosphoenolpyruvate synthase   
PA14_41470 PA1787 acnB aconitate hydratase 2   
PA14_38440 PA2015 gnyD, ivd Citronelloyl-CoA dehydrogenase, GnyD   
PA14_37690 PA2072  putative sensory box protein GGDEF domain with I-site motif, EAL 
domainb 
PA14_30070 PA2633  putative secretion system protein   
PA14_27930 PA2799  conserved hypothetical protein PilZ domainb 
PA14_25840 PA2953  putative electron transfer flavoprotein-ubiquinone 
oxidoreductase 
FAD binding domainb 
PA14_25520 PA2980  conserved hypothetical protein   
PA14_25420 PA2989  conserved hypothetical protein PilZ domainb 
PA14_24445 PA3068 gdhB NAD-dependent glutamate dehydrogenase   
PA14_23010 PA3187 gltK, ugpC putative ATP-binding component of ABC 
transporter 
MalK, ABC-type sugar transport systems, 
ATPase componentsc 
PA14_22020 PA3244 minD cell division inhibitor MinD MinD, septum formation inhibitor-
activating ATPasec 
PA14_22010 PA3245 minE cell division topological specificity factor   
PA14_20780 PA3346  putative sensor histidine kinase/response regulator   
PA14_20760 PA3348 cheR1 putative chemotaxis protein methyltransferase   
PA14_20700 PA3353  putative glycosyltransferase PilZ domainb 
PA14_16500 PA3702 wspR probable two-component response regulator GGDEF domainb with I-site motif 
PA14_16020 PA3740  conserved hypothetical protein   
PA14_12330 PA3981  PhoH family protein   
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Previously described c-di-GMP binding proteins in P. aeruginosa include 7 PilZ domain 
proteins (there are 8 PilZ domains in P. aeruginosa, however, one did not seem to bind 
c-di-GMP in vitro [82]), the membrane associated PelD protein [98], the transcriptional 
regulator FleQ [88] and the catalytically inert GGDEF-EAL hybrid protein FimX [99]. The 
Table 3.4. (Continued) 
PA14    
numbera 
PA 
number 
(Alternate) 
gene name Product name Comment 
PA14_12100 PA3999 dacC D-ala-D-ala-carboxypeptidase   
PA14_10820 PA4108  putative HDIG domain protein HD-GYP domain [95]  
PA14_09520 PA4207 mexI probable RND efflux transporter   
PA14_39890 PA4215 phzF2 probable phenazine biosynthesis protein   
PA14_09300 PA4223 pchH putative ATP-binding component of ABC 
transporter 
putative ATP-binding 
PA14_09230 PA4229 pchC pyochelin biosynthetic protein PchC   
PA14_09050 PA4243 secY secretion protein SecY   
PA14_56000 PA4309 pctA chemotactic transducer PctA   
PA14_56830 PA4370 icmP insulin-cleaving metalloproteinase outer membrane   
PA14_57275 PA4407 ftsZ cell division protein FtsZ cell division GTPasec 
PA14_57340 PA4412 murG UDP-N-acetylglucosamine:LPS N-
acetylglucosamine  transferase 
  
PA14_57370 PA4414 murD UDP-N-acetylmuramoylalanine-D-glutamate ligase   
PA14_57570 PA4431  putative cytochrome c reductase, iron-sulfur subunit   
PA14_57850 PA4454  conserved hypothetical protein   
PA14_58150 PA4481 mreB rod shape-determining protein MreB actin-like ATPase involved in cell 
morphogenesisc 
PA14_58630 PA4519 speC putative ornithine decarboxylase   
PA14_60970 PA4608  conserved hypothetical protein PilZ domain 
PA14_62860 PA4751 ftsH, hflB cell division protein FtsH HflB, ATP-dependent Zn proteasesc 
PA14_63250 PA4785 yfcY putative acyl-CoA thiolase   
PA14_64390 PA4868 ureC urease alpha subunit   
PA14_65520 PA4958  conserved hypothetical protein adjacent to the fimX gene 
PA14_66620 PA5040 pilQ type 4 fimbrial biogenesis outer membrane protein 
PilQ precursor 
  
PA14_66750 PA5051 argS arginyl-tRNA synthetase   
PA14_66910 PA5064  conserved hypothetical protein   
PA14_68820 PA5210 gspE putative general secretory pathway related protein PulE, Type II secretory pathway, ATPase 
PulE/Tfp pilus assembly pathway, 
ATPase PilBc 
PA14_69220 PA5241 ppx, gppA exopolyphosphatase   
PA14_72380 PA5483 algB two-component response regulator AlgB AtoC, Response regulator containing 
CheY-like receiver, AAA-type ATPase, 
and DNA-binding domainsc 
PA14_72460 PA5490 cc4, cycA cytochrome c4 precursor   
PA14_73290 PA5558 atpF ATP synthase B chain   
aThose proteins are listed that were identified with a probability of ≥ 95% in at least one of three c-di-GMP pull 
downs, but not in any of the controls (with a probability of ≥ 50%). The proteins are listed according to 
ascending PA numbers. 
b
 as predicted by PFAM 
c
 as predicted by COG 
*
 not present in PA01 
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c-di-GMP binding candidate protein list was searched for these known c-di-GMP targets and 
was found to contain five PilZ domain proteins that were identified either in all experiments 
(PA3353, PA4608), twice (PA2799, PA2989) or in one experiment (PA0012). Additionally, 
two proteins containing the c-di-GMP binding motif of the I-site are listed in Table 3.4. One 
is the response regulator WspR, a characterized DGC known to be prone to allosteric 
feedback inhibition [39, 145], the second protein is the GGDEF-EAL hybrid protein PA2072. 
Further analysis of the obtained c-di-GMP interacting proteins revealed 13 proteins containing 
putative nucleotide binding sites such as GTP- and ATPases, ATP-binding components of 
ABC transporters or proteins binding the dinucleotide NAD or FAD. Among the remaining 
identified proteins, 5 are conserved hypotheticals, for example, PA3740 which was also 
identified in the PA01 pull downs, and 6 are involved in flagellum mediated chemotaxis. Two 
of these 6 proteins were found in all PA14 c-di-GMP pull down experiments: the chemotaxis 
methyltransferase CheR1 and CheD (PA0174) both of which have also been identified as 
putative c-di-GMP binding proteins in pull down experiments using PA01 lysates. 
 
3.2.6 Surface plasmon resonance binding studies with c-di-GMP 
To approve c-di-GMP binding to purified proteins in vitro, surface plasmon resonance (SPR) 
was applied with the aim to explore the interaction between an analyte in the mobile phase 
and a ligand immobilized on a sensor surface. All SPR binding studies were performed in co-
operation with the group of F. W. Herberg (Daniela Bertinetti, Stefan Möller; University of 
Kassel) and Bastian Zimmermann (Biaffin company, Kassel). 
Initially, a very sensitive method (Biacore S51 system) was used to detect direct binding of 
c-di-GMP (690.4 Da) to immobilized proteins (30-45 kDa). In these experiments binding 
signals were obtained, but the limited stability of the proteins and regeneration of the protein 
sensor surface restricted the reproducibility of these measurements (data not shown). 
Recently, a functionalized c-di-GMP derivative became available with a 6-aminohexyl-
carbamoyl group attached to the 2' alcohol group of one ribose-ring (2'-AHC-c-di-GMP, 
Figure 3.10; Biolog, Bremen). This c-di-GMP analog was successfully coupled via its linker-
amino group to a sensor chip, and binding of the purified proteins was analyzed at 20°C using 
a Biacore 3000 instrument. 
In order to verify the surface functionality of the sensor chip, interaction analysis was started 
with PA3353, a PilZ domain protein for which c-di-GMP binding has been demonstrated 
previously [82]. This protein was identified in pull down experiments of both, PA14 and 
PA01 lysates. Figure 3.14A shows the association and dissociation of PA3353-His6 to the 
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high density 2'-AHC-c-di-GMP sensor surface with increasing binding signals upon rising 
protein concentrations (2-500 nM). In a solution competition assay, a constant concentration 
of PA3353-His6 (15 nM and 5 nM, respectively) together with increasing amounts of free 
c-di-GMP (50 pM-10 µM) was added to the sensor chip. By plotting the SPR signal (for each 
c-di-GMP concentration) obtained at the end of the association phase against the 
concentration of free c-di-GMP, the apparent EC50 (half maximal effective concentration) 
value was determined to be 262 ± 66 nM for PA3353-His6 (Figure 3.14B). 
Next, the putative response regulator PA4396 was examined, which harbors a degenerate 
GGDEF domain (the conserved sequence motif is changed to DEQHF) with an intact I-site 
motif. PA4396 was expressed and purified with an N-terminal Strep-tag and tested for DGC 
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Figure 3.14. C-di-GMP binding analysis by SPR with purified proteins and a 2'-AHC-
c-di-GMP sensor chip. 
(A) PA3353-His6 binds to 2'-AHC-c-di-GMP in a concentration dependent manner (protein concentration range 
2-500 nM). (B) Solution competition assays of PA3353-His6 using protein concentrations of 15 nM (dashed line) 
and 5 nM (continuous line) revealed an EC50 value of 262 ± 66 nM. Normalized data are shown. First data points 
are in brackets, indicating SPR signals of protein incubated without c-di-GMP. (C) For Strep-PA4396 an EC50 
value of 59 ± 19 µM was determined using 100 nM protein in the competition experiments (n=2, continuous and 
dashed line, respectively). Normalized data are shown. First data points are in brackets, indicating SPR signals of 
protein incubated without c-di-GMP. (D) Solution competition assays of PA3740-His6 revealed an EC50 value of 
30 ± 12 nM (n=3, using 500 nM, 100 nM and 50 nM of protein). Normalized data are shown. First data points 
are in brackets, indicating SPR signals of protein incubated without c-di-GMP. 
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activity. As expected, Strep-PA4396 was not able to synthesize c-di-GMP from [α-32P]GTP 
(Figure 3.15). The protein was then tested for its ability to interact with the 2'-AHC-c-di-GMP 
sensor surface. SPR analysis revealed a specific interaction between Strep-PA4396 (100 nM) 
and immobilized 2'-AHC-c-di-GMP as this binding could be completely competed with free 
c-di-GMP in solution. The EC50 value was determined to be 59 ± 19 µM (Figure 3.14C) in the 
SPR solution competition assay. This verifies the degenerate GGDEF domain protein PA4396 
as a new c-di-GMP binding protein, however, the cellular function of this interaction is still 
unknown. 
 
The affinity chromatography performed on PA14 and PA01 also revealed a group of 
chemotaxis proteins as putative c-di-GMP effectors. Since flagellar driven motility is known 
as a trait also controlled by c-di-GMP, we analyzed CheR1, which was repeatedly isolated in 
the pull down experiments (identified in 5 out of the 6 affinity chromatographies performed in 
this study). CheR1 is a chemotaxis methyltransferase (see chapter 3.1.2) and does not harbor 
any known c-di-GMP binding motif. In first SPR experiments, the CheR1-His6 protein was 
immobilized on a sensor surface (Biacore S51 machine, see above) and the small ligand was 
injected over the sensor chip. Besides c-di-GMP, S-adenosylmethionine (SAM) was also 
injected, as chemotaxis methyltransferases are known to use this methyl donor as a substrate. 
In case of the c-di-GMP interaction, no binding signal could be detected, but the interaction 
between CheR1-His6 and SAM could be verified (Figure 3.1). Thereafter, 2'-AHC-c-di-GMP 
 
 
Figure 3.15. Radioactive diguanylate cyclase activity assay. 
Purified Strep-PA4396 was assayed for DGC activity by incubation with [32P]GTP at 30°C. Analysis of the 
reaction mixture by TLC after several time points demonstrated that Strep-PA4396 was not able to synthesize 
radiolabeled c-di-GMP. As controls, [32P]GTP and [32P]c-di-GMP (enzymatically synthesized by the 
constitutively active DGC PleD*) were spotted on the TLC plate. 
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was coupled to the sensor surface (Biacore 3000, see above) and injection of CheR1-His6 
resulted in a SPR signal, however, coinjection of CheR1-His6 with free c-di-GMP did not 
result in significant signal reduction. Even when various different parameters, co-factors and 
detergents (protein concentration up to 1 µM, buffer composition, pH value, SAM, cGMP, 
cAMP, MgCl2, CM dextran, DTT) were applied, the SPR signals were identical. Furthermore, 
binding to the c-di-GMP sensor surface could not be competed with a wide range of 
c-di-GMP concentrations (100 nM – 10 µM), indicating nonspecific binding of CheR1-His6 to 
the sensor surface (Figure 3.16A). To further address this question, binding experiments were 
done in presence of 100 nM c-di-GMP, cAMP and cGMP (Figure 3.16B). Injection of  
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Figure 3.16. C-di-GMP binding analysis by SPR with purified proteins and a 2'-AHC-
c-di-GMP sensor chip. 
(A) Binding analysis of purified CheR1-His6 demonstrates that CheR1 (1 µM, black line) binds to the sensor 
surface, but that binding cannot be competed with free c-di-GMP (e.g. 10 µM, gray line). (B) To analyze 
whether binding to the sensor chip is unspecific, binding experiments using 1 µM CheR1-His6 (black line) were 
done in presence of 100 nM c-di-GMP (light gray), cAMP (dark gray) or cGMP (gray line). Binding was not 
competed by any of the cyclic nucleotides indicating an unspecific mode of binding. (C) Binding analysis of 
purified PA3740-His6 demonstrates that PA3740 (800 nM, black line) binds specifically to the sensor surface. 
This binding can be competed with c-di-GMP (light gray, 1 µM), but not with cAMP (dark gray, 1 µM). cGMP 
(gray, 1 µM) causes only a slight shift. 
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CheR1-His6 to the sensor surface resulted in a low SPR signal in comparison to the employed 
protein concentration (1 µM). More importantly, binding of CheR1 could neither be competed 
with c-di-GMP, nor with cAMP and cGMP. Thus, although repeatedly isolated by affinity 
chromatography, we were not able to validate CheR1 as a c-di-GMP binding protein. 
In our search for novel c-di-GMP effectors, the conserved hypothetical protein PA3740 was 
identified in pull down experiments with both, PA14 and PA01 lysates. Due to an apparent 
toxicity to E. coli BL21 cells, PA3740-His6 was expressed by the use of an in vitro translation 
system and purified by Ni-NTA affinity chromatography (see Materials and Methods, chapter 
2.5). In SPR binding studies, PA3740-His6 was able to bind to the 2'-AHC-c-di-GMP sensor 
surface, however with low stoichiometry. This binding could be competed with free 
c-di-GMP, but not with cAMP and the injection of protein pre-incubated with cGMP resulted 
in only a slightly decreased binding signal (Figure 3.16C). In a solution competition assay 
format, an EC50 value of 30 ± 12 nM was determined for the interaction between c-di-GMP 
and PA3740-His6 (Figure 3.14D). Overall, the SPR binding studies demonstrated that PA3740 
specifically and reproducibly binds 2'-AHC-c-di-GMP with a nanomolar affinity, which 
highlights PA3740 as a novel c-di-GMP effector. The next challenge will be to reveal the 
c-di-GMP binding motif of this hypothetical protein. 
 
3.2.7 Phenotypic characterization of mutants affected in the expression of c-di-GMP 
binding proteins 
To examine the molecular function of verified c-di-GMP binding proteins in P. aeruginosa, 
the impact of PA3353, PA4396 and PA3740 on bacterial motility and biofilm formation was 
analyzed. Therefore, respective transposon mutants in the PA01 strain background (correct 
insertion of transposon was confirmed by PCR) were tested for their ability to swim, swarm 
and twitch on agar plates, or to form biofilms at the liquid-air interface in microtiter plate 
grown cultures. The PA3353 transposon mutant was obtained from the Washington Genome 
Center PA01 mutant library [101] and compared to another transposon mutant that is 
unaffected in its motility and biofilm formation behavior (therefore termed wild-type control; 
see chapter 2.1). The transposon mutants of PA4396 and PA3740 were received from the 
PA01mini-Tn5 lux transposon mutant library ([105], kindly provided by R. E. Hancock, 
University of British Columbia, Canada) and compared to their isogenic parent strain (PA01 
H103 wt). 
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PA3353 
So far, nothing is known about the cellular role of PA3353. The PA3353 gene is part of a 
predicted operon (www.pseudomonas.com) that contains a gene encoding an anti-sigma 
factor (FlgM) and a gene encoding the hypothetical protein PA3352. The anti-sigma factor 
FlgM inhibits the activity of FliA [146], an alternative sigma factor which controls the 
biosynthesis of flagellin [147]. PA3353 itself encodes a hypothetical protein, consisting of an 
N-terminal YcgR domain and a C-terminal PilZ domain. The YcgR protein from E. coli is a 
PilZ domain protein that has been shown to interact with the flagellar motor in a c-di-GMP 
dependent manner thereby acting as a molecular brake [79, 148].  
Thus, swimming assays of a PA01 mutant with a transposon insertion within PA3353 were 
performed. Compared to the wild-type control, the PA3353 transposon mutant displayed an 
increased ability to swim on 0.3% soft-agar plates (Figure 3.17A). Plasmid-borne 
complementation of the PA3353 transposon mutant resulted in a reduction of the swimming 
zone as compared with the PA3353 transposon mutant. Moreover, the swimming zone of this 
PA3353 overexpressing strain was even smaller than that of the wild-type control, indicating 
a significantly impaired ability to swim (Figure 3.17A). Growth curves in liquid cultures 
suggested that these phenotypic differences were not caused by different growth rates (data 
not shown). To assess, whether PA3353 also impacts surface-associated motility, swarming 
and twitching assays were performed. While the PA3353 transposon mutant displayed a 
swarming pattern similar to that of the wild-type control, the PA3353 overexpressing strain 
had severe difficulties to swarm (Figure 3.17B). The ability to twitch on solid surfaces was 
found to be unaffected, in both the transposon mutant and in the PA3353 overexpressing 
strain (Figure 3.17C).  
Next, biofilm formation was assayed by crystal violet (CV) staining of adherent cells. In 
comparison with the wild-type control, more cells attached to the wall of wells incubated with 
the PA3353 transposon mutant strain, while the attachment ability of cells overexpressing 
PA3353 was decreased (Figure 3.17D). As motility can have a profound impact on biofilm 
formation, the biofilm phenotypes may be caused by the altered motility behaviors of the 
PA3353 transposon mutant and PA3353 overexpressing strain. 
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Figure 3.17. Motility and biofilm formation phenotype of the PA01 PA3353 transposon 
mutant and the PA3353 overexpressing PA01 strain. 
(A) Swimming assays were performed on minimal medium soft agar plates supplemented with 0.3% agar. 
Swimming zones were measured after 18 h of incubation at 37°C. (B) Swarming assays were performed on 
minimal medium plates supplemented with 0.5% agar. The plates were incubated at 30°C for 18 h. (C) 
Twitching motility was analyzed at the plastic-agar interface of 1.5% LB agar plates and twitching zones were 
measured after incubation for 41 h at 37°C. (D) Biofilm formation was monitored in 96-well microtiter plates by 
crystal violet staining of attached biomass after 24 h of static growth in LB at 37°C. 
Each experiment was performed at least twice. Error bars are standard deviations of three replicates (in A, C) 
and eight replicates (in D), respectively.
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In E. coli, it has been demonstrated that knockout of the PilZ domain protein YcgR restores 
the impaired swimming motility of a mutant lacking the c-di-GMP phosphodiesterase YhjH. 
Genetic inactivation of YhjH is expected to lead to elevated c-di-GMP levels and thus to 
activation of YcgR, which in turn reduces flagellar motor function [79, 81]. In P. aeruginosa, 
the GGDEF-EAL hybrid protein PA5017 strongly affects swimming and swarming motility 
([149] and own observations). The GGDEF motif of this protein is imperfect (ASNEF), but 
the EAL domain contains all conserved amino acids that are required for PDE activity [62]. 
To test whether PA3353 can restore the impaired swimming and swarming motility of a 
PA5017 transposon mutant, a PA5017_PA3353 double mutant was constructed and compared 
to the wild-type control, to the PA5017 transposon mutant and to a constructed PA3353 
knockout mutant of the wild-type control. Both PA5017 strains, the PA5017 transposon 
mutant and the PA5017_PA3353 double mutant, differed slightly in their planktonic growth 
rate compared with the PA01 wild-type control (Figure 3.18). After 4 h, the two strains 
stopped growing for a short period before growing again so rapidly that after 7 h they reached 
the same optical density as the wild-type control. Swimming assays performed on 0.3% soft-
agar plates confirmed the increased swimming ability of a PA3353 mutant (here, in the wild-
type control background). Additionally, they demonstrated that inactivation of PA3353 in the 
PA5017 mutant background also slightly enhances swimming motility, however the impaired 
swimming ability of the PA5017 mutant could not be fully restored (Figure 3.19A). 
Furthermore, the PA5017_PA3353 double mutant was still reduced in its swarming motility, 
as is the case for the PA5017 transposon mutant (Figure 3.19B). Twitching motility was 
unaffected in all strains tested (wt control, PA5017 transposon mutant, wt control_PA3353 
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Figure 3.18. Growth rate of the PA01 wt control, PA5017 transposon mutant, wt 
control_PA3353 double mutant and PA5017_PA3353 double mutant. 
Bacterial growth was monitored at 37°C for 16 h. Both strains impaired in the expression of the GGDEF-EAL 
hybrid protein PA5017 (PA5017 and PA5017_PA3353) show a temporary delay in their growth rate. 
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mutant, PA5017_PA3353 double mutant, data not shown). Both the PA5017 transposon 
mutant and the PA3353 mutant in the wt control background displayed a slight increase in 
biofilm formation as compared with the wt control (Figure 3.19C). This effect was even more 
pronounced in the PA5017_PA3353 double mutant. Overall, the data derived from the 
motility and biofilm formation assays indicate that PA5017 and PA3353 are acting 
independently from each other. 
 
 
Figure 3.19. Motility and biofilm formation phenotype of a PA01 PA5017 transposon 
mutant and a PA5017_PA3353 double mutant. 
(A) Soft-agar swimming motility assay. The PA5017 transposon mutant was compared to the wt control and a wt 
control_PA3353 double mutant on one plate (black bars) and to the wt control and a PA5017_PA3353 double 
mutant on a second plate (gray bars). Error bars are standard deviations of three replicates. The experiment was 
repeated twice. (B) Swarming motility assay. Representative pictures from one out of two experiments (three 
replicates each) are shown. (C) Crystal violet staining of attached biomass. Error bars are standard deviations of 
eight replicates. 
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PA4396 
Next, a mutant with a transposon insertion within the PA4396 gene was characterized. 
PA4396 encodes a probable two-component response regulator which has an N-terminal 
receiver domain and a C-terminal degenerate (and inactive) GGDEF domain that harbors the 
secondary c-di-GMP binding site (I-site). With this domain organization, PA4396 is 
homologous to the PopA protein of Caulobacter crescentus, which has been shown to act as a 
c-di-GMP effector despite its inactive GGDEF domain [84]. The PA4396 gene is located in a 
predicted operon that also contains panE, encoding a ketopentoate reductase, PA4398, 
encoding a putative sensor kinase, and PA4399, which encodes a conserved hypothetical 
protein (www.pseudomonas.com). 
A PA01 H103 PA4396 transposon mutant displayed swimming, swarming and twitching 
motility patterns identical to those of the respective wild-type (Figure 3.20A, B and C). 
However, plasmid borne overexpression of PA4396 in the PA01 H103 wild-type resulted in 
an altered motility behavior. Compared with the wild-type, the PA4396 overexpressing strain 
showed an enhanced swimming ability, displayed a different swarming pattern and was 
clearly reduced in its ability to twitch (Figure 3.20A-C). This altered phenotype was not due 
to a difference in the growth rate relative to the wild-type (data not shown). 
In a CV biofilm assay, the PA4396 transposon mutant and the PA4396 overexpressing strain 
were able to attach to the walls of a 96-well plate comparable to the wild-type (Figure 3.20D). 
Overall, these data indicate that PA4396 impacts on bacterial motility. 
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Figure 3.20. Motility and biofilm formation phenotype of the PA4396 transposon mutant 
and the PA4396 overexpressing strain. 
(A) Swimming assays were performed on minimal medium soft agar plates supplemented with 0.3% agar. 
Swimming zones were measured after 18 h of incubation at 37°C. (B) Swarming assays were performed on 
minimal medium plates supplemented with 0.5% agar. The plates were incubated at 30°C for 18 h. (C) 
Twitching motility was analyzed at the plastic-agar interface of 1.5% LB agar plates and twitching zones were 
measured after incubation for 30 h at 37°C. (D) Biofilm formation was monitored in 96-well microtiter plates by 
crystal violet staining of attached biomass after 24 h of static growth in LB at 37°C. 
Each experiment was performed twice. Error bars are standard deviations of three replicates (in A, C) and eight 
replicates (in D), respectively. 
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PA3740 
So far, nothing is known about the hypothetical protein PA3740. Phenotypic assays using a 
PA01 H103 PA3740 transposon mutant and the PA01 H103 wild-type revealed no differences 
in motility behavior and the ability to form biofilms. Furthermore, overexpression of PA3740 
in the wild-type did not alter the swimming/swarming/twitching motility or biofilm formation 
phenotype (data not shown). 
However, an observable phenotype might be readily missed if intracellular c-di-GMP levels 
are too low and PA3740 is in an inactive state. Therefore, a PA3740 knockout mutant was 
constructed in the PA5017 mutant background, a strain that lacks the PDE PA5017 and 
should have an increased c-di-GMP level (judged from the impaired swimming and swarming 
motility of the PA5017 transposon mutant). However, the PA5017_PA3740 double mutant 
displayed the same phenotype as the PA5017 transposon mutant (Figure 3.21A-C). It shows a 
temporary delay in its growth rate, and the knockout of PA3740 could not restore the reduced 
swimming motility or the enhanced biofilm formation of the PA5017 transposon mutant 
(compared with the wild-type control). The performance of additional phenotypic assays will 
be required to elucidate the cellular function of the hypothetical, c-di-GMP binding protein 
PA3740. 
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Figure 3.21. Distinct phenotypes of a PA01 wt control_PA3740 double mutant and a 
PA5017_PA3740 double mutant. 
(A) Time course analysis of bacterial growth of the wt_control, wt_control_PA3740 double mutant, PA5017 
transposon mutant and PA5017_PA3740 double mutant. (B) Soft agar swimming motility assay. The wt control 
and PA5017 transposon mutant were compared to the wt control_PA3740 double mutant on one plate (black 
bars) and to the PA5017_PA3740 double mutant on a second plate (gray bars). Error bars are standard deviations 
of three replicates. The experiment was repeated once. (C) Crystal violet staining of attached biomass. Error bars 
are standard deviations of eight replicates. 
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3.3 Identification of the RpoS regulon by chromatin immunoprecipitation 
3.3.1 Objective 
To achieve specificity within the complex c-di-GMP signaling system, it is necessary to 
tightly control the multiple c-di-GMP metabolizing and binding proteins at the transcriptional, 
post-transcriptional and/or post-translational level. One powerful tool for elucidating 
transcriptional regulatory mechanisms on a global scale is chromatin immunoprecipitation 
combined with microarray analysis (ChIP-chip), which enables the identification of DNA 
regions that are bound by a specific transcription factor under specific growth conditions. In 
P. aeruginosa, expression of genes is tightly controlled by a large collection of transcriptional 
regulators and alternative sigma-factors which redirect transcription initiation in response to 
environmental or physiological changes [150]. The stationary phase sigma-factor RpoS has 
been implicated in the general stress response, but also in the secretion of virulence factors 
and the formation of biofilms [150-154]. In this context, aim of this thesis was to apply the 
ChIP-chip technique in order to uncover the RpoS regulon and to reveal a potential link to the 
c-di-GMP signaling network. 
 
3.3.2 The RpoS regulon as identified by the ChIP-chip technique 
To determine RpoS promoter targets on a genome-wide scale, P. aeruginosa cultures were 
grown to the onset of stationary phase (OD600 of 2.0) at which DNA-bound RpoS was cross-
linked to its DNA targets by formaldehyde fixation. After cell lysis, the RpoS-DNA 
complexes were isolated by immunoprecipitation using a polyclonal anti-RpoS serum (kindly 
provided by V. Venturi, International Center for Genetic Engineering and Biotechnology, 
Trieste, Italy). The cross-link was reversed and isolated promoter targets were further purified 
and amplified as described in the Materials and Methods section (see chapter 2.9.2). The 
samples were analyzed with a P. aeruginosa genome microarray that has been recently 
developed in our group (Dötsch et al., [104]). This custom made microarray consists of 
25-mer oligonucleotides and targets the whole P. aeruginosa PA01 genome at an average of 
one probe every 29 base pairs. All data analyses were supported by Andreas Dötsch, 
Helmholtz Center for Infection Research. Thereby, signals from two RpoS ChIP-chip 
experiments were compared to those of two controls in which an irrelevant polyclonal serum 
was employed instead of the anti-RpoS serum. The TAS software (Affymetrix) was used to 
calculate the log2-fold enrichment values, revealing 474 promoter regions that were enriched 
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by more than 0.5, out of which 128 promoter regions were even enriched by at least 1.0 log2-
fold (for the complete list of enriched promoter regions see Appendix, Table 5.2). In 298 
cases, the enriched region could be assigned to two adjacent genes with opposite orientation 
(signed as “shared promoter” in Table 5.2). 
In a previous study, Schuster et al. [136] demonstrated that 772 genes are regulated by RpoS 
in the stationary phase of growth by analyzing the transcriptome of a PA01 rpoS mutant in 
comparison with the transcriptome of the respective wild-type. They also suggested the 
consensus sequence for the RpoS binding site to be CTATACT (deduced from 16 RpoS 
regulated genes). Upon comparison of our ChIP-chip data with the transcriptome data of 
Schuster et al., 128 genes were identified as RpoS regulated genes in both studies. Of those 
128 genes, 32 had the CTATACT consensus sequence within the upstream non-coding region 
(up to 300 bp). Based on these 32 most confident hits, a new consensus sequence was 
calculated which is depicted in Figure 3.22B and Figure 3.23 shows the distribution of genes 
that were identified in our ChIP-chip experiments (A), that contain the revised RpoS 
consensus box in their non-coding upstream region (B) and/or that were differentially 
expressed in an rpoS mutant as compared with the wild-type [136] (C). The 59 genes which 
were positive in all three criteria are listed in the Appendix (Table 5.3). 
 
 
 
 
 
 
 
 
Figure 3.22. Determination of the RpoS consensus sequence. 
(A) Based on the calculation by using the 16 target genes selected by Schuster et al. [136]. (B) Based on the 
calculation by using the 32 target genes selected by Schuster et al. [136], the previous RpoS consensus box and 
the ChIP-chip experiment. 
A 
B 
3. Results   69 
 
3.3.3 Influence of RpoS on chemotaxis, biofilm formation and c-di-GMP signaling 
To understand the RpoS regulon in more detail, the list of ChIP-chip identified RpoS targets 
was scanned for genes involved in chemotaxis, biofilm formation and c-di-GMP signaling. 
RpoS has been previously shown to regulate several chemotaxis genes, especially those of 
cluster II (PA0173-PA0180) and the mcp genes PA1930, PA2573, PA2920 and PA4915 [136, 
155]. In agreement with those earlier studies, the promoter region of cheY2 (and thus the 
whole PA0173-PA0179 operon) was identified as an RpoS-binding target in our ChIP-chip 
experiments. This region also contains an RpoS consensus sequence located 115 bp upstream 
of the translational start site. Furthermore, the promoter regions of the mcp genes PA1930 
(mcpS), PA2573, PA4307 (pctC) and PA4915 were enriched by chromatin immuno-
precipitation by at least 0.5 log2-fold (Table 3.5). 
RpoS has been also reported to affect biofilm formation and production of the 
exopolysaccharides alginate [136, 151] and Psl [136, 152]. Inspection of the ChIP-chip result 
list indicates algP (encoding an alginate regulatory protein [156, 157]) and pslA (part of an 
operon encoding the Psl biosynthetic machinery [158-160]) as direct RpoS regulated genes 
(Table 3.5). Furthermore, RpoS was found to bind the promoter region of sadB, a gene 
previously described to be essential for the transition from reversible to irreversible 
attachment during biofilm formation [161]. In addition, RpoS seems to influence biofilm  
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Figure 3.23. Comparison of three different approaches to identify RpoS-regulated genes. 
(A) Genes that were enriched at least 0.5 log2-fold by ChIP-chip using an RpoS antibody. (B) Genes harboring 
one or more (re-calculated) consensus sequences (weight score ≥ 6.0) within the upstream non-coding region (up 
to 300 bp). (C) Genes differentially regulated in an rpoS mutant as compared to the wild-type [136]. 
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Table 3.5. Selected genes that are regulated by RpoS as identified by ChIP-chip. 
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chemotaxis  
 
       
PA0179 cheY2 probable two-component   
response regulator 
 1.19 200 6.71 attgTCTTTACTggaa 115 15.0 
PA1930 mcpS probable chemotaxis transducer x 0.93 61 6.99 ccgaTCTACACTggcg 86 16.3 
PA2573  probable chemotaxis transducer  1.08 -7 5.85 gttgACTATCCTtagc 41 12.1 
PA4307 pctC chemotactic transducer PctC  0.74 162 3.74 tggaTCATGGCTttcc 82  
PA4915  probable chemotaxis transducer  0.60 51 6.71 accaTCTTTACTctca 35 6.6 
 
         
biofilm          
PA0905 rsmA RsmA, regulator of secondary 
metabolites 
 0.58 161 6.26 ctggTCAATACTgggt 100 2.1 
PA0928 gacS sensor/response regulator hybrid x 0.78 85 7.46 acccGCTAAACTgcgc 71  
PA2231 pslA PslA  0.62 412 5.17 gaatGCTAAGATagct 163 6.5 
PA2586 gacA response regulator GacA  0.63 225 4.26 tggcGGTATACTtagc 169  
PA3621.1 rsmZ Regulatory RNA RsmZ  0.56 -5 6.56 agctGCTAGAATcgcg 48  
PA3974 ladS lost adherence sensor, LadS x 0.62 188 4.29 gtgtGCTAAAGTtcgg 98  
PA4856 retS regulator of exopolysaccharide and 
type III secretion, RetS 
 0.66 77 6.74 cttgGCTATAATccgg 38  
PA5253 algP alginate regulatory protein AlgP x 0.82 58 4.78 gcggGCAATCCTggcg 100  
PA5346 sadB SadB  1.21 50 2.52 tccaGCTCGCATggtc 17  
          
c-di-GMP          
PA0861 rbdA hypothetical protein  1.32 264 7.13 agccACTAGACTccta 169 2.6 
PA1727 mucR MucR x 1.23 182 5.17 tcgtGCAATAATatca 59  
PA2072  conserved hypothetical protein  0.74 57 6.33 ggatGCTTAACTataa 60 4.2 
PA2572  probable two-component   
response regulator 
x 1.39 -1 6.10 tcggACTATGCTtgcc 52 13.2 
PA3311  conserved hypothetical protein x 0.93 6 3.67 acaaGCTCAGCT 8 13.3 
PA4108  hypothetical protein x 0.99 -11 3.87 cccaTCTCGGCTaccg 55  
PA4781  probable two-component   
response regulator 
 1.60 58 4.79 agcgTCTTCAATacgg 59 6.2 
PA4929  hypothetical protein x 0.76 22 1.37 tatcTCTAGGAAtggg 50 4.7 
PA1097 fleQ transcriptional regulator FleQ  0.89 197 5.82 tttgACTTAACTagtg 104  
PA2799  hypothetical protein x 1.04 8 5.45 acggTATAAACTttga 70 1.8 
PA2960 pilZ type 4 fimbrial biogenesis    
protein PilZ 
 0.83 42 - - -  
PA3353  hypothetical protein  0.95 19 - - -  
PA3740  hypothetical protein  0.59 122 2.2 tgcaTCTAGCCAtcat 31  
PA4608  hypothetical protein x 0.59 123 5.3 catgGCTTGGCTatag 46 2.9 
a
 genes with an RpoS consensus box (>6.0) are underlined, genes differentially expressed in an rpoS mutant are 
in bold 
b
 enriched promoter region could belong to two adjacent genes on opposite strands 
c as described by Schuster et al. [136] 
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formation indirectly via the GacS/GacA two-component signal transduction pathway (Table 
3.5). This system regulates the expression of a variety of phenotypes, including extracellular 
virulence factors, quorum sensing molecules and biofilm formation [162, 163]. Upon 
phosphorylation by the sensor kinase GacS, the GacA response regulator activates 
transcription of only two genes – rsmY and rsmZ [164], both specifying small regulatory 
RNAs which antagonize the activity of the regulatory protein RsmA [165, 166]. RsmA 
primarily acts as a translation initiation inhibitor by binding at or near the ribosome-binding 
region of target mRNAs [167, 168], and has been shown to negatively affect the expression of 
hundreds of genes – including those of the pel and psl operon [168, 169]. Our genome-wide 
analysis of RpoS-DNA interactions revealed the promoter regions of gacS, gacA, rsmZ and 
rsmA as direct targets of RpoS (Table 3.5). Moreover, two promoters of genes encoding other 
sensor kinases known to intersect with the GacS/GacA pathway and to influence RsmZ levels, 
were enriched by at least log2-fold in the ChIP-chip experiments, namely retS (regulator of 
exopolysaccharide and type III secretion, [170]) and ladS (lost adherence sensor, [171]). 
A recent transcriptome study in E. coli has shown that RpoS significantly impacts the 
expression of genes associated with the c-di-GMP signaling network [100]. To find out 
whether RpoS plays a similar role in P. aeruginosa, we searched our ChIP-chip result list for 
genes encoding proteins that metabolize or bind c-di-GMP. Of the 41 GGDEF/EAL/HD-GYP 
domain encoding genes, we identified 8 as direct targets of RpoS (Table 3.5): one gene 
encodes a GGDEF domain protein (PA4929), four genes encode GGDEF-EAL hybrid 
proteins (PA0861, PA1727, PA2072 and PA3311), and three genes encode the HD-GYP 
proteins of P. aeruginosa (PA2572, PA4108, PA4781). With the exception of PA1727 and 
PA4108, all genes have been reported to be transcriptionally regulated by RpoS [136] and 
three of those (PA0861, PA2072 and PA2572) additionally contain an RpoS consensus box in 
their promoter region. Overall these data indicate a strong influence of RpoS on the c-di-GMP 
metabolism. Furthermore, the expression of four PilZ domain proteins (PA2799, 
PilZ/PA2960, PA3353, PA4608) seems to be RpoS regulated as suggested by our ChIP-chip 
results. Only PA2799 and PA4608 were shown to have reduced expression in an rpoS mutant 
[136], and none of the four respective gene promoter regions harbors an RpoS consensus box. 
RpoS also bound to the promoter regions of the c-di-GMP binding transcriptional regulator 
FleQ and of the hypothetical, c-di-GMP binding protein PA3740. Both genes have not been 
described to be RpoS regulated genes by previous transcriptional studies. 
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3.3.4 Establishment of gel shift assays to validate RpoS-DNA interactions 
To confirm the ChIP-chip results, binding of purified His6-RpoS to DNA was analyzed in 
vitro by electrophoretic mobility shift assays (EMSA or gel shift assays). This method relies 
on a decreased mobility of protein-bound DNA in a native polyacrylamide gel, as compared 
with the unbound DNA fragment. For the establishment of EMSAs with the sigma factor 
RpoS, the promoter region of cheY2 was chosen as target DNA for three reasons: (i) this 
region was enriched by more than 1.0 log2-fold in the ChIP-chip experiment, (ii) this region 
contains a conserved RpoS binding box and (iii) the expression of cheY2 strongly depends on 
the presence of RpoS as revealed by transcriptome analysis [136] (see also Table 3.5). As a 
nonspecific DNA-probe, either the rsaL/lasI intergenic region (igr) or a part of the gltA 
coding region was chosen (both regions were not enriched in the ChIP-chip experiments). 
Initially, purified, his-tagged RpoS was incubated with a fluorescence-labeled, double-
stranded 210 bp DNA fragment, spanning the region of –190 to +20 bp relative to the 
translational start of cheY2. However, the level of RpoS binding was very low under a variety 
of reaction conditions tested (amount of His6-RpoS, addition of core RNA polymerase, 
incubation time; data not shown). Previous studies with E. coli RpoS have demonstrated that 
this sigma factor only weakly binds to double-stranded DNA, but tightly binds to “molten” 
(i.e. partially single-stranded) DNA [172]. Thus, purified His6-RpoS was incubated with a 
fluorescence-labeled 30 bp fragment of the cheY2 promoter region that included the RpoS 
consensus box (-126 to -96 bp upstream of the translational start). While no shift was 
observed with the double-stranded DNA probe and the single-stranded template (forward) 
probe, RpoS clearly shifted the single-stranded non-template (reverse) DNA probe (Figure 
3.24A). This shift was demonstrated to be specific because (i) RpoS did not alter the mobility 
of the nonspecific igr DNA fragment, (ii) the RpoS-cheY2 complex could be partially 
supershifted with an RpoS antibody and (iii) the RpoS-cheY2 shift could be reversed by 
adding single-stranded, non-labeled cheY2 fragments, but not by adding single-stranded, non-
labeled igr fragments (Figure 3.24A and B). Interestingly, the addition of non-labeled cheY2 
reverse strand reduced RpoS binding to the labeled reverse strand only partially, while the 
addition of the cheY2 forward strand completely abolished the RpoS binding. The total 
circumvention of RpoS binding could be caused by double strand formation of the non-
labeled forward and the labeled reverse DNA strand. 
We then used the gel shift assay to verify rsmA as direct target of RpoS. An influence of 
RpoS on the expression of RsmA was already suggested by the transcriptome study of 
Schuster et al. [136] and the promoter region of the respective gene was significantly enriched 
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in our ChIP-chip experiments. For EMSA reactions, a 30 bp DNA fragment was constructed 
that contains the RpoS binding motif located 100 bp upstream of the translational start site of 
rsmA. Figure 3.25A demonstrates that purified His6-RpoS is able to bind to the single-
stranded template (forward) rsmA DNA. The occurrence of two shifted bands may be 
explained by a partially degraded RpoS protein. 
Next, we analyzed RpoS binding to the promoter region of PA0861 (rbdA), a gene that 
encodes a GGDEF-EAL hybrid protein and which is differentially expressed in an rpoS  
 
 
 
Figure 3.24. Establishment of electrophoretic mobility shift assays (EMSAs) for the 
stationary phase sigma factor RpoS. 
All EMSAs were performed using short DNA probes (30-33 bp) and purified His6-RpoS. cheY2 was used as 
specific RpoS target, while igr served as a negative control. (A) RpoS binds to the single-stranded reverse (ss 
rev) cheY2 DNA probe, but not to the single-stranded forward (ss for) or the double-stranded (ds) cheY2 DNA 
probe. (B) RpoS binds specifically to ss rev cheY2, as the complex can be partially supershifted with an RpoS 
antibody and as binding of RpoS to ss rev cheY2 can be competed with single-stranded, non-labeled specific 
DNA probe (nl cheY2, 10-20x molar excess) but not with the non-specific control DNA probe (nl igr, 20x molar 
excess). 
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Figure 3.25. EMSA results for three distinct RpoS targets. 
All EMSAs were performed using short DNA probes (30-33 bp) and purified His6-RpoS. cheY2 served as a 
positive control and gltA as a negative control. (A) Rpos binds to the rsmA single-stranded forward DNA probe. 
The occurrence of two shifted bands might be caused by partially degraded His6-RpoS. (B) RpoS binding to 
PA0861 could not be confirmed under the used EMSA conditions. (C) RpoS does not bind to any of the PA3353 
DNA fragments (single-stranded or double-stranded). ss for – single-stranded forward, ss rev – single-stranded 
reverse, ds – double-stranded. 
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mutant [136]. The promoter region of this gene was strongly enriched by chromatin 
immunoprecipitation and harbors an RpoS consensus sequence (-169 bp relative to the 
translational start site). Surprisingly, we were not able to confirm RpoS binding to this region 
in vitro (Figure 3.25B). Perhaps, the DNA fragment used for the gel shift experiments 
(spanning the region -180 to -150 bp) does not represent the correct RpoS binding site. 
Alternatively, additional factors may be required for binding of RpoS to this DNA region. 
Our ChIP-chip results also suggested PA3353 to be part of the RpoS regulon. The PA3353 
gene encodes a PilZ domain protein, which binds c-di-GMP with nanomolar affinity (see 
chapter 3.2.6). No RpoS binding motif can be found in the PA3353 promoter region. Based 
on the highest signal in the ChIP-chip experiments, the 33 bp-fragment directly located in 
front of the translational start site of PA3353 was chosen for EMSA reactions. However, no 
interaction of RpoS could be detected with either the double-stranded DNA fragment, or the 
single-stranded template or non-template strand (Figure 3.25C). Again, the wrong DNA 
fragment could have been chosen for the gel shift assays or RpoS only binds to the promoter 
regions in co-operation with other regulators which are not present under in vitro conditions. 
On the other hand, it cannot be excluded that ChIP enrichment of the PA3353 promoter 
region is an artifact and PA3353 thus represents a false-positive. 
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4 Discussion 
Many bacteria are able to adopt two fundamentally different lifestyles. While the planktonic 
mode of growth enables dissemination and exploration of novel niches, growing within 
multicellular, matrix-encased biofilms offers protection and survival in unfavorable 
environments [3]. The formation of biofilms is not only a widespread phenomenon in nature, 
but also in clinical settings in which they impede successful treatment of chronic infections. 
Biofilm bacteria are much less susceptible to antibiotics than their planktonic counterparts and 
the difficulty to eradicate them is a prime concern of modern medicine [9]. There is an 
exploding interest in knowledge about cellular factors and molecular mechanisms controlling 
biofilm formation with the aim to identify putative therapeutic targets that will help to fight 
biofilm-related infections. 
An exceedingly suitable model organism for studying the genetic and mechanistic principles 
of biofilm formation is the opportunistic human pathogen Pseudomonas aeruginosa. It is 
equipped with a large and complex genome which was recently sequenced facilitating the 
genetic analysis of this versatile organism [11]. Moreover, P. aeruginosa displays various 
types of motility that can be biased by complex chemosensory systems but also readily forms 
biofilm communities on a wide variety of natural and artificial surfaces. Thereby, a large 
collection of transcriptional regulators and alternative sigma factors permits this organism to 
tightly control its lifestyle and to adapt to diverse ecological niches. In this context, the aim of 
this thesis was to elucidate how P. aeruginosa integrates and translates extra- and intracellular 
signals to regulate the transition between motile and sessile lifestyles in order to give an 
appropriate response to a changing environment. 
 
4.1 The P. aeruginosa chemotaxis methyltransferase CheR1 impacts on 
bacterial surface sampling 
Motility is not only a characteristic trait of planktonic bacteria, but also an integral part of 
biofilm formation. In P. aeruginosa, several studies demonstrated an involvement of flagella- 
and pili-mediated motility on attachment and subsequent biofilm formation [51, 54, 58, 153, 
173-175]. However, the contribution of chemotaxis to the establishment of biofilms has been 
less intensively studied. 
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There are several reports concluding that – depending on the model organism and 
experimental settings – chemotaxis is either required or dispensable for bacterial biofilm 
formation. The chemotactic signal transduction pathway of E. coli and S. Typhimurium is 
most likely the best characterized signal system at all, but studies of other organisms revealed 
much more diversity and complexity in chemotactic signaling than had been previously 
anticipated. Most motile environmental bacteria have multiple homologs of the E. coli che 
genes and many more mcp genes than the five found in the enteric bacteria [19]. 
P. aeruginosa is chemotactic to most of the organic compounds that it can grow on and 
encodes 26 mcp genes and four chemotaxis-like signal transduction systems [41]. One 
chemotaxis system (Pil-Chp, PA0408-PA0417) has been implicated in pili-mediated 
twitching motility [37, 38] and another one (Wsp, PA3702-PA3708) is involved in the 
regulated expression of Pel and Psl exopolysaccharides [39]. The two remaining chemotaxis 
systems (Che1, PA1456-PA1464 and PA3348-PA3349; Che2, PA0173-PA0179) are both 
involved in flagella-mediated chemotaxis [32-35]: while the Che1 system is absolutely 
required for this chemotactic response, the precise role of the Che2 system is still unclear. 
This complex chemotactic signaling equipment renders P. aeruginosa probably a good model 
microorganism for investigating the roles of chemotaxis in bacterial adaptation to diverse 
environmental niches, including the establishment of structured bacterial communities. 
 
4.1.1 Characterization of the chemotaxis methyltransferase CheR1 
In this thesis we provide evidence that CheR1 (PA3348) is a P. aeruginosa chemotaxis 
methyltransferase which transfers a methyl group from the methyl donor SAM to a methyl-
accepting chemotaxis protein. As determined by surface plasmon resonance studies, CheR1 
binds SAM at a KD of approximately 60 µM, which is in the same order of magnitude as has 
been demonstrated for Salmonella CheR [176]. Receptor methylation by CheR is required for 
adaptation to persistent stimuli and binding of attractants causes increased methylation levels 
[18]. It has previously been shown that the MCPs PctA, PctB and/or PctC are responsible for 
the detection of several amino acids in P. aeruginosa [142]. In accordance with these results, 
we could demonstrate in this thesis that in vitro methylation of the MCP PctA by CheR1 
could be enhanced by the addition of serine but not of glutamine, the latter of which was 
shown to be specifically detected by PctB [142]. 
In E. coli, highly abundant transmembrane receptors harbor a conserved NWETF motif at the 
extreme C-terminal end of the MCP which recruits CheR to the receptor cluster and is 
required for efficient methylation and demethylation [137, 138]. Here we demonstrate that the 
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MCP PctA was methylated by CheR1 despite the lack of a conserved C-terminal pentapeptide 
sequence. Similarly, a pentapeptide-independent methyltransferase has been characterized in 
the thermophilic bacterium Thermotoga maritima [177]. Co-crystallization of CheR from 
S. Typhimurium with the conserved NWETF pentapeptide demonstrated that the CheR 
β-subdomain is the region that interacts with the pentapeptide sequence [178]. β-subdomains 
can be divided into two groups: those with longer β-loops, found in CheR proteins from 
organisms containing MCPs with the pentapeptide recognition motif, and those with shorter 
β-loops, found in organisms that lack MCPs with the pentapeptide recognition motif [177-
179]. Interestingly, in P. aeruginosa, CheR2 (PA0175) has a long β-loop and CheR1 has a 
short β-loop [177]. Moreover, only two out of 26 chemoreceptors have the conserved C-
terminal pentapeptide motif and both genes encoding those chemoreceptors are located in the 
close proximity of the che2 system. Overall, this might indicate that CheR2 uses a 
pentapeptide-dependent methylation mechanism, whereas CheR1 uses a pentapeptide-
independent methylation mechanism and that this is one way of preventing crosstalk between 
different chemotaxis systems in P. aeruginosa. 
 
4.1.2 CheR1 impacts on bacterial surface sampling 
A recent publication on the influence of motility and chemotaxis in Agrobacter tumefaciens 
revealed an impact of chemotaxis on both, attachment and biofilm formation [53]. In this 
thesis, the P. aeruginosa cheR1 mutant did not exhibit a phenotype in the CV assay. 
Nevertheless, soft-agar plate assays and confocal microscope analysis of static biofilms 
clearly demonstrate that CheR1 activity is not only essential for flagella-mediated chemotaxis 
but that it is also involved in the formation of structured biofilms. Interestingly, CheR1 
activity seems to be important at two developmental steps within the process of biofilm 
formation. In the initial phase of biofilm formation, chemotaxis seems to promote bacterial 
movement in close proximity to the surface, which enables surface sampling prior to 
irreversible attachment. Later, flagella-mediated chemotaxis seems to be required for the 
formation and consolidation of a more structured community. 
As far as we are aware, the only study examining biofilm formation of a P. aeruginosa che1 
chemotaxis mutant (cheY) was performed by Barken et al. [58]. They demonstrated that not 
type IV pili-driven but flagellum-driven motility is involved in the formation of cap structures 
in biofilms grown in a flow chamber irrigated with glucose minimal medium. Besides cheY 
and fliM mutants (the latter lack the polar flagellum), also a P. aeruginosa rhlA mutant 
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deficient in biosurfactant production displayed reduced cap formation [180]. Since swarming 
motility requires both the presence of biosurfactants and flagellar activity, Barken et al. [58] 
suggested that flagellum-driven surface-associated motility (by means of swarming) rather 
than directed motility (swimming in response to the sensing of certain metabolites) is required 
for cap formation. In this thesis, we used different experimental settings (static growth 
conditions, nutrient-rich medium), nevertheless, we also demonstrated a role of flagellum-
mediated motility in the formation of structured biofilms. However, since our cheR1 mutant 
displayed normal swarming motility on 0.5% agar plates, we rather hypothesize that 
chemotaxis driven swimming motility is necessary for formation of mature biofilm structures. 
A role for a substrate gradient that directs the motile bacteria has been suggested before [181]. 
In conclusion, one reasonable model for the role of motility and chemotaxis in biofilm 
formation in P. aeruginosa is that the efficiency and frequency of surface sampling may be 
influenced through chemotactic processes. This is important for initial sampling of bacteria to 
the surface and as the biofilm matures, chemotactic cues may stimulate dispersion. The 
released motile bacteria in the planktonic phase have the potential to colonize new sites and 
promote lateral expansion of the biofilm or to reattach in a coordinated chemotaxis-driven 
way, thus fine-tuning the architecture of biofilm structures. 
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4.2 A chemical proteomics approach identifies c-di-GMP binding proteins of 
P. aeruginosa 
The chemotaxis system is one system which is able to translate environmental signals into an 
adaptive answer of the bacterial cell. Another system is the c-di-GMP signaling network in 
which an extra- or intracellular (first) signal is translated into a c-di-GMP (second) signal via 
the activity of diguanylate cyclases and phosphodiesterases. High levels of the second 
messenger c-di-GMP are known to promote the switch from motility to sessility and much 
effort has been undertaken to understand the particular role of c-di-GMP in the establishment 
and maintenance of bacterial biofilms. Thus far, research has mainly focused on cellular 
processes responsible for the synthesis and degradation of c-di-GMP, whereas we are only at 
the beginning to understand the role of c-di-GMP effectors and downstream signaling 
pathways. 
In this thesis, we aimed at the identification of c-di-GMP binding proteins by using an 
enrichment tool that particularly targets the c-di-GMP effector sub-proteome. Chemically 
synthesized c-di-GMP was immobilized on a solid support and used for the isolation of 
c-di-GMP binding proteins out of complex protein mixtures in P. aeruginosa. Our chemical 
proteomics approach [182] also involved high-resolution mass spectrometry which assures 
unambiguous identifications of the affinity purified c-di-GMP binding proteins. 
No c-di-GMP affinity resin has been described so far, although other cyclic nucleotide affinity 
beads have been previously used for the isolation of their respective interactomes [183, 184]. 
The main obstruction for the development of c-di-GMP affinity beads was the lack of ample 
amounts of this cyclic di-nucleotide needed for the synthesis of c-di-GMP resins. 
 
4.2.1 Preparation of a c-di-GMP affinity resin  
Groundwork for this thesis was the chemical synthesis of sufficient amounts of c-di-GMP and 
the performance and optimization of a coupling reaction with epoxy-activated sepharose 
(Michael Morr, Helmholtz Center for Infection Research and Frank Schwede, Biolog 
company, Bremen). C-di-GMP was successfully immobilized on the sepharose beads with an 
overall efficiency of 75%. Especially when small ligands are immobilized, a critical step is to 
retain binding activity of the molecule. In c-di-GMP, the N7 and O6 of the guanyl-ring act as 
main hydrogen bond acceptors and, in addition, H-bonds to the phosphate groups of the 
c-di-GMP backbone have been shown to mediate interactions between c-di-GMP and amino 
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acids of the target protein [68, 99, 145, 185-187]. Analysis of the functional groups involved 
in the chemical binding to the sepharose beads revealed that c-di-GMP was linked to this 
matrix mainly via its guanyl-N1 group (Figure 3.10). Although this group generally also can 
be involved in protein binding, the variety of other interactions between c-di-GMP and its 
target and the presence of various byproducts in the coupling reaction seemed to be sufficient 
to mediate binding of the immobilized c-di-GMP to PA14 and PA01 effector proteins. 
 
4.2.2 The c-di-GMP and control bead sub-proteome 
In addition to specific interaction partners, a large number of proteins are expected to co-
purify during affinity chromatography because of their abundance and a nonspecific binding 
mode to the sepharose matrix. To identify common contaminating proteins, an epoxy-
activated sepharose transformed with ethanolamine was used as a negative control. Analysis 
of this control revealed a “bead-proteome” [188] that proved to be larger than the c-di-GMP 
sub-proteome. This bead-proteome served as a reference to validate the results of the 
c-di-GMP pull down and to reduce the rate of false-positives. However, especially the large 
size of the reference bead-proteome bears the risk of the elimination of true-positives. For 
example, the transcriptional regulator and approved c-di-GMP effector FleQ [88] was found 
in the c-di-GMP pull down but also in the controls and thus was excluded from the list of 
c-di-GMP binding proteins. 
Our final lists of protein candidates that directly or indirectly interact with c-di-GMP included 
PilZ domain proteins and proteins with I-site motifs, but also proteins without any known 
c-di-GMP binding motif (Table 3.2 and Table 3.4). These lists are not only largely impacted 
by the definition of the inclusion and exclusion criteria based on protein identification scores 
and the reference proteome, but the listed c-di-GMP interacting proteins are also those of a 
certain time point (here: stationary phase of bacterial growth) and a certain subcellular 
localization (here: mainly cytoplasmic fraction). Thus, differences in culture conditions and 
cell extract preparations, the use of altered parameters defining the identification of proteins 
and an alternative bead-proteome, are expected to originate in the identification of additional 
c-di-GMP effector candidates. 
 
4.2.3 SPR is a useful tool to validate c-di-GMP/protein interactions 
Another part of this thesis was the generation of a robust and sensitive c-di-GMP binding 
assay in order to verify c-di-GMP binding in vitro. In co-operation with the group of F. W. 
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Herberg (University of Kassel), a SPR based assay using a 2'-AHC-c-di-GMP sensor chip to 
detect c-di-GMP/protein interactions was established. 2'-AHC-c-di-GMP is a novel, 
functionalized c-di-GMP analog with a linker group attached to 2'OH of one ribose-unit 
(Figure 3.10) and can be easily immobilized via the terminal amino group of the linker using 
primary amine coupling. Advantages of the SPR technique are the low sample consumption, 
the high sensitivity and that binding reaction can be followed in real time. In a solution 
competition assay, it furthermore enables the determination of EC50 (half-maximal effective 
concentration) values for unmodified ligands reflecting the potency of a ligand to interact with 
the target. This value can then be used to estimate whether the affinity is in the range of 
biologically effective c-di-GMP concentrations (<50 nM to a few µM) [59]. 
In pull down experiments using either PA01 or PA14 lysates, the PilZ domain protein 
PA3353 was repeatedly identified. SPR solution competition experiments for PA3353 
revealed an EC50 value of approximately 260 nM, which is in agreement with the sub-
micromolar KD values observed for other PilZ domains [59] and thus demonstrates the 
applicability of our method. 
We also examined the putative response regulator PA4396, which is included in our list of 
putative c-di-GMP binding proteins and harbors a degenerate GGDEF domain with the 
c-di-GMP binding I-site motif. Purified Strep-PA4396 was able to bind to the 2'-AHC-
c-di-GMP sensor surface, however, in SPR competition experiments, the EC50 value was 
determined to be approximately 60 µM, which is slightly higher than any known affinity of a 
c-di-GMP binding site [59]. The in vitro binding assays might be impeded by the use of 
improperly folded proteins, the absence of important co-factors or interaction partners and the 
lack of post-translational modifications. Further investigations should reveal whether, for 
example, phosphorylation of the receiver domain of PA4396 might enhance the affinity of 
this response regulator to its ligand. 
A third protein from the list of putative c-di-GMP effectors, the chemotaxis methyltransferase 
CheR1, was tested in SPR for c-di-GMP binding. CheR1 has no common c-di-GMP binding 
motif, but the repeated identification in pull downs in both the PA01 and PA14 strains, and 
the correlation to flagellum mediated motility renders CheR1 an interesting c-di-GMP binding 
candidate. However, SPR binding studies revealed a nonspecific binding mode of CheR1-His6 
to c-di-GMP as the binding event could not be efficiently competed with up to 10 µM free 
c-di-GMP. Further investigations should reveal whether the absence of important co-factors 
or interaction partners in vitro might be responsible for the lack of specific binding or whether 
CheR1 itself is not binding c-di-GMP but stably interacts with a c-di-GMP effector protein. 
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Besides PA3353 and PA4396, we identified PA3740, a conserved hypothetical protein, as a 
novel type of c-di-GMP effector protein. Upon injection of PA3740-His6, a specific and 
reproducible binding to the 2'-AHC-c-di-GMP sensor chip was observed, despite the lack of 
any domain previously described to specifically interact with c-di-GMP. With an EC50 value 
of approximately 30 nM, PA3740 shows a high affinity to c-di-GMP similar to those of PilZ 
domain effectors. The next challenge will be to identify the exact binding site of c-di-GMP to 
this protein. One way to achieve this is by determining the tertiary structure of PA3740 in 
presence and absence of c-di-GMP via X-ray crystallography or NMR studies. However, 
those experiments require a large amount of highly pure PA3740 protein, which can currently 
not be provided as heterologous overexpression of PA3740 in E. coli is impeded by an 
apparent toxicity of PA3740 to its host cells. 
 
4.2.4 The c-di-GMP binding proteins PA3353 and PA4396 influence motility 
behavior of P. aeruginosa 
To reveal the cellular function of verified c-di-GMP binding proteins, cells lacking or 
overexpressing the respective protein were analyzed for their motility behavior and ability to 
form biofilms. Those phenotypic assays suggested that the PilZ domain protein PA3353 
interferes with flagella-mediated motility. Mutants affected in the expression of PA3353 
displayed an enhanced swimming motility, but normal ability to swarm and twitch. 
Overexpression of PA3353 impaired swimming as well as swarming motility, while twitching 
motility remained unaffected. The PA3353 gene is directly located downstream of one of the 
three chromosomal regions that are associated with flagellar regulons (Region III, PA3348-
PA3352) [189] supporting the link of PA3353 to flagellar motility. With the YcgR-PilZ-
domain organization, PA3353 might be the P. aeruginosa counterpart of the PilZ domain 
protein YcgR in E. coli, which has been demonstrated to slow down the flagellar motor upon 
c-di-GMP binding [79, 148]. Further studies are required to clarify the role PA3353 plays in 
swimming and/or swarming motility. 
Our phenotypic analyses indicated an involvement in bacterial motility also for the putative 
response regulator PA4396. Whereas a PA4396 transposon mutant displayed wild-type 
motility behavior, overexpression of this protein in the wild-type enhanced swimming and 
swarming motility, while twitching motility was reduced. The ability to form biofilms in CV 
assays was unaffected in both strains, the PA4396 mutant and PA4396 overexpressing strain. 
A recent study performed by Kulasekara et al. [62] furthermore demonstrated that cells 
4. Discussion   85 
overexpressing PA4396 were impaired in their ability to kill Chinese hamster ovary (CHO) 
cells. This might have been caused by a dysfunction of adherence factors, such as pili or 
flagella [190-192], leading to reduced attachment of bacteria to host cells. Alternatively, 
overexpression of PA4396 might have impacted the functionality of the type three secretion 
system which is activated upon adherence to mammalian cells and which delivers toxins from 
the bacteria into host cells [193]. More work is necessary to understand how PA4396 
influences motility behavior and cytotoxicity towards CHO cells. 
 
4.2.5 The cellular function of PA3740 is still unknown 
Despite much effort, our motility and biofilm formation assays did not reveal a particular 
phenotype of a mutant affected in the expression of the hypothetical protein PA3740 nor of a 
strain overexpressing PA3740. This protein might be involved in processes which we did not 
examined yet (such as the production of virulence factors), or we might have missed the right 
conditions under which PA3740 becomes activated. Recently, we developed a polyclonal 
anti-PA3740 serum which will be a useful tool for further studies aiming at the identification 
of the cellular role of PA3740. First western blot analyses using purified PA3740 protein 
indicated the functionality of this antiserum (data not shown). This offers the opportunity to 
perform PA3740 pull down assays in order to isolate potential interaction partners of PA3740. 
Another possibility would be to use the serum in conjunction with immunofluorescence to 
identify the localization site of PA3740 in the bacterial cell. 
Taken together, we have validated a c-di-GMP affinity resin as a valuable novel tool for the 
isolation of c-di-GMP binding proteins and demonstrated the applicability of the 2'-AHC-
c-di-GMP sensor chip for SPR binding studies. In general, affinity chromatography proved to 
be sufficient for the isolation of c-di-GMP binding proteins harboring known but also new 
c-di-GMP binding motifs in the model organism P. aeruginosa. The next challenge will be to 
unravel the cellular function of those c-di-GMP binding proteins and to access which role 
they play in the downstream communication of the c-di-GMP signal. The use of chemical 
proteomics for the discovery of novel c-di-GMP binding motifs also in other bacterial species 
might be the basis for new studies and will significantly contribute to our understanding of the 
c-di-GMP signaling network. 
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4.3 The regulon of the P. aeruginosa stationary phase sigma factor RpoS as 
revealed by ChIP-chip analysis 
Environmental signals can not only be integrated and processed via the chemotaxis and 
c-di-GMP signaling systems, but also via the activation of global regulators which control the 
transcription of specific subsets of genes. A major challenge is to identify those particular 
regulons on a global scale, and to understand how they are intertwined with other regulatory 
networks. P. aeruginosa possesses an extraordinary number of two-component regulatory 
systems, transcriptional regulators and alternative sigma factors allowing successful 
adaptation to diverse ecological niches. The alternative sigma factor RpoS is activated upon 
entry into the stationary phase of growth and has been shown to affect production of virulence 
factors and to mediate stress response [151, 194, 195]. Moreover, RpoS seems to be involved 
in the control of biofilm growth as cells lacking RpoS develop significantly thicker biofilms 
in a flow chamber than respective wild-type cells [153]. Thereby it would be interesting to 
know whether RpoS controls transcription of genes directly linked to biofilm formation or of 
genes encoding components of other regulatory systems, such as the c-di-GMP signaling 
network, which in turn impact biofilm formation. 
In the past years, transcript profiling was used in a wide range of bacteria to identify global 
regulons of alternative sigma factors (for example [196-201]). However, a transcriptomic 
approach does not reveal the primary binding targets of the transcription factor under study 
and is unable to reveal regulatory cascades in which one regulator controls expression of 
many others. Recently, chromatin immunoprecipitation in combination with hybridization to 
microarrays (ChIP-chip) has emerged as a powerful and complementary tool, since it 
measures protein-DNA interaction in vivo on a genomic scale. Initially developed for 
eukaryotic cells, ChIP-chip was now also successfully applied in bacteria (reviewed in [202, 
203]) and has been used in some cases to analyze the chromosome-wide binding profile of 
RNA polymerase with different sigma factors [132, 204-206]. 
 
4.3.1 Evaluation of the RpoS regulon 
In this thesis, we aimed at the identification of the P. aeruginosa RpoS regulon by performing 
ChIP experiments in combination with a high-resolution P. aeruginosa genome microarray 
[104]. Our ChIP-chip approach proved to be a very robust and reproducible method that led to 
the identification of more than 400 RpoS promoter targets. Categorization of those RpoS 
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targets revealed a large subset of enriched promoter sites (128) upstream of genes that have 
been shown to be subject of differential transcription in an rpoS mutant (Schuster et al. [136]) 
and approximately half of those (59) harbored an RpoS consensus sequence (Figure 3.23). 
Since transcript profiling measures the consequences of protein binding rather than the 
binding event itself, the transcriptional profile also reflects secondary effects on gene 
expression. This may account for the large number of genes that were differentially regulated 
in an rpoS mutant but that did not show RpoS binding in vivo (643). 
On the other hand, for a large fraction of ChIP-chip identified RpoS targets (345 of which 81 
harbor an RpoS binding motif) no detectable effect on transcription of the neighboring genes 
was observed by Schuster et al. [136] in an rpoS mutant. This phenomenon of “unexpected” 
protein-DNA interaction has been also observed by other groups comparing ChIP-chip 
experiments with transcriptional profiling data and several explanations have been proposed 
[202, 207]. For example, the transcriptome profile might have been determined under non-
activating conditions in which a bound transcription factor does not influence the transcript 
level of specific genes. Alternatively, the influence of the transcription factor on gene 
expression might be only weak and is easily overridden by a second regulatory protein. 
Furthermore, a DNA-bound transcription factor may have a different task than regulating 
gene transcription or it has bound to a target site with no functional relevance. 
We also observed that a subset of genes identified to be RpoS regulated by our ChIP-chip 
approach as well as by the transcriptome study of Schuster et al. [136] does not harbor the 
conserved RpoS binding motif in their upstream region (69 out of 128). A likely explanation 
for this phenomenon – that has also been described before – could be that co-operative 
interactions with other transcriptional factors enable the binding to those non-consensus 
regions or that differences in local DNA topology influence the sequence preference of 
transcription factors [202]. 
 
4.3.2 Influence of RpoS on chemotaxis and biofilm formation 
The RpoS regulon as revealed by our ChIP-chip approach contained several chemotaxis 
related genes confirming the role of RpoS in the expression of the Che2 system and some 
methyl-accepting chemotaxis proteins (Table 3.5) [136, 155].  
Furthermore, some of the identified RpoS targets are evidently linked to biofilm formation, 
such as pslA, a gene required for the synthesis of exopolysaccharides [158-160] (Table 3.5). A 
recent study by Irie et al. [152] demonstrated that pslA is transcriptionally activated by RpoS 
and translationally repressed by binding of the regulatory protein RsmA to the large 5' 
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untranslated region of the pslA transcript. Interestingly, RsmA itself seems to be regulated by 
RpoS as indicated by several, independent observations. Although continuously expressed, 
intracellular levels of RsmA peak in the stationary phase [167, 168] and a mutant affected in 
the expression of RpoS displays reduced rsmA transcript levels in the stationary phase but not 
in the logarithmic phase of growth [136]. Moreover, the non-coding region located upstream 
of rsmA harbors a conserved RpoS binding motif and was demonstrated to be bound by RpoS 
in our ChIP experiments (Table 3.5). This binding could be verified in vitro by electrophoretic 
mobility shift assays. We also identified other RpoS targets in the ChIP-chip assays that 
interfere with RsmA and thus exopolysaccharide production (Table 3.5), namely rsmZ, gacA, 
gacS, retS and ladS. The activity of RsmA is antagonized by the small regulatory RNA RsmZ,  
 
 
 
 
Figure 4.1. A model of the complex Gac/Rsm regulatory network in P. aeruginosa. 
Upon phosphorylation by the sensor kinase GacS, GacA activates expression of the small regulatory RNAs 
RsmY and RsmZ, which are antagonizing the activity of the translational repressor RsmA. Free RsmA promotes 
the production of virulence factors (e.g. type three secretion system – TTSS, type IV pili, Toxine A, Lipase A), 
while it represses translation of transcripts required for biofilm formation (psl, pel) and for production of 
homoserine lactone (HSL) quorum sensing signals. The positive influence of RsmA on virulence factor 
production is believed to occur via indirect mechanisms, e.g. by controlling expression of regulatory factors. 
Sequestration of RsmA by RsmY/Z leads to a shift from acute virulence to chronic, biofilm-related virulence. 
There are two other sensor kinases influencing the expression levels of RsmY/Z and thus, RsmA activity: RetS 
inhibits activation of GacA leading to high levels of free RsmA, while LadS promotes GacA activity and thus 
inhibition of RsmA by RsmY/Z binding. The environmental signals leading to activation of the RetS/GacS/LadS 
sensor kinases are still unknown. This figure is based on previously published models [168, 208]. Dashed lines – 
indirect regulation, continuous lines – direct regulation. 
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which is transcriptionally regulated by the GacS/GacA two component signaling system and 
the entangled sensor kinases LadS and RetS [164-166, 170, 171]. While RetS is an antagonist 
of the GacS sensor kinase and negatively influences GacA dependent rsmZ expression, LadS 
promotes transcription of rsmZ [170, 171, 209]. Thus, RpoS seems to contribute to the 
expression of nearly all components (with the exception of RsmY that also antagonizes RsmA 
activity [165]) of a complex regulatory network that can integrate yet unidentified signals via 
the sensor kinases LadS, GacS and RetS to regulate either biofilm formation and the 
production of quorum sensing signals or the synthesis and secretion of various virulence 
factors [208] (Figure 4.1). 
 
4.3.3 RpoS strongly influences the c-di-GMP signaling network 
Our ChIP-chip data also revealed a strong link between RpoS and the c-di-GMP signaling 
network. Of the 41 genes encoding GGDEF/EAL/HD-GYP domain proteins in the strain 
PA01, we identified eight as direct RpoS targets (Table 3.5 and Table 4.1). Three of those 
harbor the conserved RpoS binding motif in their promoter region and they have also been 
demonstrated to be expressed at lower levels in an rpoS mutant as compared to the parent 
wild-type strain [136]. Another three do not have an RpoS consensus sequence in their non-
coding upstream region but still were differentially expressed in an rpoS mutant [136] and 
thus are obviously directly regulated by RpoS. 
RpoS targets that were identified by ChIP-chip, transcriptional profiling and the presence of 
an RpoS box 
The three c-di-GMP associated genes identified by all three criteria (ChIP-chip, 
transcriptome, RpoS box) are PA0861, PA2072 and PA2572. So far, RpoS/target-DNA 
interactions under in vitro conditions (electrophoretic mobility shift assays) were only tested 
for PA0861. In those gel shift assays, we could not prove binding of RpoS to a 30 bp 
fragment of the PA0861 promoter region, which was most likely due to inappropriate reaction 
conditions. 
PA0861 was recently characterized by An et al. and is a GGDEF-EAL hybrid protein 
involved in the regulation of biofilm dispersal therefore also termed RbdA [210]. RbdA 
seems to promote swarming and swimming motility as well as rhamnolipid production, thus 
factors required for biofilm dispersal, while it negatively influences exopolysaccharide 
production. Although RbdA contains both a highly conserved GGDEF and EAL domain, it  
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Table 4.1. The RpoS controlled c-di-GMP regulon. 
 ChIP-chip         
log2-fold enrichment 
RpoS-Box      
weight score 
Transcriptome  
fold change 
[136]a 
GGDEF    
PA0169   -2.3 
PA0290    
PA0338    
PA0847   5.4 
PA1107  6.61  
PA1120   3.6 
PA1851    
PA2771   11.6 
PA2870    
PA3177    
PA3343   2.1 
PA3702   2.1 
PA4332    
PA4396    
PA4843   -2.1 
PA4929 0.76  4.7 
PA5487    
GGDEF-EAL    
PA0285    
PA0575  6.99  
PA0861 1.32 7.13 2.6 
PA1181   2 
PA1433    
PA1727 1.23   
PA2072 0.74 6.33 4.2 
PA2567   -1.7 
PA3258    
PA3311 0.93  13.3 
PA4367    
PA4601    
PA4959    
PA5017  6.33  
PA5295    
PA5442    
EAL/HD-GYP    
PA2133    
PA2200    
PA2572 1.39 6.10 13.2 
PA2818    
PA3825   4.8 
PA3947    
PA4108 0.99   
PA4781 1.60  6.2 
PilZ    
PA0012  6.10  
PA2799 1.04  1.8 
PA2960 0.83   
PA2989    
PA3353 0.95   
PA3542    
PA4324    
PA4608 0.59  2.9 
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primarily seems to function as a phosphodiesterase. An and co-workers [210] were unable to 
detect any diguanylate cyclase activity of purified RbdA protein. Instead, the GGDEF domain 
appears to stimulate PDE activity of the neighboring EAL domain by binding GTP, a 
phenomenon that already has been described for a GGDEF-EAL protein in C. crescentus 
[122]. Furthermore, the RbdA PDE activity is also modulated by a PAS domain which is 
located upstream of the GGDEF and EAL domain and which is probably involved in oxygen 
sensing [210]. 
The hypothetical protein PA2072 has not been studied in detail so far. Analysis of the amino 
acid sequence reveals that the protein has an extracellular sensory domain (CHASE4, [211]) 
in combination with an intracellular PAS domain, GGDEF domain and EAL domain [62]. 
The frequent occurrence of GGDEF-EAL hybrid proteins has been termed a “biochemical 
conundrum” [212], and it was suggested that either one of the two domains is enzymatically 
inactive or the protein can switch between both catalytic activities (c-di-GMP synthesis and 
degradation, respectively) in response to the oligomerization state or the sensing of 
environmental signals. Alternatively, both domains might be active and create a very precise 
concentration of c-di-GMP [71, 212]. In PA2072, the GGDEF as well as the EAL domain is 
highly conserved and detailed biochemical studies are required to uncover the preferential 
enzymatic activity of this protein. 
The third c-di-GMP associated gene identified to be RpoS regulated by ChIP-chip, 
transcriptional profiling and the presence of an RpoS box is PA2572. It was recently 
characterized by Ryan et al. [95] and encodes a putative response regulator with an HD-GYP 
domain. The PA2572 gene is adjacent to a gene encoding a probable sensor kinase (PA2571). 
The two genes are divergently transcribed and thus RpoS could regulate the expression of 
both PA2571 and PA2572. Consistently, both genes are differentially expressed in an rpoS 
mutant [136]. Cells affected in the expression of PA2572 produce higher levels of 
rhamnolipids and display a biofilm architecture that is different from the wild-type. They are 
furthermore reduced in their ability to kill larvae of the Greater Wax Moth Galleria 
mellonella [95]. The HD-GYP domain of the PA2572 protein differs from other HD-GYP 
domains by having variant key residues (YN-GYP) and it seems not to harbor any 
phosphodiesterase activity. It would be interesting to know whether this “degenerate” HD-
GYP domain is still able to bind c-di-GMP and is thus acting as a c-di-GMP effector. 
However, it was not identified as a c-di-GMP binding protein in our pull down experiments 
using the c-di-GMP affinity resin. 
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RpoS targets that were identified by ChIP-chip and transcriptional profiling 
There are three further genes that are involved in c-di-GMP metabolism and that were 
identified as RpoS dependent genes by both our ChIP-chip approach and the transcriptome 
study of Schuster et al. [136]: PA4929, PA3311 and PA4781 (Table 4.1). However, they do 
not posses the conserved RpoS binding motif in their non-coding upstream region suggesting 
that RpoS either binds to an altered sequence motif or that other factors mediate DNA-binding 
of RpoS to the promoter region of PA4929, PA3311 and PA4781, respectively. 
PA4929 encodes for a hypothetical protein whose cellular role is still uncharacterized. The 
presence of a highly conserved GGDEF domain proposes a function as a diguanylate cyclase 
which might be activated in response to external signals sensed by the associated 7TMR-
DISMED2 domain (seven-transmembrane receptor with diverse intracellular signaling 
modules, [213]). 
The PA3311 gene product is a conserved hypothetical protein and another example of a 
GGDEF-EAL fusion protein. Additionally it harbors an N-terminal MHYT domain which has 
been suggested to be able to sense oxygen, carbon monoxide or nitrogen monoxide [214]. 
Both the GGDEF and EAL domain of PA3311 are well conserved although the characteristic 
sequence motif within the GGDEF domain is changed to AGDEF. So far, the catalytic 
activity of this protein has not been described, but a mutant with a transposon insertion within 
the PA3311 coding sequence was shown to have an enhanced ability for pellicle (biofilm) 
formation [62]. 
The last gene identified by ChIP-chip and by transcriptional profiling is PA4781, which 
encodes an HD-GYP domain that is fused to an N-terminal response regulator domain. No 
gene encoding a sensor kinase is found in the genomic proximity of PA4781. The work of 
Ryan et al. [95] provides evidence that PA4781 acts as a c-di-GMP degrading enzyme which 
positively influences swarming and twitching motility and which contributes to virulence in 
the Galleria model. 
RpoS targets either identified by ChIP-chip or by transcriptional profiling 
In the ChIP experiments, RpoS also bound to the promoter regions of PA1727, encoding a 
GGDEF-EAL protein regulating alginate biosynthesis [215], and PA4108, encoding a HD-
GYP domain protein with PDE activity [95] (Table 4.1). However, these genes were 
expressed at same rates in an rpoS mutant and the respective wild-type strain [136] and no 
RpoS binding motif can be detected in their promoter region. Thus, the influence of RpoS on 
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these genes should be further tested by gel shift assays or transcriptional reporter fusion 
studies to verify RpoS dependent transcription of these genes. 
On the other hand, some promoter regions of genes for which RpoS regulated transcription 
was suggested by the transcriptome study of Schuster et al. [136] were not bound by RpoS in 
our ChIP-experiments (Table 4.1). Only one of those ten genes, PA1120 (tpbB/yfiN), harbors 
a conserved RpoS binding sequence located in the non-coding upstream region of the 
PA1121-PA1120-PA1119 operon, supporting the hypothesis of a direct RpoS regulation. For 
the remaining genes further studies are required to determine whether they are directly 
affected by RpoS, or whether their expression depend on transcription factors which in turn 
are regulated by RpoS. 
RpoS may establish a c-di-GMP signaling sub-network 
In addition to RpoS activated expression of c-di-GMP metabolizing enzymes, the ChIP-chip 
and transcriptional profiling studies also revealed a role for RpoS in the transcription of genes 
encoding for c-di-GMP binding proteins, such as the PilZ domain proteins PA2799 and 
PA4608 (Table 3.5 and Table 4.1). Thus, a whole c-di-GMP signaling sub-network seems to 
be established by RpoS upon entry into the stationary phase of growth. A strong impact of 
RpoS on c-di-GMP signaling has also been demonstrated for E. coli [100] in which RpoS 
triggers expression of c-di-GMP metabolizing proteins controlling the production of biofilm-
associated curli fimbriae. 
By promoting transcription of genes only under certain environmental (growth) conditions, 
RpoS might help to enable specificity within the complex c-di-GMP signaling network in 
which a multitude of c-di-GMP synthesizing and degrading enzymes regulate bacterial 
behavior via multiple c-di-GMP effectors. The challenge will be to identify the nature of the 
bacterial response that is triggered by RpoS controlled c-di-GMP signaling pathways in 
P. aeruginosa. 
In summary, we have successfully applied the ChIP-chip technique to an alternative sigma 
factor of P. aeruginosa providing exciting insights into the global RpoS “sigmolon” [207]. 
The use of the powerful combination of ChIP-chip and transcriptional profiling studies for the 
rapid identification of diverse regulons will be an important step on our way to understand the 
various mechanisms of gene regulation in P. aeruginosa and their interdependencies with 
other complex regulatory networks that determine bacterial behavior. 
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4.4 The decision how to live: Conclusions 
Bacteria often thrive in protected, surface-associated biofilm communities but also 
occasionally return to the planktonic mode of growth to rapidly multiply and disperse to 
colonize novel habitats. The successful transition between motile and sessile lifestyles is 
essential for fitness and survival of microorganisms and requires the sensing and integration 
of various environmental cues into an adaptive response. 
Based on results of this thesis, a model is provided of how Pseudomonas aeruginosa – and 
most likely other bacterial species – can use different mechanisms to determine an appropriate 
response to changes in its surroundings (Figure 4.2). One way is to directly react in a 
behavioral manner upon sensing of environmental cues. This mechanism is for instance 
enabled by the chemotaxis machinery that promotes swimming motility into a favorable 
direction upon detection of a substrate gradient. Moreover, as demonstrated in this thesis, the 
 
 
 
Figure 4.2. Model of how bacteria can use different mechanisms to integrate extra- and 
intracellular signals into the regulation of motility versus sessility. 
Some bacterial signaling systems are able to transmit perceived signals to associated regulators which directly 
influence motility or biofilm formation. Other signal systems translate sensed signals into the second messenger 
c-di-GMP which is a key player in the regulation of motility versus sessility by binding to diverse effector 
molecules. Alternatively, sensing of certain signals first trigger a switch in gene expression by the activation of 
transcriptional regulators (TR). This may lead to the production of factors directly required for a motile or sessile 
lifestyle and/or to the expression of other regulatory pathways which control bacterial behavior on the single-cell 
level. 
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Che1 chemotaxis system of P. aeruginosa also plays an important role in efficient surface 
sampling and the formation of biofilm structures. It will be interesting to see whether the 
chemotaxis system also influences biofilm formation in other bacterial species. 
A second possibility to integrate environmental signals into regulatory pathways that control 
the transition between a motile or a sessile lifestyle is via the c-di-GMP signaling system. In 
this case, external or cellular cues are firstly translated into the second messenger c-di-GMP, 
which then can bind to diverse effector molecules able to interfere with motility or biofilm 
formation. Many details of the c-di-GMP network are still uncharacterized, but tools such as 
presented in this thesis will significantly contribute to the analysis and thus understanding of 
this complex signaling system. 
Changes in the environment can also trigger the activation of transcriptional regulators 
causing a switch in gene expression. This may lead to the selective production of factors 
directly required for motility or biofilm formation. Alternatively, other regulatory systems 
might be expressed enabling the integration of further signals and thus a fine-tuning of the 
bacterial output response that determines bacterial behavior. For example, in this thesis we 
demonstrated that the alternative sigma factors RpoS regulates transcription of genes being 
part of the GacS/GacA and/or the c-di-GMP signaling system. Future studies will reveal how 
other sigma factors and global regulators contribute to the careful decision whether to settle 
down or move away. 
Overall, bacteria can rely on diverse traits to regulate the transition between motile planktonic 
and sessile multicellular lifestyles. Knowledge on factors that are essential for the switch 
between both lifestyles is an important step on our way to counteract problems caused by the 
persistent, biofilm-associated mode of growth. 
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5 Appendix 
 
Table 5.1. Genes encoding GGDEF and/or EAL/HD-GYP domains in P. aeruginosa PA01. 
PA number Gene name I-site 
motifa 
GGDEF 
sequence 
EAL or 
HD-GYP 
sequence 
Partner domainsb Selected 
references 
PA0169 siaD yes GGEEF   [62, 216] 
PA0290  yes GGEEF  PAC [62] 
PA0338  yes GGEEF  PAC [62] 
PA0847  yes GGDEF  TM, CHASE4, HAMP, PAS, PAC [62] 
PA1107 roeA yes GGEEF  TM [62, 217] 
PA1120 tpbB, yfiN yes GGDEF  TM, HAMP [62, 126, 218, 219] 
PA1851  yes GGEEF  TM [62] 
PA2771  yes GGEEF  GAF [62] 
PA2870  yes GGEEF   [62] 
PA3177  yes GGEEF   [62] 
PA3343  yes GGEEF  TM [62] 
PA3702 wspR yes GGEEF  REC [40, 62, 145, 220] 
PA4332 sadC yes GGEEF  TM [62, 217, 221] 
PA4396  yes DEQHF  REC [62] 
PA4843  yes GGEEF  REC [62] 
PA4929  yes GGDEF  7TMR-DISMED2 [62] 
PA5487  yes GGEEF   [62] 
PA0285  no GGDEF ESL TM, PAS, PAC [62] 
PA0575  yes GGDEF EAL TM, SBP bac 3, PAS, PAC [62] 
PA0861 rbdA yes GGDEF ELL TM, PAS [62, 210] 
PA1181  yes GGDEF ELL MASE1, PAS, PAC [62] 
PA1433  no RGGEF KVL TM, HAMP [62] 
PA1727 mucR yes GGDEF EAL TM, MHYT [62, 215] 
PA2072  yes GGDEF EAL TM, CHASE4, PAS [62] 
PA2567  no SPTRF EAL GAF [62] 
PA3258 rapA no GGDDF EAL CBS [62, 222] 
PA3311  yes AGDEF EAL TM, MHYT [62] 
PA4367 bifA no GGDQF EAL TM [62, 223] 
PA4601 morA no GGDEF EAL TM, PAS, PAC [62, 126, 224] 
PA4959 fimX no GDSIF EVL REC [62, 99, 225] 
PA5017  no ASNEF EAL GAF, PAS, PAC [62, 149] 
PA5295  no GSDEF EAL  [62] 
PA5442  no SGDEF EAL TM, PAC, PAS [62] 
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Table 5.1. (Continued) 
PA number Gene name I-site 
motifa 
GGDEF 
sequence 
EAL or 
HD-GYP 
sequence 
Partner domainsb Selected 
references 
PA2133  - - ETL  [62] 
PA2200  - - EAL  [62] 
PA2572  - - YN-GYP REC [95] 
PA2818 arr - - EAL TM [62, 226] 
PA3825  - - EVL TM [62] 
PA3947 rocR - - EVL REC [62, 143, 227] 
PA4108  - - HD-GYP  [95] 
PA4781  - - HD-GYP REC [95] 
a
 RXXD motif located five amino acids in front of the GGDEF sequence 
b as listed by Kulasakara et al. [62] 
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Table 5.2. Genes identified by ChIP-chip that were enriched at least 0.5 log2-fold. 
           
RpoS ChIP-chip  RpoS consensus sequence (revised, 300 bp upstream)  Transcriptome 
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PA0001 dnaA     0.54 93  5.89 tccgGCTACAATaggc  55  0 
PA0016 trkA     0.65 6  0.00    0 
PA0026 plcB     0.87 68  5.84 tcagGCTTCACTcact  26  2.40 
PA0051 phzH     0.58 4  5.29 ctgtTCTATCATtggc  185  0 
PA0052      0.87 -2  6.51 gccgGCTTGACTgagg  40  7.10 
PA0053      0.75 505  6.10 cgttACTATGCTcgaa  0  0 
PA0081   x   0.62 90  4.85 tgccGCAAGGCTtgtc  231  0 
PA0082   x   0.62 276  4.48 tgccACAAGAATtttg  128  0 
PA0094   x   0.90 254  3.58 acgtCCATCACTggcg  232  -2.40 
PA0095   x   0.90 -2  5.92 cgcgCCTATGCTgctt  65  0 
PA0105 coxB     0.93 245  7.84 gctgTCTATACTccca  151  18.30 
PA0109   x   1.60 26  0.00    16.40 
PA0110   x   1.60 -12  0.00    3.10 
PA0122      0.80 139  3.96 ccagCCTATAGTgaag  126  1.7 
PA0179      1.19 200  6.71 attgTCTTTACTggaa  115  15.00 
PA0195 pntAA     0.63 454  4.57 gtgaGCTAGACCtccg  72  2.00 
PA0296   x   0.62 287  4.48 ttcgGATTGACTcata  60  0 
PA0297 spuA  x   0.62 -10  6.24 caacGCTAAGCTcggc  47  0 
PA0309   x   0.69 36  0.00    0 
PA0310   x   0.69 11  2.57 cggcGAAAGCCTcgtc  30  0 
PA0311   x   0.63 182  2.10 acagAGTAGCCTgccg  235  0 
PA0312   x   0.63 82  6.37 cagtTCTATCCTaagg  187  1.8 
PA0314   x   0.63 83  6.24 cccgGCTAAGCTgaac  60  2.40 
PA0315   x   0.63 208  5.92 cgggCCTATGCTgttc  256  4.10 
PA0330 rpiA  x   0.55 158  6.74 ggccGCTATAATtcgt  128  0 
PA0331 ilvA1  x   0.55 98  3.57 ctggAGTAGACTccgg  42  0 
PA0332      0.64 57  6.24 ggctGCTAAGCTtcac  93  2.1 
PA0354      1.24 80  6.74 ctgcGCTATAATcgcg  34  0 
PA0366   x   1.22 160  4.68 agagTATTTACTctag  113  0 
PA0367   x   1.22 128  5.78 acctTCTACGCTgtca  59  0 
PA0376 rpoH     1.56 77  6.97 gagtGCTACACTgcgc  37  0 
PA0380      0.64 12  6.56 tcggGCTAGAATgccg  41  0 
PA0394   x   1.07 11  3.00 agcaGGTAGAATgccg  189  0 
PA0395 pilT  x   1.07 202  0.00    0 
PA0397   x   0.70 61  5.67 attgCCTATCCTgtag  47  2.40 
PA0398   x   0.70 91  5.99 ctccGCTAACCTgcgg  53  0 
PA0422      1.13 56  4.82 tgccGCTAGTCTtgag  37  0 
PA0432 sahH  x   0.64 193  6.74 cgccGCTATAATcgcc  173  0 
PA0433   x   0.64 94  2.67 caggCCTAGGCCtgct  190  0 
PA0450   x   1.20 296  4.25 caagACATAACTtgtc  62  0 
PA0451   x   1.20 82  7.13 ctggACTAGACTgaga  105  2.40 
PA0455 dbpA  x   0.63 19  7.64 ggctGCTAGACTagcc  40  1.9 
PA0456   x   0.63 327  5.22 gttcGCTTTCCTcagt  184  0 
PA0458   x   2.15 180  6.63 cttcTCTATGCTtggg  38  0 
PA0459   x   2.15 439  2.05 aactGCATTACCgcca  145  18.30 
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PA0482 glcB  x   0.71 312  1.42 ctggTCTAGAGCagag  23  0 
PA0483   x   0.71 -7  7.13 cttgCCTATACTcccg  34  5.20 
PA0484      1.37 38  1.35 ACTCCCATtcgt  31  10.3 
PA0506      0.70 13  6.69 atggGCTTTACTgaga  249  5 
PA0547   x   2.03 25  7.13 cggtACTAGACTgcgc  16  0 
PA0548 tktA  x   2.03 220  4.82 tgtaTCAAAAATtttt  201  0 
PA0563      0.76 186  6.97 tacgGCTACACTgtgc  89  0 
PA0577 dnaG     0.63 41  6.61 aattGCTATGCTgccg  47  0 
PA0588      1.64 212  6.00 tcttCCTTTACTccgt  229  4.7 
PA0607 rpe     0.69 54  5.89 aacgGCTACAATgcgc  41  0 
PA0610 prtN     0.50 104  2.84 ccgcTCTACAACttca  80  0 
PA0652 vfr  x   0.70 240  3.20 gagcTCTCCGCTgagc  101  0 
PA0653   x   0.70 30  6.24 ctgtGCTAAGCTggcg  37  0 
PA0671   x   0.86 154  3.53 acagCAAATACTgtat  158  0 
PA0672 hemO  x   0.86 150  4.54 gcatCCTTTCCTgtga  109  0 
PA0704      0.58 126  4.75 atggGCTATACCtccc  96  24.20 
PA0715      0.74 439  5.26 ttttTCTCTACTggga  173  0 
PA0730      0.81 319  4.54 ccggCCTTTCCTgccc  219  1.9 
PA0732      0.58 5  6.24 cgacGCTAAGCTgaat  63  1.9 
PA0743      0.51 71  6.26 agcgTCTAAGCTgttt  57  4 
PA0759   x   0.86 138  5.55 gagtTCTATGATgacg  42  0 
PA0760   x   0.86 133  6.05 ccgcCCTATAATgccg  34  0 
PA0769      0.77 56  6.47 aataACTACACTgaca  23  1.8 
PA0775      0.66 17  5.89 ctcgGCTACAATtcgg  47  0 
PA0788      1.03 71  7.13 gacaACTAGACTtccc  23  3.10 
PA0789      0.61 493  4.38 atccGCTTCCCTaccc  70  0 
PA0805   x   0.94 493  4.72 ggaaACTTTCCTgcca  177  0 
PA0806   x   0.94 66  4.48 gcctGATTGACTttca  207  0 
PA0826.2 ssrA   x  0.60 20  n.d.    n.d. 
PA0833      1.69 66  6.61 cttgGCTATGCTctaa  68  0 
PA0837 slyD     0.85 -3  5.56 caggACAAGACTgcca  155  0 
PA0838      2.30 178  6.24 aactGCTAAGCTggta  156  3.4 
PA0858      0.75 106  7.64 ctgcGCTAGACTacgc  121  0 
PA0861      1.32 264  7.13 agccACTAGACTccta  169  2.60 
PA0872 phhA  x   0.59 41  5.00 tccgTCAAGAATatgt  214  0 
PA0873 phhR  x   0.59 241  2.29 gtcaCATATTCTtgac  80  0 
PA0887.1    x  0.90 22  n.d.    n.d. 
PA0888 aotJ     0.66 196  6.69 atttGCTTTACTcatt  276  0 
PA0905 rsmA     0.58 161  6.26 ctggTCAATACTgggt  100  2.1 
PA0905.1    x  0.54 -8  n.d.    n.d. 
PA0905.2    x  0.56 60  n.d.    n.d. 
PA0916   x   1.34 29  6.56 tgccGCTAGAATtgcg  63  2.50 
PA0917 kup  x   1.34 216  5.99 gGCTAACCTcggt  245  0 
PA0928 gacS  x   0.78 85  7.46 acccGCTAAACTgcgc  71  0 
PA0929   x   0.78 99  2.70 atcgTGAATACTggca  41  0 
PA0938      0.69 15  6.40 cagtTCTAAAATaact  116  0 
PA0945 purM  x   0.63 58  4.60 cgtgGCAAGCCTgata  98  0 
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PA0946   x   0.63 154  4.18 gcgtGCAACGCTgttt  163  0 
PA0962   x   1.01 284  4.16 ggatTATAGCCTgaaa  243  0 
PA0963 aspS  x   1.01 154  6.74 tcagGCTATAATcccc  202  0 
PA0968      0.57 2  4.49 tggtTCTAGAGT  8  0 
PA0976.1    x  0.88 6  n.d.    n.d. 
PA1003 mvfR     0.62 480  5.84 ttgcGCTTCACTgacc  164  0 
PA1004 nadA     0.69 209  4.37 cgggTATAAAATcgag  45  0 
PA1013.1    x  0.78 3  n.d.    n.d. 
PA1014      2.42 164  5.22 tgcaGCTTTCCTagga  205  0 
PA1040   x   0.70 96  4.82 tcagGCTAGTCTtggc  35  0 
PA1041   x   0.70 33  6.71 ggggTCTTTACTccct  49  29.2 
PA1054      0.50 240  6.24 tcttGCTAAGCTtcaa  250  1.8 
PA1064   x   0.51 10  0.00    0 
PA1065   x   0.51 8  0.00    2.80 
PA1074 braC  x   0.76 124  6.99 ccgcTCTACACTgtac  115  0 
PA1075   x   0.76 173  4.40 agtGCTCCACTcttc  295  0 
PA1076      0.87 15  7.64 cctgGCTAGACTgatt  36  0 
PA1097 fleQ     0.89 197  5.82 tttgACTTAACTagtg  104  0 
PA1113      0.90 455  5.99 cggtGCTAACCTgcgg  38  0 
PA1117      0.50 40  6.56 ggctGCTAGAATatcc  59  2.4 
PA1118      2.20 37  7.64 ggatGCTAGACTga  10  3.00 
PA1127   x   0.57 85  4.49 gtgaTCTAGAGTaatc  71  0 
PA1128   x   0.57 48  5.05 tggcTCAATGCTgcat  42  0 
PA1157      0.53 61  5.89 attgGCTACAATgcgg  66  0 
PA1168      0.88 203  5.50 ggttTCTTTGCTgttt  61  0 
PA1176 napF     0.77 3  0.00    39 
PA1177 napE  x   1.02 8  6.44 agggTCTAGGCTttct  39  50.00 
PA1178 oprH  x   1.02 212  3.88 aaagCCTAGACCctac  188  0 
PA1190      1.09 46  7.13 cgttCCTATACTgcga  111  3.30 
PA1199      1.18 86  3.65 ggaaGCATTCCTcacc  27  0 
PA1208      0.65 21  1.55 tgggTCCATACTttgc  118  0 
PA1284   x   0.66 137  2.98 ctggCCTATAACtcgc  68  0 
PA1285   x   0.66 -7  1.35 gagtTATAGGCCagcg  69  0 
PA1289      0.94 67  6.47 tttcACTACACTtcaa  103  30.60 
PA1290   x   0.53 -2  5.09 gcgtGCTAGCATgaac  41  0 
PA1291   x   0.53 112  3.80 gcctTCTTACATaccg  101  0 
PA1299      0.71 64  7.13 ggggACTAGACTatcg  37  0 
PA1304   x   0.58 140  0.83 cgcgCCTACCCAccga  85  0 
PA1305   x   0.58 7  5.27 agcgGCTATCATaagc  43  0 
PA1317 cyoA     1.15 506  5.04 atccGCTTGCCTtctc  154  0 
PA1333      0.62 72  6.95 gggaCCTAGACTcaat  98  0 
PA1342   x   0.71 93  6.47 tgccACTACACTgttc  129  1.6 
PA1343   x   0.71 357  5.06 cacgTCTTGCCTtcct  40  0 
PA1366      0.91 222  4.40 atgGCTTTGATgcta  297  2.70 
PA1414      0.86 31  0.22 ccgcAGTAAAGTtgtt  24  0 
PA1415      1.26 -7  5.67 acgCCTATCCTtctg  41  2.30 
PA1421 gbuA  x   0.74 105  2.62 gaccCCTAAAACaacc  34  0 
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PA1422 gbuR  x   0.74 100  7.64 agcgGCTAGACTtcgc  82  2.30 
PA1430 lasR     1.62 289  3.66 ttcgCATAAAATgtga  293  2.40 
PA1440   x   1.07 61  5.39 ctggACTACAATccag  41  0 
PA1441   x   1.07 125  2.12 tgctCCATCCCTtgcg  51  0 
PA1474   x   0.73 175  7.82 ggccGCTATACTggtg  201  0 
PA1475 ccmA  x   0.73 109  3.87 cctaTCTCGGCTggca  196  0 
PA1525 alkB2  x   0.62 157  2.11 tgatCCTTTTATccag  174  0 
PA1526   x   0.62 22  2.03 catcCATATACCcccg  42  0 
PA1528 zipA     0.56 115  3.91 gcagTGTAAACTtgtg  153  0 
PA1544 anr  x   1.49 194  3.32 gaatTCTTCCATtgga  219  0 
PA1545   x   1.49 50  1.71 ggggGCTCAAGTtcgc  64  0 
PA1551      1.09 97  2.49 caggCGTATAATcagt  84  0 
PA1554      1.10 224  6.26 cgcgTCTAAGCTgctc  240  0 
PA1562 acnA  x   0.52 206  3.68 tcgaACAACGCTatcc  204  2 
PA1563   x   0.52 119  4.96 gccaTATACACTggac  82  0 
PA1580 gltA  x   1.28 86  4.67 tcccTCTATAGTggtg  64  0 
PA1581 sdhC  x   1.28 261  7.84 actgTCTATACTcggc  128  0 
PA1590 braB     2.65 289  5.27 atgcGCTATCATtgcc  212  0 
PA1603      0.82 -9  6.56 GCTAGAATgaag  38  0 
PA1639      0.86 86  3.98 cggcGCTCGAATtccc  88  0 
PA1644      0.55 173  3.25 taggGCAAGTCTagcc  112  0 
PA1650      1.20 162  5.48 ggggACTAACCTgggt  63  3.30 
PA1674 folE2     0.54 22  4.82 acgtCCTACCCTccgc  39  0 
PA1677   x   0.98 84  3.01 taccACTTTAGTgcgc  84  0 
PA1678   x   0.98 85  6.56 atcgGCTAGAATgtcg  44  0 
PA1727   x   1.23 182  5.17 tcgtGCAATAATatca  59  0 
PA1728   x   1.23 169  5.51 tgacGCTACCCTgaaa  134  4.30 
PA1730      2.32 197  7.66 ctgtTCTAGACTtatc  232  3.00 
PA1736      0.67 285  3.86 tGCATGAATcagt  299  0 
PA1753      1.17 1  4.64 tgctGCTAATCTgcta  47  0 
PA1754 cysB     0.72 -9  3.35 caaaCCATTAATatgg  67  1.8 
PA1758 pabB  x   0.50 164  6.05 gcgaACTAGAATtcct  37  0 
PA1759   x   0.50 -1  3.45 taccACAATGATaatg  29  0 
PA1777 oprF     0.66 -5  5.43 ttctGATAAACTtgcc  73  0 
PA1799   x   1.32 134  4.03 ggcgCATATAATgcca  41  0 
PA1800 tig  x   1.32 96  6.05 ctctACTAGAATgcat  69  0 
PA1802 clpX     0.63 75  6.24 ctccGCAATACTggcg  98  0 
PA1812 mltD     0.56 41  6.58 cattTCTAGAATcggc  42  0 
PA1838 cysI     1.11 447  5.10 ttacCATATACTcaaa  126  0 
PA1859   x   0.88 3  6.61 catcGCTATGCTtcgg  35  0 
PA1860   x   0.88 81  3.70 caggGCAATCATtgcc  72  5.60 
PA1881   x   0.71 154  7.66 ttgaTCTAGACTttcg  119  11.40 
PA1882   x   0.71 175  5.35 acgcGCTAGGATcgct  121  0 
PA1888   x   0.98 199  2.45 ccggAAAAGAATctcc  26  19.20 
PA1889   x   0.98 29  2.82 ccgcGAAAGGCTgggg  68  0 
PA1899 phzA2     1.08 311  3.09 cctgTCAAATCTggtt  196  0 
PA1929   x   0.93 309  5.53 ccgcGCTATGATcgct  80  0 
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PA1930   x   0.93 61  6.99 ccgaTCTACACTggcg  86  16.30 
PA1941      0.62 10  3.70 cgccGCAATCATcgcc  264  -2.00 
PA1951      0.58 -1  4.84 ttgaTCTAGTCTgaaa  53  42.20 
PA2009 hmgA  x   0.66 118  3.30 ttccACTCAAATtacg  108  0 
PA2010   x   0.66 41  3.67 tcaaGCTATAACgtcg  37  0 
PA2024   x   1.88 4  6.61 atggGCTATGCTtgtc  28  6.70 
PA2025 gor  x   1.88 139  4.86 cgcGCTTACCTccac  141  0 
PA2047   x   0.91 32  5.06 gggtTCTTGCCTgaaa  118  2.00 
PA2048   x   0.91 380  3.95 tcccCCTAATCTggct  256  0 
PA2072      0.74 57  6.33 ggatGCTTAACTataa  60  4.20 
PA2076      0.58 229  7.82 cctgGCTATACTggcg  261  0 
PA2196      0.71 40  7.82 cggcGCTATACTcatg  63  0 
PA2231 pslA     0.62 412  5.17 gaatGCTAAGATagct  163  6.5 
PA2246 bkdR  x   1.02 271  4.48 aactACAAGAATcgct  32  0 
PA2247 bkdA1  x   1.02 37  7.13 gaagCCTATACTgaaa  211  0 
PA2363      1.02 55  0.00    6.2 
PA2364   x   0.62 8  3.84 gcaaAATAAAATtttc  23  4.90 
PA2365   x   0.62 199  3.90 cgatGCATTGCTcccc  37  14.20 
PA2384      0.53 111  3.85 ggatGCTCGGCTtcgg  53  0 
PA2425 pvdG  x   0.98 405  5.03 tcgcGCAATGCTccgc  197  0 
PA2426 pvdS  x   0.98 237  4.94 cgacGCATGACTgcaa  230  0 
PA2466 foxA     0.58 101  3.62 tccgGCTTTACCgatt  46  0 
PA2475      0.81 40  7.84 gccaTCTATACTccct  42  3.30 
PA2501      0.89 114  7.64 tggaGCTAGACTgaca  45  0 
PA2534   x   1.22 -3  4.65 tcatTCTTCGCTctgc  80  0 
PA2535   x   1.22 120  3.69 ttttCCTTCCCTcccg  25  0 
PA2562   x   0.58 67  6.26 cggtTCTAAGCTatcg  44  1.9 
PA2563   x   0.58 288  6.61 atcaGCTATGCTgccg  223  0 
PA2571   x   1.39 77  3.52 tcagGCAAGCATagtc  36  5.80 
PA2572   x   1.39 -1  6.10 tcggACTATGCTtgcc  52  13.20 
PA2573      1.08 -7  5.85 gttgACTATCCTtagc  41  12.10 
PA2581.1    x  1.01 158  n.d.    n.d. 
PA2583.1    x  0.96 -1  n.d.    n.d. 
PA2586 gacA     0.63 225  4.26 tggcGGTATACTtagc  169  0 
PA2618      1.24 57  4.74 ctggCATAAACTtgct  36  4.10 
PA2621   x   0.97 145  4.67 aaagGCAAAGCTtttt  18  0 
PA2622 cspD  x   0.97 211  5.82 agcgCCTTGACTaact  146  0 
PA2623 icd  x   1.09 95  5.51 ctggGCTACCCTagaa  50  0 
PA2624 idh  x   1.09 262  5.24 caacGCTCTACTggcg  131  0 
PA2712      0.73 351  2.09 gctcGCACAGCTcgct  280  0 
PA2736.1    x  0.73 22  n.d.    n.d. 
PA2745   x   1.42 156  3.88 cggcCCTAGACCtatt  139  0 
PA2746   x   1.42 34  5.92 ctggACTAGGCTggaa  35  7.60 
PA2779   x   1.78 78  3.91 ggaaCCAAGCCTcgcc  53  3.00 
PA2780   x   1.78 328  5.10 ttcgCATATACTccgg  217  -3.20 
PA2790      1.96 332  6.17 caggGCTAGCCTtatc  264  0 
PA2798   x   1.04 237  4.78 actgGCAATCCTggcg  207  2.20 
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PA2799   x   1.04 8  5.45 acggTATAAACTttga  70  1.8 
PA2800   x   0.67 56  5.81 agccTATATACTgcgc  66  0 
PA2801   x   0.67 45  4.94 ctttGCATGACTagtc  87  0 
PA2813      0.72 -3  1.48 tcctTCTTCGGTccat  89  0 
PA2814   x   0.51 55  2.23 gtcaGCTTGGCCggtt  75  0 
PA2815   x   0.51 96  6.24 acggGCTAAGCTcgag  44  2.50 
PA2816      0.64 68  6.56 attgGCTAGAATcgac  42  2.00 
PA2817      0.83 21  1.90 ccgcGAAACCCTttat  42  0 
PA2823   x   1.18 44  0.00    0 
PA2824   x   1.18 37  2.08 ttctCCTCGGATcgga  74  2.30 
PA2840   x   0.56 246  5.90 ccggTCAAAACTgacc  174  0 
PA2841   x   0.56 63  4.77 gacgTCTATACCgacg  41  3.50 
PA2851 efp     0.66 25  4.17 tttgTCTTTCATccat  23  0 
PA2853 oprI     1.12 -3  4.29 tactGCTAAAGTcggg  146  0 
PA2854      0.67 66  5.24 actgTCTTTCCTactc  42  0 
PA2910   x   0.90 261  6.61 gcctGCTATGCTgccg  184  0 
PA2911   x   0.90 374  3.20 ctgcGATTTCCTgcgc  46  0 
PA2931   x   0.63 35  5.43 gatgGCTTGAATatct  93  0 
PA2932 morB  x   0.63 89  4.16 tataAATTTACTtgac  93  0 
PA2937      0.72 -1  2.39 caggGAAAACCTcgcc  28  8.40 
PA2938   x   1.14 125  3.82 attgTCTACAGTgtgc  114  0 
PA2939   x   1.14 374  4.13 cgctCCTAGTCTggca  100  137.40 
PA2958.1    x  0.76 8  n.d.    n.d. 
PA2960 pilZ     0.83 42  0.00    0 
PA2971   x   0.91 8  6.05 cgtcCCTATAATggcg  17  0 
PA2972   x   0.91 100  1.67 tagcCATAAACCgctg  61  0 
PA2975 rluC     0.58 -3  4.87 tgttTCAAGGCTttgg  218  0 
PA3016   x   0.55 195  3.91 cgccTGTAAACTgcgc  95  0 
PA3017   x   0.55 11  2.86 aatgAAAACACTatcc  32  0 
PA3019   x   1.25 49  5.56 ctcgCCTAAGCTtagc  93  0 
PA3020   x   1.25 175  6.24 aacgGCTAAGCTtagg  144  0 
PA3032 snr1     0.50 169  3.46 ttttCATAGCCTgagt  216  10.7 
PA3039   x   0.65 124  4.05 tcatTAAAGACTgcca  183  0 
PA3040   x   0.65 170  5.63 gcagTCTTTAATgaaa  118  0 
PA3046   x   0.59 58  0.99 gtcgGCTACTGTctgt  57  0 
PA3047   x   0.59 251  5.53 atttTCTACCCTccgt  31  0 
PA3050 pyrD     0.89 63  6.74 gacgGCTATAATcggc  42  0 
PA3103 xcpR  x   0.79 178  5.74 actaACAATACTgacg  75  0 
PA3104 xcpP  x   0.79 40  2.61 agtaGGTAGCCTactg  25  0 
PA3109      1.00 67  6.38 ctctGCTAAAATgcag  38  0 
PA3133      0.51 54  4.03 tatgCATATAATattt  38  0 
PA3138 uvrB  x   1.27 42  2.11 ggcgTCACAGCTccct  24  0 
PA3139   x   1.27 144  6.76 ggtgTCTATAATaacc  91  0 
PA3143      0.72 -5  0.00    0 
PA3162 rpsA     0.71 205  4.54 cccgACTTGCCTggcg  171  0 
PA3179   x   0.71 86  4.13 ccggCCTAGTCTagcg  113  3.20 
PA3180   x   0.71 60  7.64 tcccGCTAGACTaggc  45  0 
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PA3200   x   0.69 219  5.86 ccatTCTTCACTggaa  25  3.00 
PA3201   x   0.69 -5  3.92 ggttGCTATTATgccg  37  0 
PA3215   x   0.69 10  2.28 gtttAGTATCCTtggg  65  0 
PA3216   x   0.69 131  6.95 ggatACTAAACTggcc  80  3.30 
PA3223 acpD     0.66 141  5.53 attcTCTACCCTcacc  47  0 
PA3236   x   0.51 249  3.78 ggctGCTCTCCTttga  289  0 
PA3237   x   0.51 43  4.40 cctgGATAGGCTttcg  49  0 
PA3260   x   1.74 79  3.14 gcctGATAAGATggcg  30  0 
PA3261   x   1.74 23  7.82 actgGCTATACTgctg  50  2.60 
PA3288   x   0.75 35  3.10 tcagGCTAGCCCagtt  50  0 
PA3289   x   0.75 43  6.17 ctggGCTAGCCTgagg  35  2.10 
PA3300 fadD2  x   0.50 227  4.48 gaggACAAGAATaa  10  0 
PA3301   x   0.50 18  6.56 cgctGCTAGAATgcgc  44  0 
PA3309      0.59 41  4.17 ggctTCTTTCATttca  231  0 
PA3310   x   0.93 148  2.44 gcccGATAGAGTtcgg  65  0 
PA3311   x   0.93 6  3.67 acaaGCTCAGCT  8  13.30 
PA3326   x   0.64 112  6.61 catgGCTATGCTtcac  190  0 
PA3327   x   0.64 367  4.98 ccctGCAAGAATtaac  192  -4.30 
PA3338   x   0.70 1  3.92 ggcgGCTATTATaggc  38  0 
PA3339   x   0.70 66  6.05 cgcgCCTATAATagcc  41  0 
PA3340      1.65 258  6.56 ttccGCTAGAATcgcc  256  3.60 
PA3347      0.58 94  4.62 tgatTCAAGCCTtccc  42  3.7 
PA3353      0.95 19  0.00    0 
PA3418 ldh  x   1.80 69  7.13 cctgCCTATACTgaag  69  18.10 
PA3419   x   1.80 175  2.93 tgggGCTCCCCTgctt  239  0 
PA3450   x   1.17 199  1.44 gttgGGTATTCTattt  99  0 
PA3451   x   1.17 5  6.29 cccgCCTACACTgaaa  44  35.70 
PA3452 mqoA     1.06 210  1.83 acgcACTCACATcggg  96  3.8 
PA3464   x   0.99 205  2.86 cattGGTAGGCTtgcc  43  0 
PA3465   x   0.99 10  7.64 ggcgGCTAGACTttcc  47  7.70 
PA3477 rhlR     0.67 7  4.85 atcgGCAAGGCTgcgc  78  1.8 
PA3479 rhlA     0.50 260  3.19 agttACTTGTCTgccg  103  0 
PA3529   x   0.51 262  3.35 cggaCAAAGACTtagc  136  0 
PA3530   x   0.51 -4  4.37 tccaACTCAACTtccc  27  0 
PA3531 bfrB     0.97 195  4.08 tatgCCTTCAATtcaa  152  0 
PA3572      1.17 -12  7.13 caggACTAGACTgaag  43  0 
PA3573   x   0.55 339  4.36 agtgCCTTGCCTgcca  38  0 
PA3574   x   0.55 24  6.38 cgcgGCTAAAATcggt  59  0 
PA3580   x   0.83 265  3.71 cctcTCTTGTCTgttc  256  0 
PA3581 glpF  x   0.83 -2  3.65 gacaGCATTCCTttgt  86  0 
PA3621 fdxA     0.81 69  6.56 agctGCTAGAATcgcg  48  0 
PA3621.1 rsmZ   x  0.56 -5  n.d.    n.d. 
PA3629 adhC  x   0.51 121  6.99 gtttTCTACACTttcc  66  0 
PA3630   x   0.51 9  5.17 tcagGCAATAATcaaa  40  0 
PA3687 ppc  x   1.93 113  4.06 tcagACTAGACCcgat  125  0 
PA3688   x   1.93 92  5.30 accaGCTTGGCTcagg  177  12.90 
PA3722      0.58 72  2.99 tggcAATATGATgtta  61  0 
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PA3740      0.59 122  2.20 tgcaTCTAGCCAtcat  31  0 
PA3745 rpsP     0.66 60  2.57 gcgtGCATTCATtttg  41  0 
PA3786   x   0.75 134  6.63 gccgTCTATGCTggcg  140  0 
PA3787   x   0.75 36  3.93 gtttGCAACCCTtgcg  78  3.20 
PA3815      1.16 123  5.09 ttctGCTAGCATgtag  124  0 
PA3817   x   0.94 43  3.34 ctgaCCTCTGCTgtag  55  0 
PA3818   x   0.94 107  6.56 ttctGCTAGAATggcc  43  0 
PA3824 queA  x   0.98 97  2.93 ctggGCTCCCCTggaa  219  0 
PA3824.1   x x  0.98 3  n.d.    n.d. 
PA3833      0.68 9  0.00    2.40 
PA3834 valS     0.50 -7  7.82 ccccGCTATACTcccg  62  0 
PA3855      0.56 -1  5.56 atctCCTAAGCTcgcc  36  2 
PA3858   x   0.70 106  5.48 atgcGCTTTGCTaagg  173  4 
PA3859   x   0.70 189  3.87 gcgcACTTCCCTtagc  140  0 
PA3902   x   0.72 63  5.61 gccgGATAGACTgctt  40  0 
PA3903 prfC  x   0.72 156  6.74 taccGCTATAATcctg  67  0 
PA3918 moaC     0.71 45  3.89 tatgTATACAATcatc  97  0 
PA3919   x   0.99 438  4.06 taacACTAGACCtcgc  264  0 
PA3920   x   0.99 64  4.87 gatgTCAAGGCTgaac  83  0 
PA3945      1.07 77  6.47 aaagACTACACTccgg  132  5.90 
PA3956      0.65 39  5.92 ctggCCTATGCTtgac  36  0 
PA3957   x   1.10 53  1.68 tgacGCAAGGGTtcgc  37  3.00 
PA3958   x   1.10 7  1.94 gcGGTACCCTcccg  59  0 
PA3974 ladS  x   0.62 188  4.29 gtgtGCTAAAGTtcgg  98  0 
PA3975 thiD  x   0.62 21  2.68 tagtGGTAAGCTcacg  16  0 
PA4005      0.65 -2  0.00    0 
PA4027      0.96 20  0.00    0 
PA4031 ppa     1.14 89  6.05 tatgCCTATAATcgcg  47  0 
PA4107   x   0.99 333  2.44 gccgCGTTTACTgtgg  21  0 
PA4108   x   0.99 -11  3.87 cccaTCTCGGCTaccg  55  0 
PA4116      1.20 64  4.16 tcctGCTACTCTtttc  44  0 
PA4241 rpsM     0.96 91  5.32 ccttTCTTGGCTtcct  47  0 
PA4242 rpmJ     0.63 15  0.00    0 
PA4249 rpsH     0.58 100  6.58 gatcTCTAGAATaccc  102  0 
PA4277 tufB     0.57 85  1.23 acccGCTCCAGTcaag  185  0 
PA4277.1    x  0.70 7  n.d.    n.d. 
PA4277.2    x  0.74 0  n.d.    n.d. 
PA4277.3    x  0.73 143  n.d.    n.d. 
PA4280.5 16S rRNA  x x  0.55 374  n.d.    n.d. 
PA4281 sbcD  x   0.55 297  5.42 ggcgTCAACACTtatt  152  0 
PA4294   x   0.61 23  1.28 ggatTAATACCTtttc  31  16.10 
PA4295 fppA  x   0.61 39  2.31 cgaaAAAAGGCTgaag  18  0 
PA4305 rcpC  x   1.15 321  5.45 tggtTCTTGAATaacg  176  11.20 
PA4306 flp  x   1.15 87  7.66 tgaaTCTAGACTcggg  192  76.00 
PA4307 pctC     0.74 162  3.74 tggaTCATGGCTttcc  82  0 
PA4311      1.73 100  6.95 ctttCCTAGACTtgaa  107  3.50 
PA4314 purU1  x   0.54 105  6.56 tgccGCTAGAATggcg  41  0 
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PA4315 mvaT  x   0.54 153  4.26 gGGTATACTccag  258  0 
PA4361   x   0.55 141  4.47 ggttGCTAGAGTcgcg  40  0 
PA4362   x   0.55 42  6.01 aaggTCTAACCTgaaa  38  9.2 
PA4366 sodB     0.59 185  5.74 ggagCCTAGGCTccga  161  0 
PA4383   x   0.70 103  6.95 gttcCCTAGACTggca  197  0 
PA4384   x   0.70 124  1.06 atgcCATCTCCTgtcg  117  0 
PA4421   x   0.52 17  4.67 gattTCTATAGTgtgc  82  0 
PA4421.1 rnpB  x x  0.52 280  n.d.    n.d. 
PA4433 rplM  x   0.51 31  5.82 ctgtCCTTGACTtgtc  76  0 
PA4434   x   0.51 213  4.16 tcgtTATAGCCTcagg  241  0 
PA4456   x   0.88 84  5.03 GCAATGCTctgt  300  0 
PA4457   x   0.88 328  4.93 cccgCCTTTAATccag  24  0 
PA4462 rpoN     0.77 192  4.03 caggCATATAATttgc  96  0 
PA4494   x   0.83 59  7.82 cttgGCTATACTcgcg  30  0 
PA4495   x   0.83 216  5.38 tggtCCAAGACTggcg  87  0 
PA4496      0.84 196  6.99 aacaTCTACACTgaac  114  0 
PA4514   x   1.07 155  3.27 attgCCAATGATattg  189  0 
PA4515   x   1.07 61  3.70 attgGCAATCATttcg  29  0 
PA4523   x   1.25 264  6.76 tatcTCTATAATgaat  126  1.80 
PA4524 nadC  x   1.25 20  4.80 aatgGCAAAAATcggg  246  0 
PA4546 pilS     0.53 210  7.46 cttgGCTAAACTgcag  271  0 
PA4568 rplU  x   0.87 195  4.54 tggcACTTGCCTcggc  164  0 
PA4569 ispB  x   0.87 44  4.54 cgggCCTTTCCTtgac  68  0 
PA4595   x   1.21 147  5.10 ctgtCATATACTtggc  47  0 
PA4596   x   1.21 344  5.89 gtctGCTACAATtgat  166  0 
PA4602 glyA3     0.82 114  3.46 atggCCTTTCATgtgc  76  0 
PA4606      1.90 119  7.66 ccgcTCTAGACTaagg  90  0 
PA4607   x   0.59 78  3.98 ctcgCCAAAGCTgcta  50  5.1 
PA4608   x   0.59 123  5.30 catgGCTTGGCTatag  46  2.90 
PA4613 katB  x   0.63 409  4.18 cgctCCTTACCTtggt  54  0 
PA4614 mscL  x   0.63 116  7.48 ttccTCTAAACTtcgt  161  3.1 
PA4631      0.82 65  6.95 tcggCCTAGACTgctg  33  0 
PA4634   x   0.57 223  2.53 tcgcAATCGACTaggg  184  0 
PA4635   x   0.57 201  3.69 tgtcCCTTCCCTcgcg  119  0 
PA4639      0.55 215  5.03 caagGCAATGCTgcgg  71  0 
PA4648      0.83 134  4.94 tcaaGCATGACTggcg  162  83.10 
PA4656   x   0.73 201  4.61 tgttCCTTGGCTgagt  162  2 
PA4657   x   0.73 211  6.24 acgcGCAATACTgtac  80  0 
PA4658      0.81 67  5.37 aagtTCTAGGATgtgt  74  0 
PA4674      0.57 496  5.03 gctcGCAATGCTtcat  191  0 
PA4675      0.70 38  3.47 ccagGCATGCCTcatt  97  0 
PA4690.5 16S rRNA   x  0.62 299  n.d.    n.d. 
PA4702      0.83 84  7.84 ctctTCTATACTcacg  39  11.20 
PA4703      0.91 169  6.97 ggccGCTACACTtctg  183  15.2 
PA4726.2   x x  0.79 93  n.d.    n.d. 
PA4727 pcnB  x   0.79 267  3.47 atccGCATGCCTtgcc  271  0 
PA4758 carA     0.83 46  3.91 attcTGTAAACTacag  135  0 
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PA4758.1    x  0.99 1  n.d.    n.d. 
PA4764 fur  x   0.72 48  5.32 actaTCTTGGCTgggc  78  0 
PA4765 omlA  x   0.72 48  2.80 tcggGCTTTTATttgc  41  0 
PA4781      1.60 58  4.79 agcgTCTTCAATacgg  59  6.2 
PA4826      1.01 226  2.77 gaggTCTATAAAaccc  223  0 
PA4837   x   0.60 44  3.89 cattTCTTTTCTggtg  21  0 
PA4838   x   0.60 96  5.79 aaatGATATACTataa  117  0 
PA4849      0.67 2  6.35 cggtGCTATCCTcgtc  36  0 
PA4856 retS     0.66 77  6.74 cttgGCTATAATccgg  38  0 
PA4874   x   0.78 87  7.64 agtcGCTAGACTtcag  53  7.50 
PA4875   x   0.78 308  7.64 cgcgGCTAGACTgacg  275  2.10 
PA4915      0.60 51  6.71 accaTCTTTACTctca  35  6.60 
PA4922 azu  x   0.63 164  3.31 ctgtGCTAAAACagga  158  0 
PA4923   x   0.63 110  5.51 agccGCTACCCTgtgc  42  0 
PA4928   x   0.76 47  2.96 cctcCCATTCCTagag  31  0 
PA4929   x   0.76 22  1.37 tatcTCTAGGAAtggg  50  4.70 
PA4935 rpsF     0.88 138  6.58 cttcTCTAGAATgtcg  123  0 
PA4971 aspP  x   1.87 108  3.34 tcgcGCTTGAGTtcgg  172  0 
PA4972   x   1.87 133  5.34 actcACTTCACTcggg  233  2.30 
PA4973 thiC  x   0.52 181  4.25 tggaCCATGACTgccg  293  0 
PA4974   x   0.52 273  3.57 tggcTCTTCGATcagt  89  0 
PA4997 msbA  x   0.64 107  6.97 ctgtGCTACACTccgg  36  0 
PA4998   x   0.64 -1  3.80 ggttTCTTACATgctg  103  0 
PA5014 glnE  x   1.32 16  4.24 taatTCTTGGATgttc  202  0 
PA5015 aceE  x   1.32 264  6.37 ggTCTATCCTgttt  279  0 
PA5033      0.51 -9  5.92 ctgtCCTATGCTgctg  57  0 
PA5036 gltB     0.90 181  4.17 ttcgTCTTTCATtttg  163  0 
PA5044 pilM  x   1.32 114  2.16 ctggTATCTAATgtga  60  0 
PA5045 ponA  x   1.32 69  6.33 attcGCTTAACTcttt  39  0 
PA5058 phaC2  x   0.62 144  3.67 acagGCTATAACtgag  77  13.5 
PA5060 phaF  x   0.69 14  0.00    0 
PA5103      1.15 120  3.92 agcgTCTACACCgaaa  115  4.60 
PA5110 fbp     0.71 87  1.82 cgtcGATCGGCTgcgc  131  0 
PA5143 hisB  x   0.72 53  6.05 cctgCCTATAATgctg  54  0 
PA5144   x   0.72 106  1.84 cacaGCTAACACtgca  147  0 
PA5156      1.14 324  3.97 tgccGCTTGCATcgtg  294  0 
PA5160.1    x  1.05 -4  n.d.    n.d. 
PA5161 rmlB     0.64 236  4.02 ttcgAATAGAATgccg  157  0 
PA5170 arcD     0.82 226  5.86 aatgTCTTCACTctca  35  2.80 
PA5195   x   0.65 132  2.37 aggcGATCCACTcgcg  191  0 
PA5196   x   0.65 76  6.56 ccctGCTAGAATgccg  102  2.8 
PA5208   x   1.22 10  7.13 gtggCCTATACTtttc  37  1.8 
PA5209   x   1.22 102  3.71 cgcgCCTTTGATctgg  60  0 
PA5210      0.67 28  1.56 GCTTCGCCgcta  37  0 
PA5253 algP  x   0.82 58  4.78 gcggGCAATCCTggcg  100  0 
PA5254   x   0.82 66  4.06 ccatACTAGACCcgca  92  0 
PA5282   x   0.61 93  2.23 ttaaGCACAAATccga  123  0 
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PA5283   x   0.61 68  6.33 ttgtGCTTAACTgttc  41  0 
PA5285      1.06 86  5.48 tataACTAACCTgctt  34  0 
PA5286      0.63 1  6.56 ccgcGCTAGAATgcgc  47  0 
PA5288 glnK  x   1.16 368  2.78 gcACTATCCCcggg  298  0 
PA5289   x   1.16 70  7.64 tcgtGCTAGACTgccg  37  0 
PA5300 cycB     0.84 208  4.85 tgccGCAAGGCTttgc  147  0 
PA5304 dadA     0.55 30  7.13 tcttCCTATACTgcgc  71  0 
PA5319 radC  x   0.83 25  5.17 atggGCTAAGATagca  57  0 
PA5320 coaC  x   0.83 113  4.60 taagGCAAGCCT  8  0 
PA5343   x   0.63 105  6.29 gacgCCTACACTgccc  39  0 
PA5344   x   0.63 31  6.61 agccGCTATGCTtggc  34  0 
PA5346 sadB     1.21 50  2.52 tccaGCTCGCATggtc  17  0 
PA5347      0.56 34  5.89 aacaGCTACAATgcgc  43  0 
PA5359   x   0.59 48  5.06 ggTCTTGCCTcggg  102  6.50 
PA5360 phoB  x   0.59 55  2.99 cgagGCAAGACC  8  0 
PA5369.5 16S rRNA   x  0.53 411  n.d.    n.d. 
PA5424      0.52 96  6.99 ctttTCTACACTgtcc  59  4 
PA5426 purE  x   1.21 189  4.26 ttgcGGTATACTgcgc  127  0 
PA5427 adhA  x   1.21 157  2.34 ggggGCTACCGTccgt  192  0 
PA5438   x   0.84 78  1.05 acggCGTTGGCTgggc  69  0 
PA5439   x   0.84 6  1.92 ctgtAGTAACCTtgta  64  0 
PA5491   x   0.71 3  4.73 gaagTATATAATgccg  116  0 
PA5492   x   0.71 179  5.81 gcatTATATACTtccg  73  0 
PA5528   x   0.68 49  4.59 gcagACTAGCATccgc  294  0 
PA5529   x   0.68 311  4.82 ggatGCTAGTCTgcgg  73  0 
PA5536   x   0.67 19  1.73 ttgtTATAGTATaacg  36  0 
PA5537   x   0.67 92  5.51 tccgGCTACCCTgggc  35  0 
PA5561 atpI         0.66 148   7.13 ccccCCTATACTctgc  97   0 
a
 Genes with an RpoS consensus box (> 6.0) are underlined, genes differentially expressed in an rpoS mutant in 
bold 
b
 Enriched promoter region could belong to two adjacent genes on opposite strands 
c
 Non-coding gene, for which consensus sequence and transcriptome were not determined (n.d.) 
d
 Low scoring (< 6.0) consensus sequences are in italics  
e
 as described by Schuster et al. [136] 
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Table 5.3. Genes identified by ChIP-chip, that also possess an upstream RpoS sequence motif 
and exhibited a difference of gene expression in an rpoS mutant [136]. 
      
ChIP-chip  Revised consensus box 300 bp upstream  Transcriptome
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PA0052  
 
0.87 -2  6.51 gccgGCTTGACTgagg 40  7.1 
PA0105 coxB  0.93 245  7.84 gctgTCTATACTccca 151  18.3 
PA0179   1.19 200  6.71 attgTCTTTACTggaa 115  15.0 
PA0312   0.63 82  6.37 cagtTCTATCCTaagg 187  1.8 
PA0314   0.63 83  6.24 cccgGCTAAGCTgaac 60  2.4 
PA0332   0.64 57  6.24 ggctGCTAAGCTtcac 93  2.1 
PA0451   1.20 82  7.13 ctggACTAGACTgaga 105  2.4 
PA0455 dbpA  0.63 19  7.64 ggctGCTAGACTagcc 40  1.9 
PA0483   0.71 -7  7.13 cttgCCTATACTcccg 34  5.2 
PA0506   0.70 13  6.69 atggGCTTTACTgaga 249  5.0 
PA0588   1.64 212  6.00 tcttCCTTTACTccgt 229  4.7 
PA0732   0.58 5  6.24 cgacGCTAAGCTgaat 63  1.9 
PA0743   0.51 71  6.26 agcgTCTAAGCTgttt 57  4.0 
PA0769   0.77 56  6.47 aataACTACACTgaca 23  1.8 
PA0788   1.03 71  7.13 gacaACTAGACTtccc 23  3.1 
PA0838   2.30 178  6.24 aactGCTAAGCTggta 156  3.4 
PA0861   1.32 264  7.13 agccACTAGACTccta 169  2.6 
PA0905 rsmA  0.58 161  6.26 ctggTCAATACTgggt 100  2.1 
PA0916   1.34 29  6.56 tgccGCTAGAATtgcg 63  2.5 
PA1041   0.70 33  6.71 ggggTCTTTACTccct 49  29.2 
PA1054   0.50 240  6.24 tcttGCTAAGCTtcaa 250  1.8 
PA1117   0.50 40  6.56 ggctGCTAGAATatcc 59  2.4 
PA1118   2.20 37  7.64 ggatGCTAGACTga 10  3.0 
PA1177 napE  1.02 8  6.44 agggTCTAGGCTttct 39  50.0 
PA1190   1.09 46  7.13 cgttCCTATACTgcga 111  3.3 
PA1289   0.94 67  6.47 tttcACTACACTtcaa 103  30.6 
PA1342   0.71 93  6.47 tgccACTACACTgttc 129  1.6 
PA1422 gbuR  0.74 100  7.64 agcgGCTAGACTtcgc 82  2.3 
PA1730   2.32 197  7.66 ctgtTCTAGACTtatc 232  3.0 
PA1881   0.71 154  7.66 ttgaTCTAGACTttcg 119  11.4 
PA1930   0.93 61  6.99 ccgaTCTACACTggcg 86  16.3 
PA2024   1.88 4  6.61 atggGCTATGCTtgtc 28  6.7 
PA2072   0.74 57  6.33 ggatGCTTAACTataa 60  4.2 
PA2475   0.81 40  7.84 gccaTCTATACTccct 42  3.3 
PA2562   0.58 67  6.26 cggtTCTAAGCTatcg 44  1.9 
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Table 5.3. (Continued) 
      
ChIP-chip  Revised consensus box 300 bp upstream  Transcriptome
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PA2572   1.39 -1  6.10 tcggACTATGCTtgcc 52  13.2 
PA2815   0.51 96  6.24 acggGCTAAGCTcgag 44  2.5 
PA2816   0.64 68  6.56 attgGCTAGAATcgac 42  2.0 
PA3216   0.69 131  6.95 ggatACTAAACTggcc 80  3.3 
PA3261   1.74 23  7.82 actgGCTATACTgctg 50  2.6 
PA3289   0.75 43  6.17 ctggGCTAGCCTgagg 35  2.1 
PA3340   1.65 258  6.56 ttccGCTAGAATcgcc 256  3.6 
PA3418 ldh  1.80 69  7.13 cctgCCTATACTgaag 69  18.1 
PA3451   1.17 5  6.29 cccgCCTACACTgaaa 44  35.7 
PA3465   0.99 10  7.64 ggcgGCTAGACTttcc 47  7.7 
PA3945   1.07 77  6.47 aaagACTACACTccgg 132  5.9 
PA4306 flp  1.15 87  7.66 tgaaTCTAGACTcggg 192  76.0 
PA4311   1.73 100  6.95 ctttCCTAGACTtgaa 107  3.5 
PA4362   0.55 42  6.01 aaggTCTAACCTgaaa 38  9.2 
PA4523   1.25 264  6.76 tatcTCTATAATgaat 126  1.8 
PA4614 mscL  0.63 116  7.48 ttccTCTAAACTtcgt 161  3.1 
PA4702   0.83 84  7.84 ctctTCTATACTcacg 39  11.2 
PA4703   0.91 169  6.97 ggccGCTACACTtctg 183  15.2 
PA4874   0.78 87  7.64 agtcGCTAGACTtcag 53  7.5 
PA4875   0.78 308  7.64 cgcgGCTAGACTgacg 275  2.1 
PA4915   0.60 51  6.71 accaTCTTTACTctca 35  6.6 
PA5196   0.65 76  6.56 ccctGCTAGAATgccg 102  2.8 
PA5208   1.22 10  7.13 gtggCCTATACTtttc 37  1.8 
PA5424   0.52 96  6.99 ctttTCTACACTgtcc 59  4.0 
a
 as described by Schuster et al. [136] 
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